Section 73

EurekaMag Full Text Articles Chapter 72,180


Dickson, I. 2018: NASH: Successful phase II trial of FGF19 analogue. Nature Reviews. Gastroenterology and Hepatology 15(5): 256
Neuschwander-Tetri, B.A. 2010: NASH: Thiazolidinediones for NASH--one pill doesn't fix everything. Nature Reviews. Gastroenterology and Hepatology 7(5): 243-244
Greenhill, C. 2017: NASH: Understanding how steatosis progresses to NASH. Nature Reviews. Endocrinology 13(1): 5
Gariani, K.; Jornayvaz, F.ço.R. 2020: NASH: a less known but severe complication of diabetes. Revue Medicale Suisse 16(697): 1197-1199
Spahr, L.; Giostra, E.; Negro, F.; Goossens, N. 2020: NASH: new terminology and what else is new in 2020. Revue Medicale Suisse 16(704): 1544-1547
Neuschwander-Tetri, B.A. 2014: NASH: the tribulations of conducting NASH trials. Nature Reviews. Gastroenterology and Hepatology 11(5): 274-276
Zheng, M.; Wang, Z.; Ru, Q.; Fu, H.; Zhang, J.; Pan, Z.; Wang, J.; Xie, Q.; Zhao, X. 2022: NASICON type KTi2(PO4)3 decorated by NTCDA-derived carbon layer for enhanced lithium/sodium storage. Journal of Colloid and Interface Science 606(Part 2): 1906-1917
Wu, M.; Ni, W.; Hu, J.; Ma, J. 2019: NASICON-Structured NaTi 2 (PO 4 ) 3 for Sustainable Energy Storage. Nano-MicroLetters 11(1): 44
Chen, M.; Hua, W.; Xiao, J.; Cortie, D.; Chen, W.; Wang, E.; Hu, Z.; Gu, Q.; Wang, X.; Indris, S.; Chou, S-Lei.; Dou, S-Xue. 2019: NASICON-type air-stable and all-climate cathode for sodium-ion batteries with low cost and high-power density. Nature Communications 10(1): 1480
Yousif, A.; Drou, N.; Rowe, J.; Khalfan, M.; Gunsalus, K.C. 2020: NASQAR: a web-based platform for high-throughput sequencing data analysis and visualization. Bmc Bioinformatics 21(1): 267
Marzo, E.; Montbrau, C.; Moreno, M.-C.; Roca, M.è; Sitjà, M.; March, R.; Gow, S.; Lacoste, S.; Ellis, J. 2021: NASYM, a live intranasal vaccine, protects young calves from bovine respiratory syncytial virus in the presence of maternal antibodies. Veterinary Record 188(11): E83
Zhao, C.; Cai, X.; Wang, Y.; Wang, D.; Wang, T.; Gong, H.; Sun, H.; Jia, Q.; Zhou, W.; Wu, Z.; Li, Z.; Xiao, J. 2020: NAT1 promotes osteolytic metastasis in luminal breast cancer by regulating the bone metastatic niche via NF-κB/IL-1B signaling pathway. American Journal of Cancer Research 10(8): 2464-2479
Tao, W.; Tian, G.; Xu, S.; Li, J.; Zhang, Z.; Li, J. 2021: NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC. Cancer Cell International 21(1): 413
Zhang, Y.; Jing, Y.; Wang, Y.; Tang, J.; Zhu, X.; Jin, W-Lin.; Wang, Y.; Yuan, W.; Li, X.; Li, X. 2021: NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduction and Targeted Therapy 6(1): 173
Headriawan, A.; Pramono, A.A.; Sukadi, A.; Chairulfatah, A.; Maskoen, A.M.; Nataprawira, H.M. 2021: NAT2 Gene rs1041983 is Associated with Anti-Tuberculosis Drug Induced Hepatotoxicity Among Pediatric Tuberculosis in Bandung, Indonesia. Application of Clinical Genetics 14: 297-303
Lakkakula, S.; Mohan Pathapati, R.; Chaubey, G.; Munirajan, A.Kannan.; Lakkakula, B.Vks.; Maram, R. 2014: NAT2 genetic variations among South Indian populations. Human Genome Variation 1: 14014
Wang, C.-L.; Liu, Z.-P.; Guo, L. 2021: NAT2 knockdown inhibits the development of colorectal cancer and its clinical significance. European Review for Medical and Pharmacological Sciences 25(9): 3460-3469
Yuliwulandari, R.; Susilowati, R.Wilujeng.; Wicaksono, B.Dani.; Viyati, K.; Prayuni, K.; Razari, I.; Kristin, E.; Syafrizal; Subagyo; Sri Diana, E.; Setiawati, S.; Ariyani, A.; Mahasirimongkol, S.; Yanai, H.; Mushiroda, T.; Tokunaga, K. 2016: NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis. Journal of Human Genetics 61(6): 533-537
Luo, S.; Surapaneni, A.; Zheng, Z.; Rhee, E.P.; Coresh, J.; Hung, A.M.; Nadkarni, G.N.; Yu, B.; Boerwinkle, E.; Tin, A.; Arking, D.E.; Steinbrenner, I.; Schlosser, P.; Köttgen, A.; Grams, M.E. 2020: NAT8 Variants, N-Acetylated Amino Acids, and Progression of CKD. Clinical Journal of the American Society of Nephrology: Cjasn 16(1): 37-47
Bhargava, S.; Chopra, K.K.; Arora, V.K. 2021: NATCON virtual 2020 - Challenges and way ahead. Indian Journal of Tuberculosis 68(1): 1-2
Fluge, Øystein.; Bruland, O.; Akslen, L.A.; Varhaug, J.E.; Lillehaug, J.R. 2002: NATH, a novel gene overexpressed in papillary thyroid carcinomas. Oncogene 21(33): 5056-5068
Quinn, J.M.; Bencko, V.ír.; Bongartz, A.V.; Stoeva, P.; Atanasoska Arsov, A.; De Porzi, S.; Bohonek, M.; Ti, R.; Taylor, J.; Mitchell, J.; Reinhard, V.; Majovsky, P.; Kuca, J.; Kral, P.; Fazekas, L.; Bubenik, Z. 2020: NATO and evidence-based military and disaster medicine: case for Vigorous Warrior Live Exercise Series. Central European Journal of Public Health 28(4): 325-330
Schiermeier, Q. 2003: NATO reform promises more publicity for less science. Nature 422(6929): 248
Ansell, W.F. 1964: Natural History of Aggression. Nature 202: 1032
Brochard, C.èn.; Rabilloud, M.-L.; Hamonic, S.ép.; Bajeux, E.; Pagenault, M.ël.; Dabadie, A.; Gerfaud, A.; Viel, J.-F.ço.; Tron, I.; Robaszkiewicz, M.; Bretagne, J.-F.ço.; Siproudhis, L.; Bouguen, G.; Cruchant, E.; Alexandre, J.-L.; Arnaud Seyrig, J. 2022: Natural History of Perianal Crohn's Disease: Long-term Follow-up of a Population-Based Cohort. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 20(2): E102-E110
Shiroshita, H.; Etoh, T.; Yasuda, K.; Inomata, M.; Kitano, S. 2016: Natural Orifice Translumenal Endoscopic Surgery. Nihon Geka Gakkai Zasshi 117(5): 376-380
Kaisinova, A.; Achabaeva, A.; Starokozhko, L.; Gaydamaka, I.; Kaisinova, E.; Kazakov, V. 2021: Natural Therapeutic Factors in Medical Rehabilitation of Patients with Post-Covid-19 at Outpatient Treatment Stage. Georgian Medical News 318: 110-114
Karpisek, V.; Hasnine, T.; Cicek, N.; Yuan, Q. 2021: Natural Wetlands Contribution on Phosphorus Removal in Small Northern Communities in Canada. Environmental Technology 2021: 1-18
Thody, J.; Folkes, L.; Moulton, V. 2020: NATpare: a pipeline for high-throughput prediction and functional analysis of nat-siRNAs. Nucleic Acids Research 48(12): 6481-6490
Perna, S.; Pinoli, P.; Ceri, S.; Wong, L. 2020: NAUTICA: classifying transcription factor interactions by positional and protein-protein interaction information. Biology Direct 15(1): 13
Wang, R.; Li, M.; Wu, W.; Qiu, Y.; Hu, W.; Li, Z.; Wang, Z.; Yu, Y.; Liao, J.; Sun, W.; Mao, J.; Zhu, Y.Z. 2021: NAV2 positively modulates inflammatory response of fibroblast-like synoviocytes through activating Wnt/β-catenin signaling pathway in rheumatoid arthritis. Clinical and Translational Medicine 11(4): E376
Vanderpool, D. 2020: Navigating the Ada: what Clinicians Need to Know: Part two. Innovations in Clinical Neuroscience 17(1-3): 49-50
Menzies-Gow, A.; Colice, G.; Griffiths, J.M.; Almqvist, G.; Ponnarambil, S.; Kaur, P.; Ruberto, G.; Bowen, K.; Hellqvist, Ås.; Mo, M.; Garcia Gil, E. 2020: NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma. Respiratory Research 21(1): 266
Wang, S.; Li, W.; Hu, L.; Cheng, J.; Yang, H.; Liu, Y. 2020: NAguideR: performing and prioritizing missing value imputations for consistent bottom-up proteomic analyses. Nucleic Acids Research 48(14): E83
Lin, W.; Wu, X.; Wen, J.; Fei, Y.; Wu, J.; Li, X.; Zhang, Q.; Dong, Y.; Xu, T.; Fan, Y.; Wang, N. 2021: Nicotinamide retains Klotho expression and ameliorates rhabdomyolysis-induced acute kidney injury. Nutrition: 91-92: 111376
Lovelock, J.E. 1975: NAtural halocarbons in the air and in the sea. Nature 256(5514): 193-194
Merda, D.éb.; Felten, A.; Vingadassalon, N.ém.; Denayer, S.; Titouche, Y.; Decastelli, L.; Hickey, B.; Kourtis, C.; Daskalov, H.; Mistou, M.-Y.; Hennekinne, J.-A. 2020: NAuRA: Genomic Tool to Identify Staphylococcal Enterotoxins in Staphylococcus aureus Strains Responsible for FoodBorne Outbreaks. Frontiers in Microbiology 11: 1483
Tinelli, M.; Pugliatti, M.; Antonovici, A.; Hausmann, B.; Hellwig, K.; Quoidbach, V.; Sørensen, P.S. 2021: Averting multiple sclerosis long-term societal and healthcare costs: the Value of Treatment (VoT) project. Multiple Sclerosis and Related Disorders 54: 103107
Voronkov, M.; Nikonov, G.; Naumov, R.; Abernethy, J.; Isakulyan, L. 2021: NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamics. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 159: 105734
Shi, J.L.; Zai, W.S.; Xiong, Z.L.; Wan, H.J.; Wu, W.R. 2021: NB-LRR genes: characteristics in three Solanum species and transcriptional response to Ralstonia solanacearum in tomato. Planta 254(5): 96
Jing, Z.; Wacera W, F.; Takami, T.; Takanashi, H.; Fukada, F.; Kawano, Y.; Kajiya-Kanegae, H.; Iwata, H.; Tsutsumi, N.; Sakamoto, W. 2021: NB-LRR-encoding genes conferring susceptibility to organophosphate pesticides in sorghum. Scientific Reports 11(1): 19828
Dong, D.; Chen, S.; Feng, C.; Xiong, H.; Xu, X. 2020: NB-UVB Induces Melanocytic Differentiation of Human Hair Follicle Neural Crest Stem Cells. Annals of Dermatology 32(4): 289-297
Ye, J.; Huang, H.; Luo, G.; Yin, L.; Li, B.; Chen, S.; Li, H.; Yang, Y.; Yang, X. 2020: NB-UVB irradiation attenuates inflammatory response in psoriasis. Dermatologic therapy 33(4): e13626
Pacifico, A.; Damiani, G.; Iacovelli, P.; Conic, R.R.Z.; Gonzalez, S.; Morrone, A. 2021: NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo. Dermatologic Therapy 34(2): E14776
Li, Z.D.; Abuduxikuer, K.; Zhang, J.; Yang, Y.; Qiu, Y.-L.; Huang, Y.; Xie, X.-B.; Lu, Y.; Wang, J.-S. 2020: NBAS disease: 14 new patients, a recurrent mutation, and genotype-phenotype correlation among 24 Chinese patients. Hepatology Research: the Official Journal of the Japan Society of Hepatology 50(11): 1306-1315
Juvvuna, P.Kumar.; Mondal, T.; Di Marco, M.; Kosalai, S.Thankaswamy.; Kanduri, M.; Kanduri, C. 2021: NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma. Neuro-OncologyAdvances 3(1):Vdab 056
Barbuskaite, D.; Pedersen, F.D.; Christensen, H.L.; Johnsen, L.Ø; Praetorius, J.; Damkier, H.H. 2020: NBCe2 (Slc4a5) Is Expressed in the Renal Connecting Tubules and Cortical Collecting Ducts and Mediates Base Extrusion. Frontiers in Physiology 11: 560
Li, Q.; Chai, L.; Dong, G.; Zhang, X.; Du, L. 2021: NBD-Based Environment-Sensitive Fluorescent Probes for the Human Ether-a-Go-Go-Related Gene Potassium Channel. Frontiers in Molecular Biosciences 8: 666605
Huang, H.; Ji, X.; Jiang, Y.; Zhang, C.; Kang, X.; Zhu, J.; Sun, L.; Yi, L. 2020: NBD-based fluorescent probes for separate detection of cysteine and biothiols via different reactivities. Organic and Biomolecular Chemistry 18(21): 4004-4008
Bindesbøll, C.; Aas, A.; Ogmundsdottir, M.Helga.; Pankiv, S.; Reine, T.; Zoncu, R.; Simonsen, A. 2020: NBEAL1 controls SREBP2 processing and cholesterol metabolism and is a susceptibility locus for coronary artery disease. Scientific Reports 10(1): 4528
Gunay-Aygun, M.; Falik-Zaccai, T.C.; Vilboux, T.; Zivony-Elboum, Y.; Gumruk, F.; Cetin, M.; Khayat, M.; Boerkoel, C.F.; Kfir, N.; Huang, Y.; Maynard, D.; Dorward, H.; Berger, K.; Kleta, R.; Anikster, Y.; Arat, M.; Freiberg, A.S.; Kehrel, B.E.; Jurk, K.; Cruz, P.; Mullikin, J.C.; White, J.G.; Huizing, M.; Gahl, W.A. 2011: NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nature Genetics 43(8): 732-734
Boscolo Nata, F.; Tirelli, G.; Capriotti, V.; Marcuzzo, A.V.; Sacchet, E.; Šuran-Brunelli, A.N.; de Manzini, N.ò 2021: NBi utility in oncologic surgery: An organ by organ review. Surgical Oncology 36: 65-75
Nguyen, T.; Shafi, A.; Nguyen, T-Minh.; Schissler, A.Grant.; Draghici, S. 2020: NBIA: a network-based integrative analysis framework - applied to pathway analysis. Scientific Reports 10(1): 4188
Zhang, C.; Xiao, L.; Huang, Y.; Zhang, L.; Jiang, D.; Shao, W.; Zheng, J.; Hu, F.; Chu, M.; Huang, J.; Gong, X.; Zhou, Y.; Qiu, X. 2021: NBIGV-DB: a dedicated database of non-B cell derived immunoglobulin variable region. Gene 772: 145378
Myers, J.A.; Vigneswaran, Y.; Gabryszak, B.; Fogg, L.F.; Francescatti, A.B.; Golner, C.; Bines, S.D. 2014: NBME subject examination in surgery scores correlate with surgery clerkship clinical experience. Journal of Surgical Education 71(2): 205-210
Wen, J.; Cerosaletti, K.; Schultz, K.J.; Wright, J.A.; Concannon, P. 2013: NBN phosphorylation regulates the accumulation of MRN and ATM at sites of DNA double-strand breaks. Oncogene 32(37): 4448-4456
Ruda-Kucerova, J.; Amchova, P.; Siska, F.; Tizabi, Y. 2021: NBQX attenuates relapse of nicotine seeking but not nicotine and methamphetamine self-administration in rats. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 2021: 1-23
Huang, J.; Linares, J.F.; Duran, A.; Xia, W.; Saltiel, A.R.; Müller, T.D.; Diaz-Meco, M.T.; Moscat, J. 2021: NBR1 is a critical step in the repression of thermogenesis of p62-deficient adipocytes through PPARγ. Nature Communications 12(1): 2876
Yang, J-Qi.; Liu, H.; Diaz-Meco, M.T.; Moscat, J. 2010: NBR1 is a new PB1 signalling adapter in Th2 differentiation and allergic airway inflammation in vivo. EMBO Journal 29(19): 3421-3433
Shi, J.; Fung, G.; Deng, H.; Zhang, J.; Fiesel, F.C.; Springer, W.; Li, X.; Luo, H. 2015: NBR1 is dispensable for PARK2-mediated mitophagy regardless of the presence or absence of SQSTM1. Cell Death and Disease 6: E1943
Zhang, J.; Jiang, H.; Feng, X.; Wang, L.; Yang, X. 2021: NBR2 promotes the proliferation of glioma cells via inhibiting p15 expression. Journal of Buon: Official Journal of the Balkan Union of Oncology 26(2): 388-394
Serin, E.; Zalesky, A.; Matory, A.; Walter, H.; Kruschwitz, J.D. 2021: NBS-Predict: a prediction-based extension of the network-based statistic. Neuroimage 244: 118625
Tomioka, K.; Miyamoto, T.; Akutsu, S.Natsuko.; Yanagihara, H.; Fujita, K.; Royba, E.; Tauchi, H.; Yamamoto, T.; Koh, I.; Hirata, E.; Kudo, Y.; Kobayashi, M.; Okada, S.; Matsuura, S. 2021: NBS1 I171V variant underlies individual differences in chromosomal radiosensitivity within human populations. Scientific Reports 11(1): 19661
Bosso, G.; Cipressa, F.; Moroni, M.Lina.; Pennisi, R.; Albanesi, J.; Brandi, V.; Cugusi, S.; Renda, F.; Ciapponi, L.; Polticelli, F.; Antoccia, A.; di Masi, A.; Cenci, G. 2019: NBS1 interacts with HP1 to ensure genome integrity. Cell Death and Disease 10(12): 951
Zhou, Z.-W.; Kirtay, M.; Schneble, N.; Yakoub, G.; Ding, M.; Rüdiger, T.; Siniuk, K.; Lu, R.; Jiang, Y.-N.; Li, T.-L.; Kaether, C.; Barzilai, A.; Wang, Z.-Q. 2020: NBS1 interacts with Notch signaling in neuronal homeostasis. Nucleic Acids Research 48(19): 10924-10939
Zhang, B.; Tang, Z.; Li, L.; Lu, L-Yu. 2020: NBS1 is required for SPO11-linked DNA double-strand break repair in male meiosis. Cell Death and Differentiation 27(7): 2176-2190
Zhang, X.; Yi, N. 2020: NBZIMM: negative binomial and zero-inflated mixed models, with application to microbiome/metagenomics data analysis. Bmc Bioinformatics 21(1): 488
Gomih, A.; Banks, B.; McKeithan, L.; Rajabiun, S. 2018: NC-REACH: a Rural Patient-Centered Medical Home for people Living with HIV who Experience Unstable Housing. American Journal of Public Health 108(S7): S525-S527
Padilla, C.C.; Bristow, L.A.; Sarode, N.; Garcia-Robledo, E.; Gómez Ramírez, E.; Benson, C.R.; Bourbonnais, A.; Altabet, M.A.; Girguis, P.R.; Thamdrup, B.; Stewart, F.J. 2016: NC10 bacteria in marine oxygen minimum zones. Isme Journal 10(8): 2067-2071
Li, Z.-Y.; Li, X.; Tan, B.; Lv, P.-L.; Zhao, H.-P. 2020: NC10 bacteria promoted methane oxidation coupled to chlorate reduction. Biodegradation 31(4-6): 319-329
Ren, H.; Lu, M.; Xie, Y-Ying.; Gao, N.; Xu, H-Zhang.; Yao, T-En.; He, N.; He, Q-Yang.; Chen, R-Xian. 2012: NC1101, a novel tetrahydropyrimidine-containing bleomycin analog from Streptomyces verticillus var. pingyangensis n. var. Journal of Antibiotics 65(6): 327-329
Qi, X.; Wang, X.; Ren, H.; Zhang, F.; Zhang, X.; He, N.; Guo, W.; Chen, R.; Xie, Y.; He, Q. 2017: NC1404, a novel derivative of Bleomycin with modified sugar moiety obtained during the preparation of Boningmycin. Journal of Antibiotics 70(9): 970-973
Cui, G.; Dong, Q.; Duan, J.; Zhang, C.; Liu, X.; He, Q. 2020: NC2 complex is a key factor for the activation of catalase-3 transcription by regulating H2A.Z deposition. Nucleic Acids Research 48(15): 8332-8348
Schluesche, P.; Stelzer, G.; Piaia, E.; Lamb, D.C.; Meisterernst, M. 2007: NC2 mobilizes TBP on core promoter TATA boxes. Nature Structural and Molecular Biology 14(12): 1196-1201
Vicente, A.M.; Macciardi, F.; Verga, M.; Bassett, A.S.; Honer, W.G.; Bean, G.; Kennedy, J.L. 1997: NCAM and schizophrenia: genetic studies. Molecular Psychiatry 2(1): 65-69
Morsy, S. 2020: NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome. Medical Hypotheses 145: 110342
Lehembre, F.; Yilmaz, M.; Wicki, A.; Schomber, T.; Strittmatter, K.; Ziegler, D.; Kren, A.; Went, P.; Derksen, P.W.B.; Berns, A.; Jonkers, J.; Christofori, G. 2008: NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO Journal 27(19): 2603-2615
Shukrun, R.; Golan, H.; Caspi, R.; Pode-Shakked, N.; Pleniceanu, O.; Vax, E.; Bar-Lev, D.D.; Pri-Chen, S.; Jacob-Hirsch, J.; Schiby, G.; Harari-Steinberg, O.; Mark-Danieli, M.; Dekel, B.; Toren, A. 2019: NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic target. Oncogenesis 8(9): 48
Rasmussen, K.Krighaar.; Falkesgaard, M.Hansen.; Winther, M.; Roed, N.Kulahin.; Quistgaard, C.Louise.; Teisen, M.Nygaard.; Edslev, S.Marie.; Petersen, D.Leander.; Aljubouri, A.; Christensen, C.; Thulstrup, P.Waaben.; Lo Leggio, L.; Teilum, K.; Walmod, P.Schledermann. 2018: NCAM2 Fibronectin type-III domains form a rigid structure that binds and activates the Fibroblast Growth Factor Receptor. Scientific Reports 8(1): 8957
Dannlowski, U.; Kugel, H.; Grotegerd, D.; Redlich, R.; Suchy, J.; Opel, N.; Suslow, T.; Konrad, C.; Ohrmann, P.; Bauer, J.; Kircher, T.; Krug, A.; Jansen, A.; Baune, B.T.; Heindel, W.; Domschke, K.; Forstner, A.J.; Nöthen, M.M.; Treutlein, J.; Arolt, V.; Hohoff, C.; Rietschel, M.; Witt, S.H. 2015: NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major Depression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 40(11): 2510-2516
Zhang, X.; Wang, H.; Han, Y.; Zhu, M.; Song, Z.; Zhan, D.; Jia, J. 2020: NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway. Oncotargets and Therapy 13: 11315-11326
Jiang, L.; Ren, L.; Chen, H.; Pan, J.; Zhang, Z.; Kuang, X.; Chen, X.; Bao, W.; Lin, C.; Zhou, Z.; Huang, D.; Yang, J.; Huang, H.; Wang, L.; Hou, N.; Song, L. 2020: NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer. Cell Death and Disease 11(7): 547
Wu, Y.; Lin, Y.; Pan, J.; Tu, X.; Xu, Y.; Li, H.; Chen, Y. 2021: NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway. Cancer Cell International 21(1): 443
Dong, M.; Xu, T.; Cui, X.; Li, H.; Li, X.; Xia, W. 2021: NCAPG upregulation mediated by four micro RNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer. Oncology Letters 21(4): 323
Kim, B.; Kim, S.W.; Lim, J.-Y.; Park, S.-J. 2020: NCAPH Is Required for Proliferation, Migration and Invasion of Non-small-cell Lung Cancer Cells. Anticancer Research 40(6): 3239-3246
Xiong, Q.; Fan, S.; Duan, L.; Liu, B.; Jiang, X.; Chen, X.; Xiong, C.; Tao, Q.; Wang, J.; Zhang, H.; Chen, C.; Duan, Y. 2020: NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer. Molecular Medicine Reports 22(4): 2916-2924
Qiu, X.; Gao, Z.; Shao, J.; Li, H. 2020: NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics. Annals of Human Genetics 84(6): 437-446
Yin, L.; Jiang, L-Ping.; Shen, Q-Shuo.; Xiong, Q-Xia.; Zhuo, X.; Zhang, L-Long.; Yu, H-Jing.; Guo, X.; Luo, Y.; Dong, J.; Kong, Q-Peng.; Yang, C-Ping.; Chen, Y-Bin. 2017: NCAPH plays important roles in human colon cancer. Cell Death and Disease 8(3): E2680
Mullard, A. 2016: NCATS launches 'periodic table' for medicinal product ingredients. Nature Reviews. Drug Discovery 15(6): 375
Edgar, R.; Barrett, T. 2006: NCBI GEO standards and services for microarray data. Nature Biotechnology 24(12): 1471-1472
Kuznetsov, A.; Bollin, C.J. 2021: NCBi Genome Workbench: Desktop Software for Comparative Genomics, Visualization, and GenBank Data Submission. Methods in Molecular Biology 2231: 261-295
Slotta, D.J.; Barrett, T.; Edgar, R. 2009: NCBI Peptidome: a new public repository for mass spectrometry peptide identifications. Nature Biotechnology 27(7): 600-601
Dou, Y.; Barbosa, I.; Jiang, H.; Iasillo, C.; Molloy, K.R.; Schulze, W.M.; Cusack, S.; Schmid, M.; Le Hir, H.é; LaCava, J.; Jensen, T.H. 2020: NCBP3 positively impacts mRNA biogenesis. Nucleic Acids Research 48(18): 10413-10427
Li, X.; Zhang, F.; Ma, J.; Ruan, X.; Liu, X.; Zheng, J.; Liu, Y.; Cao, S.; Shen, S.; Shao, L.; Cai, H.; Li, Z.; Xue, Y. 2020: NCBP3/SNHG6 inhibits GBX2 transcription in a histone modification manner to facilitate the malignant biological behaviour of glioma cells. Rna Biology 2020: 1-17
Sugano, K. 2005: Ncc-St-439. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 681-683
Sugano, K. 2010: Ncc-St-439. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 726-728
Liu, Q.; Kong, X.; Wang, Z.; Wang, X.; Zhang, W.; Ai, B.; Gao, R.; Fang, Y.; Wang, J. 2021: NCCBM, a Nomogram Prognostic Model in Breast Cancer Patients with Brain Metastasis. Frontiers in Oncology 11: 642677
Johnson, T.; Bandini, L.A.M.; Mitteldorf, D.; Franklin, E.; Bekelman, J.E.; Carlson, R.W. 2020: NCCN Patient Advocacy Summit: Delivering Value for Patients Across the Oncology Ecosystem. Journal of the National Comprehensive Cancer Network: Jnccn 18(9): 1181-1187
Bandini, L.A.M.; Gallo, L.; Johnson, T.; Martin, K.; Schatz, A.A.; Adelson, K.; Loy, B.A.; Walters, R.S.; Wong, T.; Carlson, R.W. 2020: NCCN Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care. Journal of the National Comprehensive Cancer Network: Jnccn 18(7): 820-824
Johnson, T.; McMurry-Heath, M.; Okon, T.; Rubin, D.; Carlson, R.W. 2021: NCCN Policy Summit: Innovative Solutions to Drive down Healthcare Costs: Implications for Access to High-Quality Cancer Care. Journal of the National Comprehensive Cancer Network: Jnccn 19(9): 1021-1026
Prochazka, K.T.; Melchardt, T.; Posch, F.; Schlick, K.; Deutsch, A.; Beham-Schmid, C.; Weiss, L.; Gary, T.; Neureiter, D.; Klieser, E.; Greil, R.; Neumeister, P.; Egle, A.; Pichler, M. 2016: NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. British Journal of Cancer 115(10): 1264-1272
Maciel de Lima, A.P.; Schneider, B.C.; Bertoldi, A.éa.D.âm.; Tomasi, E.; Gonzalez, M.C.; Demarco, F.áv.F.; Domingues, M.R.; Bielemann, R.M. 2021: NCD behavioral risk factors and mortality among older adults in Brazil. Clinical Nutrition Espen 45: 462-468
Ahmed, H.; Hallam, R.; Webster, G.; Rej, A.; Croall, I.D.; Coleman, S.H.; Key, T.; Buckle, R.; Shaw, C.C.; Goodwin, J.; Aziz, I.; Sanders, D.S. 2021: NCGS like IBS 'type' symptoms is a diagnosis of exclusion. Nutrition Journal 20(1): 79
Schwartz, J.; Ginder, W. 2021: NCHA variable combination as a method to undertake LGBTQ + student subpopulation analyses. Journal of American College Health: J of Ach 2021: 1-12
Molina, A.M.; van der Mijn, J.C.; Christos, P.; Wright, J.; Thomas, C.; Dutcher, J.P.; Nanus, D.M.; Tagawa, S.T.; Gudas, L.J. 2020: NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma. Investigational new Drugs 38(5): 1383-1389
Fedorov, A.; Longabaugh, W.; Pot, D.; Clunie, D.; Pieper, S.; Lewis, R.; Aerts, H.; Homeyer, A.; Herrmann, M.; Wagner, U.; Pihl, T.; Farahani, K.; Kikinis, R. 2021: NCI Imaging Data Commons. International Journal of Radiation Oncology Biology Physics 111(3s): E101
Coles, P. 1987: NCI and Pasteur reveal details of AIDS foundations. Nature 330(6148): 507
Wadman, M. 1997: NCI apologizes for fallout study delay. Nature 389(6651): 534
Ault, A. 1998: NCI begins overhaul of late-stage cancer trials. Nature Medicine 4(11): 1219
Gottlieb, S. 1999: NCI defends research involving minority groups. Nature Medicine 5(3): 254
Gershon, D. 1994: NCI restores funding to gene therapist seen as 'too hasty'. Nature 369(6482): 598
Birmingham 1999: NCI strikes unique agreement with ireland. Nature Medicine 5(11): 1221-1222
Buchsbaum, J.C.; Vikram, B. 2021: NCi support for pediatric radiation therapy: Past, present, and future. Pediatric Blood and Cancer 68(Suppl 2): E28689
Weil, C.J.; Mechanic, L.E.; Green, T.; Kinsinger, C.; Lockhart, N.C.; Nelson, S.A.; Rodriguez, L.L.; Buccini, L.D. 2013: NCI think tank concerning the identifiability of biospecimens and "omic" data. Genetics in Medicine: Official Journal of the American College of Medical Genetics 15(12): 997-1003
Novak, K. 2003: NCI to focus on clinical trial speed. Nature Medicine 9(1): 8
Singer, D.S. 2020: NCI's Work to Advance Cancer Research while Responding to the COVID-19 Pandemic. Cancer Cell 37(6): 746-748
Mansouri, A.; Zadeh, G. 2020: NCI-CONNECT rare CNS tumor initiative: current progress and anticipated future impact. Neuro-OncologyAdvances 2(1):Vdaa 022
Hughes, R. 2008: NCI-CTC vs TNS: which tool is better for grading the severity of chemotherapy-induced peripheral neuropathy?. Nature Clinical Practice. Neurology 4(2): 68-69
Brower, V. 2015: NCI-MATCH pairs tumor mutations with matching drugs. Nature Biotechnology 33(8): 790-791
Mullard, A. 2015: NCI-MATCH trial pushes cancer umbrella trial paradigm. Nature Reviews. Drug Discovery 14(8): 513-515
Peccati, F. 2020: NCIPLOT4 Guide for Biomolecules: An Analysis Tool for Noncovalent Interactions. Journal of Chemical Information and Modeling 60(1): 6-10
Boto, R.A.; Peccati, F.; Laplaza, R.én.; Quan, C.; Carbone, A.; Piquemal, J.-P.; Maday, Y.; Contreras-Garcı A, J. 2020: NCIPLOT4: Fast, Robust, and Quantitative Analysis of Noncovalent Interactions. Journal of Chemical Theory and Computation 16(7): 4150-4158
Ghaffari, K.; Pierce, L.X.; Roufaeil, M.; Gibson, I.; Tae, K.; Sahoo, S.; Cantrell, J.R.; Andersson, O.; Lau, J.; Sakaguchi, T.F. 2021: NCK-associated protein 1 like (nckap1l) minor splice variant regulates intrahepatic biliary network morphogenesis. Plos Genetics 17(3): E1009402
Dubrac, A.; Künzel, S.E.; Künzel, S.H.; Li, J.; Chandran, R.Radhamani.; Martin, K.; Greif, D.M.; Adams, R.H.; Eichmann, A. 2018: NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy. Nature Communications 9(1): 3463
Diab, A.; Qi, J.; Shahin, I.; Milligan, C.; Fawcett, J.P. 2020: NCK1 Regulates Amygdala Activity to Control Context-dependent Stress Responses and Anxiety in Male Mice. Neuroscience 448: 107-125
Wang, B.; Wang, K.; Jin, T.; Xu, Q.; He, Y.; Cui, B.; Wang, Y. 2020: NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway. Biomedicine and PharmacoTherapy 129: 110395
Zhou, X.; Bao, W.; Zhang, D.; Yang, Y.; Du, X.; Qiu, G. 2021: NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC. Cancer Biology and Therapy 2021: 1-8
Lin, Q.; Jia, Y.; Zhang, D.; Jin, H. 2021: NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis. Cancer Cell International 21(1): 367
Guo, H.; Zhang, Q.; Dai, R.; Yu, B.; Hoekzema, K.; Tan, J.; Tan, S.; Jia, X.; Chung, W.K.; Hernan, R.; Alkuraya, F.S.; Alsulaiman, A.; Al-Muhaizea, M.A.; Lesca, G.; Pons, L.; Labalme, A.; Laux, L.; Bryant, E.; Brown, N.J.; Savva, E.; Ayres, S.; Eratne, D.; Peeters, H.; Bilan, F.éd.ér.; Letienne-Cejudo, L.; Gilbert-Dussardier, B.; Ruiz-Arana, I.-L.; Merlini, J.M.; Boizot, A.; Bartoloni, L.; Santoni, F.; Karlowicz, D.; McDonald, M.; Wu, H.; Hu, Z.; Chen, G.; Ou, J.; Brasch-Andersen, C.; Fagerberg, C.R.; Dreyer, I.; Chun-Hui Tsai, A.; Slegesky, V.; McGee, R.B.; Daniels, B.; Sellars, E.A.; Carpenter, L.A.; Schaefer, B.; Sacoto, M.J.G.; Begtrup, A.; Schnur, R.E.; Punj, S.; Wentzensen, I.M.; Rhodes, L.; Pan, Q.; Bernier, R.A.; Chen, C.; Eichler 2020: NCKAP1 Disruptive Variants Lead to a Neurodevelopmental Disorder with Core Features of Autism. American Journal of Human Genetics 107(5): 963-976
Zhong, X-Ping.; Kan, A.; Ling, Y-Hong.; Lu, L-He.; Mei, J.; Wei, W.; Li, S-Hua.; Guo, R-Ping. 2019: NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma. Cell Death and Disease 10(5): 369
Colombraro, G.C. 1989: NCLEX-RN preparation: enabling candidates to pass. Journal of Continuing Education in Nursing 20(6): 261-267
Guéguinou, M.; Pathak, T.; Robert, A.; Vandier, C.; Trebak, M.; Lecomte, T.; Raoul, W. 2021: NCLX exchanger: An ambivalent role in colorectal cancer timeline. Medecine Sciences: M/S 37(2): 124-126
Pathak, T.; Trebak, M. 2020: NCLX pumps up the heat. Cell Calcium 92: 102280
Zamani, F.; Olyaee, M.H.; Khanteymoori, A. 2020: NCMHap: a novel method for haplotype reconstruction based on Neutrosophic c-means clustering. Bmc Bioinformatics 21(1): 475
Gupta, A.; Hossain, M.M.; Miller, N.; Kerin, M.; Callagy, G.; Gupta, S. 2016: NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2α-ATF4 signalling in breast cancer. Oncogene 35(45): 5860-5871
Esteyries, S.; Perot, C.; Adelaide, J.; Imbert, M.; Lagarde, A.; Pautas, C.; Olschwang, S.; Birnbaum, D.; Chaffanet, M.; Mozziconacci, M-J. 2008: NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia. Leukemia 22(3): 663-665
Li, X.; Lozovatsky, L.; Sukumaran, A.; Gonzalez, L.; Jain, A.; Liu, D.; Ayala-Lopez, N.; Finberg, K.E. 2020: NCOA4 is regulated by HIF and mediates mobilization of murine hepatic iron stores after blood loss. Blood 136(23): 2691-2702
Gryzik, M.; Asperti, M.; Denardo, A.; Arosio, P.; Poli, M. 2021: NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in Hela cells. Biochimica et Biophysica Acta. Molecular Cell Research 1868(2): 118913
Gao, S.; Zhang, Y.; Yang, C.; Perez, G.I.; Xiao, H. 2019: NCOA5 Haplo-insufficiency Results in Male Mouse Infertility through Increased IL-6 Expression in the Epididymis. Scientific Reports 9(1): 15525
Williams, M.; Liu, X.; Zhang, Y.; Reske, J.; Bahal, D.; Gohl, T.G.; Hollern, D.; Ensink, E.; Kiupel, M.; Luo, R.; Das, R.; Xiao, H. 2020: NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21 WAF1/CIP1 overexpression, which is reversed by metformin. Oncogene 39(19): 3821-3836
Han, C.Rong.; Park, S.; Cheng, S-Yann. 2017: NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1. Scientific Reports 7(1): 18080
Yang, E.J.; Yoo, C.Yul.; Liu, J.; Wang, H.; Cao, J.; Li, F-Wei.; Pryer, K.M.; Sun, T-Ping.; Weigel, D.; Zhou, P.; Chen, M. 2019: NCP activates chloroplast transcription by controlling phytochrome-dependent dual nuclear and plastidial switches. Nature Communications 10(1): 2630
Carrega, P.; Loiacono, F.; Di Carlo, E.; Scaramuccia, A.; Mora, M.; Conte, R.; Benelli, R.; Spaggiari, G.Maria.; Cantoni, C.; Campana, S.; Bonaccorsi, I.; Morandi, B.; Truini, M.; Mingari, M.Cristina.; Moretta, L.; Ferlazzo, G. 2015: NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nature Communications 6: 8280
Zhao, L.; Lian, T.; Li, J.; Wei, S.; Li, H.; Li, C.; Wang, H. 2021: NCR3LG1(B7-H6) is a potential prognostic factor for bladder cancer patients. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 2021: 1-20
Yang, S.; Wang, Y.; Zhang, S.; Hu, X.; Ma, Q.; Tian, Y. 2020: NCResNet: Noncoding Ribonucleic Acid Prediction Based on a Deep Resident Network of Ribonucleic Acid Sequences. Frontiers in Genetics 11: 90
Yougbare, I.; Keravis, T.ér.ès.; Lugnier, C. 2021: NCS 613, a PDE4 inhibitor, by increasing cAMP level suppresses systemic inflammation and immune complexes deposition in kidney of MRL/lpr lupus- prone mice. Biochimica et Biophysica Acta. Molecular Basis of Disease 1867(3): 166019
Yougbare, I.; Belemnaba, L.; Morin, C.; Abusnina, A.; Senouvo, Y.F.; Keravis, T.ér.ès.; Lugnier, C.; Rousseau, E. 2020: NCS 613, a Potent PDE4 Inhibitor, Displays Anti-Inflammatory and Anti-Proliferative Properties on A549 Lung Epithelial Cells and Human Lung Adenocarcinoma Explants. Frontiers in Pharmacology 11: 1266
Zucker, R.S. 2003: NCS-1 stirs somnolent synapses. Nature Neuroscience 6(10): 1006-1008
Yang, Z.; He, J.; Wei, Y.; Li, W.; Liu, P.; Zhao, J.; Wei, Y. 2020: NCS-promoted thiocyanation and selenocyanation of pyrrolo[1,2-a]quinoxalines. Organic and Biomolecular Chemistry 18(44): 9088-9094
Li, H.; Lan, T.; Xu, L.; Liu, H.; Wang, J.; Li, J.; Chen, X.; Huang, J.; Li, X.; Yuan, K.; Zeng, Y.; Wu, H. 2020: NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 128
Fu, M.-Y.; Chen, W.-W.; Gao, N.; Li, S.; Du, J.; Yu, W.-Z. 2021: NCTD Retards AML HL60 Cell Proliferation via Targeting Hedgehog/SOX2 axis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 29(1): 32-37
Zhang, S.; Yang, Y.; Hua, Y.; Hu, C.; Zhong, Y. 2020: NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling. Molecular Medicine Reports 22(2): 774-782
Rossoni, G.; Manfredi, B.; Del Soldato, P.; Berti, F. 2002: NCX 4016, a nitric oxide-releasing aspirin, modulates adrenergic vasoconstriction in the perfused rat tail artery. British Journal of Pharmacology 137(2): 229-236
Romero-Sandoval, E.Alfonso.; Mazario, J.; Howat, D.; Herrero, J.F. 2002: NCX-701 (nitroparacetamol) is an effective antinociceptive agent in rat withdrawal reflexes and wind-up. British Journal of Pharmacology 135(6): 1556-1562
Kalsi, J.S.; Kell, P.D.; Cellek, S.; Ralph, D.J. 2004: NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide. International Journal of Impotence Research 16(2): 195-200
Magi, S.; Piccirillo, S.; Maiolino, M.; Lariccia, V.; Amoroso, S. 2020: NCX1 and EAAC1 transporters are involved in the protective action of glutamate in an in vitro Alzheimer's disease-like model. Cell Calcium 91: 102268
Sirabella, R.; Sisalli, M.Josè.; Costa, G.; Omura, K.; Ianniello, G.; Pinna, A.; Morelli, M.; Di Renzo, G.Maria.; Annunziato, L.; Scorziello, A. 2018: NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease. Cell Death and Disease 9(7): 725
Neubert, P.; Homann, A.; Wendelborn, D.; Bär, A.-L.; Krampert, L.; Trum, M.; Schröder, A.; Ebner, S.; Weichselbaum, A.; Schatz, V.; Linz, P.; Veelken, R.; Schulte-Schrepping, J.; Aschenbrenner, A.C.; Quast, T.; Kurts, C.; Geisberger, S.; Kunzelmann, K.; Hammer, K.; Binger, K.J.; Titze, J.; Müller, D.N.; Kolanus, W.; Schultze, J.L.; Wagner, S.; Jantsch, J. 2020: NCX1 represents an ionic Na+ sensing mechanism in macrophages. Plos Biology 18(6): E3000722
Xia, Z.; Wang, C.; Wang, X.; Yu, H.; Yao, H.; Shen, H.; Lan, X.; Wu, X.; Zhang, G. 2021: NCX3 alleviates ethanol-induced apoptosis of SK-N-SH cells via the elimination of intracellular calcium ions. Toxicology in Vitro: An International Journal Published in Association with Bibra 72: 105104
Minuz, P.; Degan, M.; Gaino, S.; Meneguzzi, A.; Zuliani, V.; Santonastaso, C.L.; Soldato, P.D.; Lechi, A. 2001: NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. British Journal of Pharmacology 134(4): 905-911
Wainwright, C.L.; Miller, A.M.; Work, L.M.; Del Soldato, P. 2002: NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. British Journal of Pharmacology 135(8): 1882-1888
Ahad, A.; Smita, S.; Mishra, G.P.; Biswas, V.K.; Sen, K.; Gupta, B.; Garcin, D.; Acha-Orbea, H.; Raghav, S.K. 2020: NCoR1 fine-tunes type-i IFN response in cDC1 dendritic cells by directly regulating Myd88-IRF7 axis under TLR9. European Journal of Immunology 50(12): 1959-1975
Giladi, N.; Gurevich, T.; Djaldetti, R.; Adar, L.; Case, R.; Leibman-Barak, S.; Sasson, N.; Caraco, Y. 2021: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: a randomized, placebo-controlled phase 2 study. Parkinsonism and Related Disorders 91: 139-145
Vrana, J.; Singh, R. 2021: NDE 4.0-A Design Thinking Perspective. Journal of Nondestructive Evaluation 40(1): 8
Shimizu, S.; Ishino, Y.; Tohyama, M.; Miyata, S. 2018: NDE1 positively regulates oligodendrocyte morphological differentiation. Scientific Reports 8(1): 7644
Byrgazov, K.; Kastner, R.; Gorna, M.; Hoermann, G.; Koenig, M.; Lucini, C.B.; Ulreich, R.; Benesch, M.; Strenger, V.; Lackner, H.; Schwinger, W.; Sovinz, P.; Haas, O.A.; van den Heuvel-Eibrink, M.; Niemeyer, C.M.; Hantschel, O.; Valent, P.; Superti-Furga, G.; Urban, C.; Dworzak, M.N.; Lion, T. 2017: NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors. Leukemia 31(1): 237-240
Pillich, R.T.; Chen, J.; Churas, C.; Liu, S.; Ono, K.; Otasek, D.; Pratt, D. 2021: NDEx: Accessing Network Models and Streamlining Network Biology Workflows. Current Protocols 1(9): E258
Daly, J.M.; Olayioye, M.A.; Wong, A.M.; Neve, R.; Lane, H.A.; Maurer, F.G.; Hynes, N.E. 1999: NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways. Oncogene 18(23): 3440-3451
Zhao, Q-Wen.; Lin, Y.; Xu, C-Rong.; Yao, Y-Liang.; Cui, Y-Hong.; Zhang, X.; Bian, X-Wu. 2017: NDGA-P21, a novel derivative of nordihydroguaiaretic acid, inhibits glioma cell proliferation and stemness. Laboratory Investigation; a Journal of Technical Methods and Pathology 97(10): 1180-1187
Chmielewska, S.J.; Skłodowski, K.; Piktel, E.; Suprewicz, Łu.; Fiedoruk, K.; Daniluk, T.; Wolak, P.ła.; Savage, P.B.; Bucki, R. 2020: NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131. Infection and Drug Resistance 13: 3277-3294
Yang, K.; Liu, S.; Li, H.; Du, N.; Yao, J.; He, Q.; Du, Y. 2020: NDM-1-Positive K. pneumoniae at a Teaching Hospital in Southwestern China: Clinical Characteristics, Antimicrobial Resistance, Molecular Characterization, Biofilm Assay, and Virulence. Canadian Journal of Infectious Diseases and Medical Microbiology 2020: 9091360
Corrêa, L.ís.L.; Kraychete, G.B.; Rezende, A.M.; Campana, E.H.; Lima-Morales, D.; Wink, P.L.; Picão, R.C. 2021: NDM-1-encoding plasmid in Acinetobacter chengduensis isolated from coastal water. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 93: 104926
Fritzsche, M.; Blom, G.; Keitel, J.; Goettsche, A.; Seegel, M.; Leicht, S.; Guessregen, B.; Hickert, S.; Reifenberg, P.; Cimelli, A.; Baranowski, R.; Desmartin, E.; Barrau, E.; Harrison, M.; Bristow, T.; O'Neill, N.; Kirsch, A.; Krueger, P.; Saal, C.; Mouton, B.; Schlingemann, J. 2022: NDMA analytics in metformin products: Comparison of methods and pitfalls. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 168: 106026
Zhang, B.; Liu, J.; Zhao, R.-S.; Xian, Q. 2021: NDMA adsorption and degradation by a new-type of Ag-MONT material carrying nanoscale zero-valent iron. Chemosphere 268: 129271
Reny, R.; Plumlee, M.H.; Kodamatani, H.; Suffet, I.H.M.; Roback, S.L. 2021: NDMA and NDMA precursor attenuation in environmental buffers prior to groundwater recharge for potable reuse. Science of the Total Environment 762: 144287
Liao, X.; Shen, L.; Jiang, Z.; Gao, M.; Qiu, Y.; Qi, H.; Chen, C. 2021: NDMA formation during ozonation of metformin: Roles of ozone and hydroxyl radicals. Science of the Total Environment 796: 149010
Shin, H.; Adesnik, H. 2021: NDNF interneurons, Spartans of the cortical column: Small in number, strong in impact. Neuron 109(13): 2041-2042
Tamaoka, S.; Suzuki, E.; Hattori, A.; Ogata, T.; Fukami, M.; Katoh-Fukui, Y. 2021: NDNF variants are rare in patients with congenital hypogonadotropic hypogonadism. Human Genome Variation 8(1): 5
Mtibaa, A.; Mastorakis, S. 2020: NDNTP: a Named Data Networking time Protocol. IEEE Network 34(6): 235-241
Wagstaff, B.A.; Zorzoli, A.; Dorfmueller, H.C. 2021: NDP-rhamnose biosynthesis and rhamnosyltransferases: building diverse glycoconjugates in nature. Biochemical Journal 478(4): 685-701
Fili, N.; Hari-Gupta, Y.; Dos Santos, Ália.; Cook, A.; Poland, S.; Ameer-Beg, S.M.; Parsons, M.; Toseland, C.P. 2017: NDP52 activates nuclear myosin VI to enhance RNA polymerase II transcription. Nature Communications 8(1): 1871
Yu, H.; Yang, F.; Dong, P.; Liao, S.; Liu, W.R.; Zhao, G.; Qin, B.; Dou, Z.; Liu, Z.; Liu, W.; Zang, J.; Lippincott-Schwartz, J.; Liu, X.; Yao, X. 2019: NDP52 tunes cortical actin interaction with astral microtubules for accurate spindle orientation. Cell Research 29(8): 666-679
Ivanov, S.; Roy, C.R. 2009: NDP52: the missing link between ubiquitinated bacteria and autophagy. Nature Immunology 10(11): 1137-1139
Kagan, V.E.; Jiang, J.; Huang, Z.; Tyurina, Y.Y.; Desbourdes, C.; Cottet-Rousselle, C.; Dar, H.H.; Verma, M.; Tyurin, V.A.; Kapralov, A.A.; Cheikhi, A.; Mao, G.; Stolz, D.; St Croix, C.M.; Watkins, S.; Shen, Z.; Li, Y.; Greenberg, M.L.; Tokarska-Schlattner, M.; Boissan, M.; Lacombe, M-L.; Epand, R.M.; Chu, C.T.; Mallampalli, R.K.; Bayır, H.; Schlattner, U. 2016: NDPK-D (NM23-H4)-mediated externalization of cardiolipin enables elimination of depolarized mitochondria by mitophagy. Cell Death and Differentiation 23(7): 1140-1151
Tan, C-Yee.; Chang, C.L. 2018: NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma. Laboratory Investigation; a Journal of Technical Methods and Pathology 98(2): 219-227
Hergovich, A.; Stegert, M.R.; Schmitz, D.; Hemmings, B.A. 2006: NDR kinases regulate essential cell processes from yeast to humans. Nature Reviews. Molecular Cell Biology 7(4): 253-264
Chiba, S.; Amagai, Y.; Homma, Y.; Fukuda, M.; Mizuno, K. 2013: NDR2-mediated Rabin8 phosphorylation is crucial for ciliogenesis by switching binding specificity from phosphatidylserine to Sec15. EMBO Journal 32(6): 874-885
Watari, K.; Shibata, T.; Fujita, H.; Shinoda, A.; Murakami, Y.; Abe, H.; Kawahara, A.; Ito, H.; Akiba, J.; Yoshida, S.; Kuwano, M.; Ono, M. 2020: NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells. Communications Biology 3(1): 107
Dong, L.; Dong, J.; Xiang, M.; Lei, P.; Li, Z.; Zhang, F.; Sun, X.; Niu, D.; Bai, L.; Lan, K. 2021: NDRG1 facilitates lytic replication of Kaposi's sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase. Plos Pathogens 17(6): E1009645
Wang, H.; Li, W.; Xu, J.; Zhang, T.; Zuo, D.; Zhou, Z.; Lin, B.; Wang, G.; Wang, Z.; Sun, W.; Sun, M.; Chang, S.; Cai, Z.; Hua, Y. 2017: NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy. Cell Death and Disease 8(9): E3048
Aikemu, B.; Shao, Y.; Yang, G.; Ma, J.; Zhang, S.; Yang, X.; Hong, H.; Yesseyeva, G.; Huang, L.; Jia, H.; Wang, C.; Zang, L.; Sun, J.; Zheng, M. 2021: NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity. International Journal of Biological Sciences 17(7): 1716-1730
Zhao, T.; Meng, Y.; Wang, Y.; Wang, W. 2021: NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation. Journal of Orthopaedic Surgery and Research 16(1): 364
Zhu, J.; Yang, L.-K.; Wang, Q.-H.; Lin, W.; Feng, Y.; Xu, Y.-P.; Chen, W.-L.; Xiong, K.; Wang, Y.-H. 2020: NDRG2 attenuates ischemia-induced astrocyte necroptosis via the repression of RIPK1. Molecular Medicine Reports 22(4): 3103-3110
Shen, L.; Qu, X.; Li, H.; Xu, C.; Wei, M.; Wang, Q.; Ru, Y.; Liu, B.; Xu, Y.; Li, K.; Hu, J.; Wang, L.; Ma, Y.; Li, M.; Lai, X.; Gao, L.; Wu, K.; Yao, L.; Zheng, J.; Zhang, J. 2018: NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis. Oncogene 37(13): 1759-1774
Wang, J.; Li, T.; Ma, L.; Liu, G.; Wang, G.; Kang, J. 2021: NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma. Open Medicine 16(1): 742-748
Wei, M.; Ma, Y.; Shen, L.; Xu, Y.; Liu, L.; Bu, X.; Guo, Z.; Qin, H.; Li, Z.; Wang, Z.; Wu, K.; Yao, L.; Li, J.; Zhang, J. 2020: NDRG2 regulates adherens junction integrity to restrict colitis and tumourigenesis. Ebiomedicine 61: 103068
Hu, C-Biao.; Sui, B-Dong.; Wang, B-Ying.; Li, G.; Hu, C-Hu.; Zheng, C-Xi.; Du, F-Ying.; Zhu, C-Hui.; Li, H-Bo.; Feng, Y.; Jin, Y.; Yu, X-Rui. 2018: NDRG2 suppression as a molecular hallmark of photoreceptor-specific cell death in the mouse retina. Cell Death Discovery 4: 32
Jandrey, E.H.F.; Moura, R.P.; Andrade, L.N.S.; Machado, C.L.; Campesato, L.Felipe.; Leite, K.Ramos.M.; Inoue, L.T.; Asprino, P.F.; da Silva, A.Paula.M.; de Barros, A.Carlos.S.D.; Carvalho, A.; de Lima, V.C.; Carraro, D.M.; Brentani, H.P.; da Cunha, I.W.; Soares, F.A.; Parmigiani, R.B.; Chammas, R.; Camargo, A.A.; Costa, Érico.T. 2019: NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. Npj Breast Cancer 5: 11
Li, R.; He, C.; Shen, L.; Wang, S.; Shen, Y.; Feng, F.; Zhang, J.; Zheng, J. 2021: NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression. Oncology Letters 22(5): 782
Xiao, R.; Lu, G.; Guo, W.; Jin, S. 2020: NDRindex: a method for the quality assessment of single-cell RNA-Seq preprocessing data. Bmc Bioinformatics 21(Suppl 16): 540
Tang, Q.; Liu, M.; Liu, Y.; Hwang, R.-D.; Zhang, T.; Wang, J. 2021: NDST3 deacetylates α-tubulin and suppresses V-ATPase assembly and lysosomal acidification. Embo Journal 40(19): E107204
Hoefs, S.J.G.; van Spronsen, F.J.; Lenssen, E.W.H.; Nijtmans, L.G.; Rodenburg, R.J.; Smeitink, J.A.M.; van den Heuvel, L.P. 2011: NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease. European Journal of Human Genetics: Ejhg 19(3): 270-274
Xu, W.-N.; Yang, R.-Z.; Zheng, H.-L.; Jiang, L.-S.; Jiang, S.-D. 2020: NDUFA4L2 Regulated by HIF-1α Promotes Metastasis and Epithelial-Mesenchymal Transition of Osteosarcoma Cells Through Inhibiting ROS Production. Frontiers in Cell and Developmental Biology 8: 515051
Chen, Z.; Wei, X.; Wang, X.; Zheng, X.; Chang, B.; Shen, L.; Zhu, H.; Yang, M.; Li, S.; Zheng, X. 2021: NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib. Cell Death and Disease 12(4): 377
Yuan, Y.; Gao, H.; Zhuang, Y.; Wei, L.; Yu, J.; Zhang, Z.; Zhang, L.; Wang, L. 2021: NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer. Therapeutic Advances in Medical Oncology 13: 17588359211027836
Hou, T.; Zhang, R.; Jian, C.; Ding, W.; Wang, Y.; Ling, S.; Ma, Q.; Hu, X.; Cheng, H.; Wang, X. 2019: NDUFAB1 confers cardio-protection by enhancing mitochondrial bioenergetics through coordination of respiratory complex and supercomplex assembly. Cell Research 29(9): 754-766
Baertling, F.; Sánchez-Caballero, L.; van den Brand, Mël.A.M.; Wintjes, L.T.; Brink, M.; van den Brandt, F.A.; Wilson, C.; Rodenburg, R.J.T.; Nijtmans, L.G.J. 2017: NDUFAF4 variants are associated with Leigh syndrome and cause a specific mitochondrial complex I assembly defect. European Journal of Human Genetics: Ejhg 25(11): 1273-1277
Pesta, D.; Jelenik, T.; Zaharia, O.-P.; Bobrov, P.; Görgens, S.; Bódis, K.ál.án.; Karusheva, Y.; Krako Jakovljevic, N.; Lalic, N.M.; Markgraf, D.F.; Burkart, V.; Müssig, K.; Knebel, B.; Kotzka, J.ör.; Eckel, J.ür.; Strassburger, K.; Szendroedi, J.; Roden, M. 2021: NDUFB6 Polymorphism Is Associated with Physical Activity-Mediated Metabolic Changes in Type 2 Diabetes. Frontiers in Endocrinology 12: 693683
D'Angelo, L.; Astro, E.; De Luise, M.; Kurelac, I.; Umesh-Ganesh, N.; Ding, S.; Fearnley, I.M.; Gasparre, G.; Zeviani, M.; Porcelli, A.M.; Fernandez-Vizarra, E.; Iommarini, L. 2021: NDUFS3 depletion permits complex i maturation and reveals TMEM126A/OPA7 as an assembly factor binding the ND4-module intermediate. Cell Reports 35(3): 109002
Xu, X.; Zhang, D.; Ding, W.; Wang, W.; Jin, N.; Ding, Z. 2021: NDV related exosomes enhance NDV replication through exporting NLRX1 mRNA. Veterinary Microbiology 260: 109167
Shan, P.; Tang, B.; Xie, S.; Zhang, Z.; Fan, J.; Wei, Z.; Song, C. 2021: NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells. Journal of Cellular Biochemistry 122(1): 3-15
May, J.L.; Hollister, R.D.; Betway, K.R.; Harris, J.A.; Tweedie, C.E.; Welker, J.M.; Gould, W.A.; Oberbauer, S.F. 2020: NDVi Changes Show Warming Increases the Length of the Green Season at Tundra Communities in Northern Alaska: a Fine-Scale Analysis. Frontiers in Plant Science 11: 1174
Zhang, Y.; Wang, X.; Li, C.; Cai, Y.; Yang, Z.; Yi, Y. 2018: NDVI dynamics under changing meteorological factors in a shallow lake in future metropolitan, semiarid area in North China. Scientific Reports 8(1): 15971
Tucker, R.; Callaham, J.A.; Zeidler, C.; Paul, A.-L.; Ferl, R.J. 2020: NDVi imaging within space exploration plant growth modules - a case study from EDEN ISS Antarctica. Life Sciences in Space Research 26: 1-9
Sugaya, Y.; Akazawa, Y.; Saito, A.; Kamitsuji, S. 2012: NDesign: software for study design for the detection of rare variants from next-generation sequencing data. Journal of Human Genetics 57(10): 676-678
Pazianas, M. 2021: NE-58025: a bisphosphonate with a low hydroxyapatite binding affinity. Jbmr Plus 5(8): E10502
Nayak S, R.; D'Souza, R.S.; Mohan, M.P.; Bharath, S.; Kamath, S.S.; Dileep, B.N.; Ravi, P.M.; N, K. 2021: NE-OBT and TFWT activity concentrations in wild plants in the vicinity of the PHWR nuclear power plant and control regions of the tropical monsoonal climatic region of the Indian subcontinent. Journal of Environmental Radioactivity 240: 106740
Yang, C-Hwa.; Yeh, Y-Jung.; Wang, J-Yuh.; Liu, Y-Wen.; Chen, Y-Lin.; Cheng, H-Wen.; Cheng, C-Mei.; Chuang, Y-Jen.; Yuh, C-Hwa.; Chen, Y-Rong. 2017: NEAP/DUSP26 suppresses receptor tyrosine kinases and regulates neuronal development in zebrafish. Scientific Reports 7(1): 5241
Sun, Q.; Zhang, Y.; Wang, S.; Yang, F.; Cai, H.; Xing, Y.; Chen, Z.; Chen, J. 2021: NEAT1 Decreasing Suppresses Parkinson's Disease Progression via Acting as miR-1301-3p Sponge. Journal of Molecular Neuroscience: Mn 71(2): 369-378
Ak Aksoy, S.; Mutlu, M.; Balcin, R.N.; Taskapilioglu, M.O.; Tekin, C.; Kaya, S.; Civan, M.N.; Kocaeli, H.; Bekar, A.; Eser Ocak, P.; Cecener, G.; Egeli, U.; Tolunay, S.; Tunca, B. 2021: NEAT1 Is a Novel Oncogenic LncRNA and Correlated with miR-143 in Pediatric Oligodendrogliomas. Pediatric Neurosurgery 56(2): 133-139
Pan, W.; Wu, A.; Yu, H.; Yu, Q.; Zheng, B.; Yang, W.; Tian, D.; Gao, Y.; Li, P. 2020: NEAT1 Negatively Regulates Cell Proliferation and Migration of Neuroblastoma Cells by miR-183-5p/FOXP1 Via the ERK/AKT Pathway. Cell Transplantation 29: 963689720943608
Jia, X.; Wei, L.; Zhang, Z. 2021: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer. Frontiers in Genetics 12: 616220
Feng, Y.; Liu, J.; Wu, R.; Yang, P.; Ye, Z.; Song, F. 2020: NEAT1 aggravates sepsis-induced acute kidney injury by sponging miR-22-3p. Open Medicine 15(1): 333-342
Li, K.; Yao, T.; Zhang, Y.; Li, W.; Wang, Z. 2021: NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential. International Journal of Biological Sciences 17(13): 3428-3440
Nishimoto, Y.; Nakagawa, S.; Okano, H. 2021: NEAT1 lncRNA and amyotrophic lateral sclerosis. Neurochemistry International 150: 105175
Naveed, A.; Cooper, J.A.; Li, R.; Hubbard, A.; Chen, J.; Liu, T.; Wilton, S.D.; Fletcher, S.; Fox, A.H. 2021: NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma. Cellular and Molecular Life Sciences: Cmls 78(5): 2213-2230
Shi, C.; Shen, C.; Liu, G.; Yang, S.; Ye, F.; Meng, J.; Pan, Y. 2021: NEAT1 promotes the repair of abdominal aortic aneurysms of endothelial progenitor cells via regulating miR-204-5p/Ang-1. American Journal of Translational Research 13(4): 2111-2126
Zhao, Y.; Wang, Z.; Mao, Y.; Li, B.; Zhu, Y.; Zhang, S.; Wang, S.; Jiang, Y.; Xu, N.; Xie, Y.; Xie, W.; Zhang, Y. 2020: NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway in SH-SY5Y cells and APP/PS1 mice. Aging 12(22): 23233-23250
Jiang, L.; Shao, C.; Wu, Q-Jia.; Chen, G.; Zhou, J.; Yang, B.; Li, H.; Gou, L-Tao.; Zhang, Y.; Wang, Y.; Yeo, G.W.; Zhou, Y.; Fu, X-Dong. 2017: NEAT1 scaffolds RNA-binding proteins and the Microprocessor to globally enhance pri-miRNA processing. Nature Structural and Molecular Biology 24(10): 816-824
Hu, H.; Chen, W.; Zhang, S.; Xue, Y.; He, Y.; Gu, Y. 2021: NEAT1/miR-101-dependent Up-regulation of DNA-PKcs Enhances Malignant Behaviors of Pancreatic Ductal Adenocarcinoma Cells. Journal of Cancer 12(18): 5622-5632
Zhang, H.; Ji, N.; Gong, X.; Ni, S.; Wang, Y. 2020: NEAT1/miR-140-3p/MAPK1 mediates the viability and survival of coronary endothelial cells and affects coronary atherosclerotic heart disease. Acta Biochimica et Biophysica Sinica 52(9): 967-974
Ning, F.; Zhu, S.; Gao, H.; Deng, Y. 2021: NEAT1/miR-146a-3p/TrkB/ShcB axis regulates the development and function of chondrocyte. Cell Cycle 2021: 1-21
Zhou, W.-J.; Wang, H.-Y.; Zhang, J.; Dai, H.-Y.; Yao, Z.-X.; Zheng, Z.; Meng-Yan, S.; Wu, K. 2020: NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma. Aging 12(22): 22759-22775
Sun, W.; Lan, X.; Zhang, H.; Wang, Z.; Dong, W.; He, L.; Zhang, T.; Zhang, P.; Liu, J.; Qin, Y. 2018: NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer. Cell Death and Disease 9(3): 380
Ellis-Guardiola, K.; Mahoney, B.J.; Clubb, R.T. 2020: NEAr Transporter (NEAT) Domains: Unique Surface Displayed Heme Chaperones that Enable Gram-Positive Bacteria to Capture Heme-Iron from Hemoglobin. Frontiers in Microbiology 11: 607679
He, L.; Davila-Velderrain, J.; Sumida, T.S.; Hafler, D.A.; Kellis, M.; Kulminski, A.M. 2021: NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data. Communications Biology 4(1): 629
Vincent, D.; Klinke, M.; Eschenburg, G.; Trochimiuk, M.; Appl, B.; Tiemann, B.; Bergholz, R.; Reinshagen, K.; Boettcher, M. 2018: NEC is likely a NETs dependent process and markers of NETosis are predictive of NEC in mice and humans. Scientific Reports 8(1): 12612
Nakaoka, H.J.; Hara, T.; Yoshino, S.; Kanamori, A.; Matsui, Y.; Shimamura, T.; Sato, H.; Murakami, Y.; Seiki, M.; Sakamoto, T. 2016: NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells. Scientific Reports 6: 22784
Wang, L.; Yin, H.; Qian, Q.; Yang, J.; Huang, C.; Hu, X.; Luo, D. 2009: NECK LEAF 1, a GATA type transcription factor, modulates organogenesis by regulating the expression of multiple regulatory genes during reproductive development in rice. Cell Research 19(5): 598-611
Cole, W.H.; Fowler, E.F. 1965: Necropsies in Hospitals of the Chicago Area. Proceedings of the Institute of Medicine of Chicago 25: 240-242
Matos, M.Almeida.; Silva, L.Lisle.Dos.Santos.; Alves, G.Bruno.; de Alcântara, W.Silva.; Veiga, D. 2018: Necrosis of the Femoral Head and Health-Related Quality of Life of Children and Adolescents. Acta Ortopedica Brasileira 26(4): 227-230
Kanadashvili, O.; Belykh, E.; Soborov, M.; Alekseev, V.; Stolyarchuk, E.; Atayan, A. 2021: Necrotic Fasciitis as a Complication of Acute Destructive Appendicitis. Georgian Medical News 311: 21-27
Greenberg-Kushnir, N.; Schushan-Eisen, I.; Elisha, N.; Peleg, B.; Leibovitch, L.; Strauss, T. 2020: Necrotizing Enterocolitis - an Ongoing Challenge. Harefuah 159(10): 745-749
Teo, M.Y.; Rosenberg, J.E. 2021: NECTIN4 Heterogeneity and Molecular Diversity in Bladder Cancers: Deconstructing the Activity of An Antibody-Drug Conjugate. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 27(18): 4950-4952
Dursun, C.; Smith, J.R.; Hayman, G.T.; Kwitek, A.E.; Bozdag, S. 2020: NECo: a node embedding algorithm for multiplex heterogeneous networks. PROCEEDINGS. IEEE International Conference on Bioinformatics and Biomedicine 2020: 146-149
Cheng, F.; Cheng, Y.; Zhao, X.; An, L.; Yang, L.; Li, Z.; Zhang, L.; He, R. 2021: NEDD4 E3 ubiquitin protein ligase serves an important role in cutaneous melanoma occurrence and development. Experimental and Therapeutic Medicine 22(6): 1382
Wan, T.; Lei, Z.; Tu, B.; Wang, T.; Wang, J.; Huang, F. 2021: NEDD4 Induces K48-Linked Degradative Ubiquitination of Hepatitis B Virus X Protein and Inhibits HBV-Associated HCC Progression. Frontiers in Oncology 11: 625169
Jeon, S.-A.; Kim, D.W.; Lee, D.-B.; Cho, J.-Y. 2020: NEDD4 Plays Roles in the Maintenance of Breast Cancer Stem Cell Characteristics. Frontiers in Oncology 10: 1680
Bae, S.Jun.; Kim, M.; Kim, S-Hee.; Kwon, Y.Eun.; Lee, J-Hoon.; Kim, J.; Chung, C.Ha.; Lee, W-Jae.; Seol, J.Hong. 2015: NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway. Nature Communications 6: 6314
Zhou, Z.; Kawabe, H.; Suzuki, A.; Shinmyozu, K.; Saga, Y. 2017: NEDD4 controls spermatogonial stem cell homeostasis and stress response by regulating messenger ribonucleoprotein complexes. Nature Communications 8: 15662
Ziegler, C.M.; Dang, L.; Eisenhauer, P.; Kelly, J.A.; King, B.R.; Klaus, J.P.; Manuelyan, I.; Mattice, E.B.; Shirley, D.J.; Weir, M.E.; Bruce, E.A.; Ballif, B.A.; Botten, J. 2019: NEDD4 family ubiquitin ligases associate with LCMV Z's PPXY domain and are required for virus budding, but not via direct ubiquitination of Z. Plos Pathogens 15(11): E1008100
Sun, L.; Amraei, R.; Rahimi, N. 2021: NEDD4 regulates ubiquitination and stability of the cell adhesion molecule IGPR-1 via lysosomal pathway. Journal of Biomedical Science 28(1): 35
Fang, D-Feng.; He, K.; Wang, N.; Sang, Z-Hong.; Qiu, X.; Xu, G.; Jian, Z.; Liang, B.; Li, T.; Li, H-Yan.; Li, A-Ling.; Zhou, T.; Gong, W-Li.; Yang, B.; Karin, M.; Zhang, X-Min.; Li, W-Hua. 2014: NEDD4 ubiquitinates TRAF3 to promote CD40-mediated AKT activation. Nature Communications 5: 4513
Kaimori, J-Ya.; Lin, C-Chao.; Outeda, P.; Garcia-Gonzalez, M.A.; Menezes, L.F.; Hartung, E.A.; Li, A.; Wu, G.; Fujita, H.; Sato, Y.; Nakanuma, Y.; Yamamoto, S.; Ichimaru, N.; Takahara, S.; Isaka, Y.; Watnick, T.; Onuchic, L.F.; Guay-Woodford, L.M.; Germino, G.G. 2017: NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology. Scientific Reports 7(1): 7733
Mao, J.; Zigo, M.; Zuidema, D.; Sutovsky, M.; Sutovsky, P. 2021: NEDD4-like ubiquitin ligase 2 protein (NEDL2) in porcine spermatozoa, oocytes, and preimplantation embryos and its role in oocyte fertilization†. Biology of Reproduction 104(1): 117-129
Lee, D-Eun.; Yoo, J.Eun.; Kim, J.; Kim, S.; Kim, S.; Lee, H.; Cheong, H. 2020: NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter. Cell Death and Disease 11(1): 38
Chen, H.; Ross, C.A.; Wang, N.; Huo, Y.; MacKinnon, D.F.; Potash, J.B.; Simpson, S.G.; McMahon, F.J.; DePaulo, J.R.; McInnis, M.G. 2001: NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene. European Journal of Human Genetics: Ejhg 9(12): 922-930
Chen, L.; Yang, Y.; Yan, H.; Peng, X.; Zou, J. 2021: NEDD4L-induced β-catenin ubiquitination suppresses the formation and progression of interstitial pulmonary fibrosis via inhibiting the CTHRC1/HIF-1α axis. International Journal of Biological Sciences 17(13): 3320-3330
Wang, Y.; Liu, Y.; Liu, J.; Kang, R.; Tang, D. 2020: NEDD4L-mediated LTF protein degradation limits ferroptosis. Biochemical and Biophysical Research Communications 531(4): 581-587
Wei, Y.; Yee, P.P.; Liu, Z.; Zhang, L.; Guo, H.; Zheng, H.; Anderson, B.; Gulley, M.; Li, W. 2020: NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation. Embo Reports 21(12): E50642
Mohanty, P.; Chatterjee, K.S.; Das, R. 2021: NEDD8 Deamidation Inhibits Cullin RING Ligase Dynamics. Frontiers in Immunology 12: 695331
Russell, R.C.; Ohh, M. 2008: NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL. Embo Reports 9(5): 486-491
Baek, K.; Scott, D.C.; Schulman, B.A. 2021: NEDD8 and ubiquitin ligation by cullin-RING E3 ligases. Current Opinion in Structural Biology 67: 101-109
den Besten, W.; Verma, R.; Kleiger, G.; Oania, R.S.; Deshaies, R.J. 2012: NEDD8 links cullin-RING ubiquitin ligase function to the p97 pathway. Nature Structural and Molecular Biology 19(5): 511-6 S1
Kittai, A.S.; Danilova, O.V.; Lam, V.; Liu, T.; Bruss, N.; Best, S.; Fan, G.; Danilov, A.V. 2021: NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells. Oncotarget 12(20): 2068-2074
Wang, S.; Xian, J.; Li, L.; Jiang, Y.; Liu, Y.; Cai, L.; Hoffman, R.M.; Jia, L.; Zhao, H.; Zhang, Y. 2020: NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma. Signal Transduction and Targeted Therapy 5(1): 123
Baek, K.; Krist, D.T.; Prabu, J.Rajan.; Hill, S.; Klügel, M.; Neumaier, L-Marie.; von Gronau, S.; Kleiger, G.; Schulman, B.A. 2020: NEDD8 nucleates a multivalent cullin-RING-UBE2D ubiquitin ligation assembly. Nature 578(7795): 461-466
Gabbasov, R.; Xiao, F.; Howe, C.G.; Bickel, L.E.; O'Brien, S.W.; Benrubi, D.; Do, T-Vy.; Zhou, Y.; Nicolas, E.; Cai, K.Q.; Litwin, S.; Seo, S.; Golemis, E.A.; Connolly, D.C. 2018: NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice. Oncogene 37(35): 4854-4870
Loskutov, Y.V.; Kozyulina, P.Y.; Kozyreva, V.K.; Ice, R.J.; Jones, B.C.; Roston, T.J.; Smolkin, M.B.; Ivanov, A.V.; Wysolmerski, R.B.; Pugacheva, E.N. 2015: NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer. Oncogene 34(28): 3662-3675
Aoki, I.; Higuchi, M.; Gotoh, Y. 2013: NEDDylation controls the target specificity of E2F1 and apoptosis induction. Oncogene 32(34): 3954-3964
Naik, S.K.; Lam, E.W-F.; Parija, M.; Prakash, S.; Jiramongkol, Y.; Adhya, A.K.; Parida, D.K.; Mishra, S.K. 2020: NEDDylation negatively regulates ERRβ expression to promote breast cancer tumorigenesis and progression. Cell Death and Disease 11(8): 703
Zhang, T.; Ye, Z.; Yang, X.; Qin, Y.; Hu, Y.; Tong, X.; Lai, W.; Ye, X. 2017: NEDDylation of PB2 Reduces Its Stability and Blocks the Replication of Influenza A Virus. Scientific Reports 7: 43691
Maghames, C.M.; Lobato-Gil, S.; Perrin, A.; Trauchessec, H.; Rodriguez, M.S.; Urbach, S.; Marin, P.; Xirodimas, D.P. 2018: NEDDylation promotes nuclear protein aggregation and protects the Ubiquitin Proteasome System upon proteotoxic stress. Nature Communications 9(1): 4376
Jayabalan, A.Kumar.; Sanchez, A.; Park, R.Young.; Yoon, S.Pil.; Kang, G-Yong.; Baek, J-Hyun.; Anderson, P.; Kee, Y.; Ohn, T. 2016: NEDDylation promotes stress granule assembly. Nature Communications 7: 12125
Loftus, S.J.; Liu, G.; Carr, S.M.; Munro, S.; La Thangue, N.B. 2012: NEDDylation regulates E2F-1-dependent transcription. Embo Reports 13(9): 811-818
Kadam, D. 2021: NEET Super-Specialty Intake: a Paradox of Demand and Supply or the Eligibility?. Indian Journal of Plastic Surgery: Official Publication of the Association of Plastic Surgeons of India 54(1): 1-3
Cappai, M.G.; Taras, A.; Biggio, G.P.; Dimauro, C.; Gatta, D.; Cossu, I.; Cherchi, R.; Pinna, W. 2021: NEFA, BHBa, UREA and Liver Enzyme Variation in the Bloodstream of Weaned Foals up to 18 Months of Age. Animals: An Open Access Journal from Mdpi 11(6)
Dirnberger, M.; Kehl, T.; Neumann, A. 2015: NEFI: Network Extraction From Images. Scientific Reports 5: 15669
Li, D.; Zhao, W.; Zhang, X.; Lv, H.; Li, C.; Sun, L. 2021: NEFM DNA methylation correlates with immune infiltration and survival in breast cancer. Clinical Epigenetics 13(1): 112
Okhrimenko, I.M.; Lyhun, N.V.; Pryimak, V.P.; Korol, Y.I.; Myroshnychenko, M.S. 2021: Negative Factors of Management Activities of the Security and Defence Sector Representatives and Directions of their Overcoming. Wiadomosci Lekarskie 74(4): 891-895
Mcleod, G.L. 1965: Negligence. New Zealand Medical Journal 64: 315-317
Wright, C.; Mazzucco, A.E.; Becker, S.M.; Sieving, P.A.; Tumminia, S.J. 2020: NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future. Translational Vision Science and Technology 9(7): 49
Ledingham, J.M.; Yates, M.; Galloway, J.B. 2020: NEIAA: driving EIA service quality in a shifting clinical landscape. Rheumatology 59(11): 3127-3128
Valencia, M.; Bentele, M.; Vaze, M.B.; Herrmann, G.; Kraus, E.; Lee, S.E.; Schär, P.; Haber, J.E. 2001: NEJ1 controls non-homologous end joining in Saccharomyces cerevisiae. Nature 414(6864): 666-669
Watson, T. 1992: NEJM restricts use of SI units. Nature 359(6392): 175
Zhang, K.; Lu, Y.; Chen, J.; Li, J.; Yadav, K.Kishor.; Yin, J.; Yang, X. 2020: NEK1 and GRN mutations coexist in a sporadic Chinese Hui descent ALS patient. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21(7-8): 624-626
Melo-Hanchuk, T.D.; Slepicka, P.Ferreira.; Meirelles, G.Vaz.; Basei, F.Luisa.; Lovato, D.Ventura.; Granato, D.Campos.; Pauletti, B.Alves.; Domingues, R.Ramos.; Leme, A.Franco.Paes.; Pelegrini, A.Luiza.; Lenz, G.; Knapp, S.; Elkins, J.M.; Kobarg, Jörg. 2017: NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin. Scientific Reports 7(1): 5445
Yao, L.; He, X.; Cui, B.; Zhao, F.; Zhou, C. 2021: NEK1 mutations and the risk of amyotrophic lateral sclerosis (ALS): a meta-analysis. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 42(4): 1277-1285
Kenna, K.P.; van Doormaal, P.T.C.; Dekker, A.M.; Ticozzi, N.; Kenna, B.J.; Diekstra, F.P.; van Rheenen, W.; van Eijk, K.R.; Jones, A.R.; Keagle, P.; Shatunov, A.; Sproviero, W.; Smith, B.N.; van Es, M.A.; Topp, S.D.; Kenna, A.; Miller, J.W.; Fallini, C.; Tiloca, C.; McLaughlin, R.L.; Vance, C.; Troakes, C.; Colombrita, C.; Mora, G.; Calvo, A.; Verde, F.; Al-Sarraj, S.; King, A.; Calini, D.; de Belleroche, J.; Baas, F.; van der Kooi, A.J.; de Visser, M.; Ten Asbroek, A.L.M.A.; Sapp, P.C.; McKenna-Yasek, D.; Polak, M.; Asress, S.; Muñoz-Bl 2016: NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nature Genetics 48(9): 1037-1042
Wang, H.; Qi, W.; Zou, C.; Xie, Z.; Zhang, M.; Naito, M.Gomi.; Mifflin, L.; Liu, Z.; Najafov, A.; Pan, H.; Shan, B.; Li, Y.; Zhu, Z-Jiang.; Yuan, J. 2021: NEK1-mediated retromer trafficking promotes blood-brain barrier integrity by regulating glucose metabolism and RIPK1 activation. Nature Communications 12(1): 4826
Haider, N.; Dutt, P.; van de Kooij, B.; Ho, J.; Palomero, L.; Pujana, M.Angel.; Yaffe, M.; Stambolic, V. 2020: NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity. Oncogene 39(30): 5252-5266
Melixetian, M.; Klein, D.Kjaersgaard.; Sørensen, C.Storgaard.; Helin, K. 2009: NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint. Nature Cell Biology 11(10): 1247-1253
Ge, W.L.; Chen, J.N.; Ji, L.H.; Zhao, J.; Xian, H.; Xu, Y.Z. 2020: NEK2 gene expression in mouse cryptorchidism model and its mechanism involved in apoptosis. Zhonghua Yi Xue Za Zhi 100(44): 3534-3538
Hao, M.; Franqui-Machin, R.; Xu, H.; Shaughnessy, J.; Barlogie, B.; Roodman, D.; Quelle, D.E.; Janz, S.; Tomasson, M.H.; Sanderson, R.D.; Qiu, L.; Frech, I.; Tricot, G.; Zhan, F. 2017: NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. Leukemia 31(7): 1648-1650
Zhang, X.; Huang, X.; Xu, J.; Li, E.; Lao, M.; Tang, T.; Zhang, G.; Guo, C.; Zhang, X.; Chen, W.; Yadav, D.Kumar.; Bai, X.; Liang, T. 2021: NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Nature Communications 12(1): 4536
Bai, R.; Yuan, C.; Sun, W.; Zhang, J.; Luo, Y.; Gao, Y.; Li, Y.; Gong, Y.; Xie, C. 2021: NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer. International Journal of Biological Sciences 17(8): 1995-2008
Jian, F.; Sun, Y.; Sun, Q.; Zhang, B.; Bian, L. 2021: NEK2 regulates cellular proliferation and cabergoline sensitivity in pituitary adenomas. Journal of Cancer 12(7): 2083-2091
Li, G.; Dong, Y.; Liu, D.; Zou, Z.; Hao, G.; Gao, X.; Pan, P.; Liang, G. 2020: NEK7 Coordinates Rapid Neuroinflammation After Subarachnoid Hemorrhage in Mice. Frontiers in Neurology 11: 551
Yan, Z.; Qu, J.; Li, Z.; Yi, J.; Su, Y.; Lin, Q.; Yu, G.; Lin, Z.; Yin, W.; Lu, F.; Liu, J. 2021: NEK7 Promotes Pancreatic Cancer Progression and its Expression Is Correlated with Poor Prognosis. Frontiers in Oncology 11: 705797
Chen, X.; Liu, G.; Yuan, Y.; Wu, G.; Wang, S.; Yuan, L. 2019: NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling. Cell Death and Disease 10(12): 906
He, Y.; Zeng, M.Y.; Yang, D.; Motro, B.; Núñez, G. 2016: NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530(7590): 354-357
Li, Y.-K.; Zhu, X.-R.; Zhan, Y.; Yuan, W.-Z.; Jin, W.-L. 2021: NEK7 promotes gastric cancer progression as a cell proliferation regulator. Cancer Cell International 21(1): 438
Freixo, F.; Martinez Delgado, P.; Manso, Y.; Sánchez-Huertas, C.; Lacasa, C.; Soriano, E.; Roig, J.; Lüders, J. 2018: NEK7 regulates dendrite morphogenesis in neurons via Eg5-dependent microtubule stabilization. Nature Communications 9(1): 2330
Yamamoto, Y.; Chino, H.; Tsukamoto, S.; Ode, K.L.; Ueda, H.R.; Mizushima, N. 2021: NEK9 regulates primary cilia formation by acting as a selective autophagy adaptor for MYH9/myosin IIA. Nature Communications 12(1): 3292
Lu, G.; Tian, S.; Sun, Y.; Dong, J.; Wang, N.; Zeng, J.; Nie, Y.; Wu, K.; Han, Y.; Feng, B.; Shang, Y. 2021: NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation. Theranostics 11(5): 2460-2474
Kurioka, D.; Takeshita, F.; Tsuta, K.; Sakamoto, H.; Watanabe, S-ichi.; Matsumoto, K.; Watanabe, M.; Nakagama, H.; Ochiya, T.; Yokota, J.; Kohno, T.; Tsuchiya, N. 2014: NEK9-dependent proliferation of cancer cells lacking functional p53. Scientific Reports 4: 6111
Bishara, L.A.; Machour, F.E.; Awwad, S.W.; Ayoub, N. 2021: NELF complex fosters BRCA1 and RAD51 recruitment to DNA damage sites and modulates sensitivity to PARP inhibition. Dna Repair 97: 103025
Ngian, Z.-K.; Lin, W.-Q.; Ong, C.-T. 2021: NELF-A controls Drosophila healthspan by regulating heat-shock protein-mediated cellular protection and heterochromatin maintenance. Aging Cell 20(5): E13348
Nishida, N.; Aiba, Y.; Hitomi, Y.; Kawashima, M.; Kojima, K.; Kawai, Y.; Ueno, K.; Nakamura, H.; Yamashiki, N.; Tanaka, T.; Tamura, S.; Mori, A.; Yagi, S.; Soejima, Y.; Yoshizumi, T.; Takatsuki, M.; Tanaka, A.; Harada, K.; Shimoda, S.; Komori, A.; Eguchi, S.; Maehara, Y.; Uemoto, S.; Kokudo, N.; Nagasaki, M.; Tokunaga, K.; Nakamura, M. 2018: NELFCD and CTSZ loci are associated with jaundice-stage progression in primary biliary cholangitis in the Japanese population. Scientific Reports 8(1): 8071
Dang, H.; Pomyen, Y.; Martin, S.P.; Dominguez, D.A.; Yim, S.Young.; Lee, J-Seog.; Budhu, A.; Shah, A.P.; Bodzin, A.S.; Wang, X.Wei. 2019: NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma. Scientific Reports 9(1): 3369
James, A.W.; Shen, J.; Zhang, X.; Asatrian, G.; Goyal, R.; Kwak, J.H.; Jiang, L.; Bengs, B.; Culiat, C.T.; Turner, A.Simon.; Seim Iii, H.B.; Wu, B.M.; Lyons, K.; Adams, J.S.; Ting, K.; Soo, C. 2015: NELL-1 in the treatment of osteoporotic bone loss. Nature Communications 6: 7362
Kudose, S.; Sekulic, M.; Mehring, C.J.; Santoriello, D.; Batal, I.; Stokes, M.B.; D'Agati, V.D.; Markowitz, G.S. 2021: NELL1-Associated Membranous Glomerulopathy After Hematopoietic Stem Cell Transplantation. Kidney International Reports 6(7): 1992-1995
Kim, H.R.; Kim, D.H.; An, J.Y.; Kang, D.; Park, J.W.; Hwang, E.M.; Seo, E.J.; Jang, I.H.; Ha, C.M.; Lee, B.J. 2020: NELL2 Function in Axon Development of Hippocampal Neurons. Molecules and Cells 43(6): 581-589
Pak, J.S.; DeLoughery, Z.J.; Wang, J.; Acharya, N.; Park, Y.; Jaworski, A.; Özkan, E. 2020: NELL2-Robo3 complex structure reveals mechanisms of receptor activation for axon guidance. Nature Communications 11(1): 1489
Jayabal, P.; Zhou, F.; Lei, X.; Ma, X.; Blackman, B.; Weintraub, S.T.; Houghton, P.J.; Shiio, Y. 2021: NELL2-cdc42 signaling regulates BAF complexes and Ewing sarcoma cell growth. Cell Reports 36(1): 109254
Kiyozumi, D.; Noda, T.; Yamaguchi, R.; Tobita, T.; Matsumura, T.; Shimada, K.; Kodani, M.; Kohda, T.; Fujihara, Y.; Ozawa, M.; Yu, Z.; Miklossy, G.; Bohren, K.M.; Horie, M.; Okabe, M.; Matzuk, M.M.; Ikawa, M. 2020: NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility. Science 368(6495): 1132-1135
Zhang, Y.; Zhu, L.; Wang, X. 2021: NEM-Tar: a Probabilistic Graphical Model for Cancer Regulatory Network Inference and Prioritization of Potential Therapeutic Targets from Multi-Omics Data. Frontiers in Genetics 12: 608042
Moliner, L.; Rodríguez-Alvarez, M.J.; Catret, J.V.; González, A.; Ilisie, Víctor.; Benlloch, Jé.M. 2019: NEMA Performance Evaluation of CareMiBrain dedicated brain PET and Comparison with the whole-body and dedicated brain PET systems. Scientific Reports 9(1): 15484
Martin, P.B.; Kigoshi-Tansho, Y.; Sher, R.B.; Ravenscroft, G.; Stauffer, J.E.; Kumar, R.; Yonashiro, R.; Müller, T.; Griffith, C.; Allen, W.; Pehlivan, D.; Harel, T.; Zenker, M.; Howting, D.; Schanze, D.; Faqeih, E.A.; Almontashiri, N.A.M.; Maroofian, R.; Houlden, H.; Mazaheri, N.; Galehdari, H.; Douglas, G.; Posey, J.E.; Ryan, M.; Lupski, J.R.; Laing, N.G.; Joazeiro, C.A.P.; Cox, G.A. 2020: NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease. Nature Communications 11(1): 4625
Serramito-Gómez, I.; Clarke, K.M.; Rodríguez-Vicente, A.E.; McGimpsey, J.E.; Abáigar, M.ía.; Díez, C.B.; Benito, R.ío.; Bullinger, L.; Mills, K.I.; Hernández Rivas, J.ús.M.ía. 2021: NEMHESYS-European Perspective on the Implementation of Next-generation Sequencing into Clinical Diagnostics. Hemasphere 5(3): E541
Tada, H.; Yoshida, S.; Yamaji, Y.; Fujisawa, K.; Ishibashi, T. 2007: NEMO mutational analysis in a Japanese family with incontinentia pigmenti. Eye 21(6): 888-890
Pescatore, A.; Esposito, E.; Draber, P.; Walczak, H.; Ursini, M.Valeria. 2016: NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II. Cell Death and Disease 7(8): E2346
Laplantine, E.; Fontan, E.; Chiaravalli, J.; Lopez, T.; Lakisic, G.; Véron, M.; Agou, F.; Israël, A. 2009: NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO Journal 28(19): 2885-2895
Legarda-Addison, D.; Hase, H.; O'Donnell, M.A.; Ting, A.T. 2009: NEMO/IKKgamma regulates an early NF-kappaB-independent cell-death checkpoint during TNF signaling. Cell Death and Differentiation 16(9): 1279-1288
Zanjani, M.B.; Davoyan, A.R.; Engheta, N.; Lukes, J.R. 2015: NEMS With Broken T Symmetry: Graphene Based Unidirectional Acoustic Transmission Lines. Scientific Reports 5: 9926
Freeman, M.; Hiebert, W. 2008: NEMS: taking another swing at computing. Nature Nanotechnology 3(5): 251-252
Pachade, S.; Porwal, P.; Kokare, M.; Giancardo, L.; Mériaudeau, F. 2021: NENet: Nested EfficientNet and adversarial learning for joint optic disc and cup segmentation. Medical Image Analysis 74: 102253
Chatterjee, S.; Das, S.; Pequito, S.ér. 2021: NEO: NEuro-Inspired Optimization-A Fractional time Series Approach. Frontiers in Physiology 12: 724044
Luwisch, H.; Rabinovich, I.; Yutkin, V.; Frank, S.; Neuman, T.; Duvdevani, M.; Youssef, F.; Hidas, G.; Gofrit, O.N. 2021: Neoadjuvant Chemotherapy before Radical Cystectomy - Might it be Offered Selectively?. Harefuah 160(9): 559-564
Friedman, N.S.; Shaham, L.; Sharon, N.; Barlev, C. 2020: Neoadjuvant Treatment of Locally Advanced Estrogen/Progesterone Positive, Her2neu Negative Breast Cancer. Harefuah 159(5): 370-375
Dixon, C.E.; Bedenice, D.; Restifo, M.; Mazan, M.; Brewer, P.; Knafo, S.E. 2021: Neonatal Intensive Care of 10 Hospitalized Giraffe Calves (Giraffa Camelopardalis) Requiring Hand-Rearing. Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 52(1): 57-66
Osovsky, M.; Fridlander, R.; Laron, T.; Sabbah, F. 2020: Neonatal Skin Manifestation of Langerhans cell Histiocytosis. Harefuah 159(10): 731-734
Ascher, K.W. 1964: Neonatal Thrombocytopenia and Thiazide Drugs. British Medical Journal 1(5395): 1395
Hawkins, S.; Garner, M.M.; Hartup, B.K. 2021: Neoplasia in Captive Cranes. Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 52(2): 689-697
Law, L.W. 1965: Neoplasms in Thymectomized Mice Following Room Infection with Polyoma Virus. Nature 205: 672-673
Rosa, C.A.d.; Ribeiro, B.R.; Bejarano, V.; Puertas, F.H.; Bocchiglieri, A.; Barbosa, A.L.D.S.; Chiarello, A.G.; Paglia, A.P.; Pereira, A.A.; Moreira, A.F.d.S.; Souza, A.C.d.; Pellegrin, A.; Gatica, A.; Medeiro, A.Z.; Pereira, A.D.; Braz, A.G.; Yanosky, A.; Valenzuela, A.E.J.; Bertassoni, A.; Prado, A.D.S.V.d.; Nava, A.F.D.; Rocha, A.; Bovo, A.A.A.; Bager, A.; Cravino, A.; Pires, A.D.S.; Martensen, A.C.; Filippini, A.; Percequillo, A.R.; Vogliotti, A.; Antunes, A.Z.; Leite de Oliveira, A.C.; da Silva de Oliveira, A.J.; Devlin, A.; de Paula, A.; Ferreira, A.S.; García-Olaechea, A.; Subalusky, A.; Sánchez, A.; de Aquino, A.C.M.M.; Srbek-Araujo, A.C.; Paldês Gonçales, A.; Araújo, A.C.L.; Gozzi, A.C.; Ochoa, A.C.; Mendes de Oliveira, A.C.;, 2020: Neotropical Alien Mammals: a Data Set of Occurrence and Abundance of Alien Mammals in the Neotropics. Ecology 101(11): E03115
Nagy-Reis, M.; Oshima, J.úl.E.d.F.; Kanda, C.Z.; Palmeira, F.B.L.; de Melo, F.R.; Morato, R.G.ça.; Bonjorne, L.; Magioli, M.; Leuchtenberger, C.; Rohe, F.; Lemos, F.G.; Martello, F.; Alves-Eigenheer, M.; da Silva, R.A.; Silveira Dos Santos, J.; Priante, C.F.át.; Bernardo, R.; Rogeri, P.; Assis, J.C.; Gaspar, L.P.; Tonetti, V.R.; Trinca, C.T.é; Ribeiro, A.d.S.; Bocchiglieri, A.; Hass, A.; Canteri, A.; Chiarello, A.G.; Paglia, A.P.; Pereira, A.A.; de Souza, A.C.; Gatica, A.; Medeiro, A.Z.; Eriksson, A.; Costa, A.N.; González-Gallina, A.; Yanosky, A.A.; Jesus de la Cruz, A.; Bertassoni, A.; Bager, A.; Bovo, A.A.A.; Cravino Mol, A.; Bezerra, A.M.R.; Percequillo, A.; Vogliotti, A.; Costa Lopes, A.M.; Keuroghlian, A.; Zúñiga Hartley, A.C.; 2020: NEOTROPICAL CARNIVORES: a data set on carnivore distribution in the Neotropics. Ecology 101(11): E03128
Ozawa, S.; Guzman, D.S.-M.; Palm, C.A.; Robertson, J.; Norvall, A.; Choi, E.; Roy, M.; Paul-Murphy, J.; Culp, W.T.N. 2021: Neoureterocystostomy and Urethral Stent Placement in a Black-Handed Spider Monkey (Ateles Geoffroyi). Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 52(2): 843-848
Gagliardi, I.; Tarquini, M.; Ambrosio, M.R.; Giannetta, E.; Borges de Souza, P.; Gafà, R.; Carnevale, A.; Franceschetti, P.; Zatelli, M.C. 2020: NEP-Score Thresholds Predict Survival of Patients with Bronchial Carcinoids. Frontiers in Endocrinology 11: 621557
De Luca, R.; Volpe, C.; Mistretta, O.; Paci, R.; Ferrera, G.; Caputo, V.; Rosati, G.; Cicero, G. 2021: NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study. European Review for Medical and Pharmacological Sciences 25(16): 5310-5317
Valerio, M.Rosaria.; Gebbia, V.; Borsellino, Nò.; Vecchia, M.La.; Serretta, V.; Pardo, S.; Cipolla, C.; Galanti, D. 2020: NEPA as antiemetic prophylaxis after failure of 5HT 3 -RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 2020: 1078155220929409
Gunn, A.D. 1965: Nephrectomy. Nursing Times 61: 67-69
Viamonte, M.; Parks, R.E. 1964: Nephroangiography. Revista Venezolana de Urologia 16: 61-94
Dawson, E.M. 1964: Nephroblastoma (Wilms' Tumour): Improved Prognosis with Actinomycin D. Medical Journal of Australia 2: 479-480
Harrison, A.R.; Ghose, R.R. 1963: Nephrocalcinosis. Proceedings of the Royal Society of Medicine 56: 925-927
Ringoir, S. 1965: Nephrolithiasis. Belgisch Tijdschrift Voor Geneeskunde 21: 94-98
Lamelin, J.P. 1963: Nephrology. Gazette Medicale de France 70: 3909-3917
Jacobs, C. 1964: Nephrology. Gazette Medicale de France 71: 4179-4190
Martin-Dupont, C. 1964: Nephrology in 1964. Journal de Medecine de Bordeaux et du Sud-Ouest 141: 1542-1545
Houtappel, H.C. 1963: Nephropexy. Nederlands Tijdschrift Voor Geneeskunde 107: 2038-2044
Thurn, P.; Buecheler, E. 1963: Nephrotomography. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 99: 784-794
Xia, J.; Bai, P.; Fan, W.; Li, Q.; Li, Y.; Wang, D.; Yin, L.; Zhou, Y. 2021: NEPdb: a Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy. Frontiers in Immunology 12: 644637
Stergiou, L.; Eberhard, R.; Doukoumetzidis, K.; Hengartner, M.O. 2011: NER and HR pathways act sequentially to promote UV-C-induced germ cell apoptosis in Caenorhabditis elegans. Cell Death and Differentiation 18(5): 897-906
Bommi, P.V.; Chand, V.; Mukhopadhyay, N.K.; Raychaudhuri, P.; Bagchi, S. 2020: NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC. Oncogene 39(8): 1784-1796
Savarino, E.; Zentilin, P.; Savarino, V. 2013: NERD: an umbrella term including heterogeneous subpopulations. Nature Reviews. Gastroenterology and Hepatology 10(6): 371-380
Varga, M.J.; Fu, Y.; Loggia, S.; Yogurtcu, O.N.; Johnson, M.E. 2020: NERDSS: a Nonequilibrium Simulator for Multibody Self-Assembly at the Cellular Scale. Biophysical Journal 118(12): 3026-3040
Hu, J.; Lei, H.; Fei, X.; Liang, S.; Xu, H.; Qin, D.; Wang, Y.; Wu, Y.; Li, B. 2015: NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells. Scientific Reports 5: 17426
Jakobsen, A-M.; Ahlman, H.; Kölby, L.; Abrahamsson, J.; Fischer-Colbrie, R.; Nilsson, O. 2003: NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids. British Journal of Cancer 88(11): 1746-1754
Taub, P.J.; Nguyen, V. 2020: NESPS Edition of Annals of Plastic Surgery. Annals of Plastic Surgery 85(S1 Suppl. 1): S1
Goligorsky, M.S. 2020: NET Formation in Dialysis: a Valuable, albeit Mysterious and Enticing Predictor of Mortality. American Journal of Nephrology 51(11): 849-851
McHugh, J. 2019: NET formation differs in SLE and vasculitis. Nature Reviews. Rheumatology 15(9): 512
McHugh, J. 2020: NET formation implicated in myositis. Nature Reviews. Rheumatology 16(4): 187
Kaynar, A.Murat.; Shapiro, S.D. 2010: NET loss of air in cystic fibrosis. Nature Medicine 16(9): 967-969
Hirabayashi, S.; Bhagat, S.; Matsuki, Y.; Takegami, Y.; Uehata, T.; Kanemaru, A.; Itoh, M.; Shirakawa, K.; Takaori-Kondo, A.; Takeuchi, O.; Carninci, P.; Katayama, S.; Hayashizaki, Y.; Kere, J.; Kawaji, H.; Murakawa, Y. 2019: NET-CAGE characterizes the dynamics and topology of human transcribed cis-regulatory elements. Nature Genetics 51(9): 1369-1379
Haritha, V.H.; George, A.; Shaji, B.V.; Anie, Y. 2020: NET-associated citrullinated histones promote LDL aggregation and foam cell formation in vitro. Experimental Cell Research 396(2): 112320
Murray, D.; Horgan, G.; Macmathuna, P.; Doran, P. 2008: NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. British Journal of Cancer 99(8): 1322-1329
Fedorova, M.S.; Snezhkina, A.V.; Lipatova, A.V.; Pavlov, V.S.; Kobelyatskaya, A.A.; Guvatova, Z.G.; Pudova, E.A.; Savvateeva, M.V.; Ishina, I.A.; Demidova, T.B.; Volchenko, N.N.; Trofimov, D.Y.; Sukhikh, G.T.; Krasnov, G.S.; Kudryavtseva, A.V. 2020: NETO2 Is Deregulated in Breast, Prostate, and Colorectal Cancer and Participates in Cellular Signaling. Frontiers in Genetics 11: 594933
Xu, J.-C.; Chen, T.-Y.; Liao, L.-T.; Chen, T.; Li, Q.-L.; Xu, J.-X.; Hu, J.-W.; Zhou, P.-H.; Zhang, Y.-Q. 2021: NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway. International Journal of Biological Sciences 17(1): 259-270
Liu, J-Yan.; Jiang, L.; He, T.; Liu, J-Jia.; Fan, J-Yan.; Xu, X-Hui.; Tang, B.; Shi, Y.; Zhao, Y-Liang.; Qian, F.; Wang, Y.; Cui, Y-Hong.; Yu, P-Wu. 2019: NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients. Cell Death and Disease 10(3): 162
Arroyo Relión, J.ús.D.; Kessler, D.; Levina, E.; Taylor, S.F. 2019: Network Classification with Applications to Brain Connectomics. Annals of Applied Statistics 13(3): 1648-1677
Wang, Y.X.R.; Sarkar, P.; Ursu, O.; Kundaje, A.; Bickel, P.J. 2019: Network Modelling of Topological Domains using Hi-C Data. Annals of Applied Statistics 13(3): 1511-1536
Nagareddy, P.R.; Sreejit, G.; Abo-Aly, M.; Jaggers, R.M.; Chelvarajan, L.; Johnson, J.; Pernes, G.; Athmanathan, B.; Abdel-Latif, A.; Murphy, A.J. 2020: NETosis Is Required for S100A8/A9-Induced Granulopoiesis After Myocardial Infarction. Arteriosclerosis Thrombosis and Vascular Biology 40(11): 2805-2807
Katkar, G.D.; Sundaram, M.S.; NaveenKumar, S.K.; Swethakumar, B.; Sharma, R.D.; Paul, M.; Vishalakshi, G.J.; Devaraja, S.; Girish, K.S.; Kemparaju, K. 2016: NETosis and lack of DNase activity are key factors in Echis carinatus venom-induced tissue destruction. Nature Communications 7: 11361
Gillot, C.; Favresse, J.; Mullier, F.ço.; Lecompte, T.; Dogné, J.-M.; Douxfils, J. 2021: NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments. Frontiers in Pharmacology 12: 708302
Ling, S.; Xu, J.-W. 2021: NETosis as a Pathogenic Factor for Heart Failure. Oxidative Medicine and Cellular Longevity 2021: 6687096
Binet, F.ço.; Wilson, A.M.; Sapieha, P. 2021: NETosis drives removal of senescent cells and favors revascularisation in retinopathy. Medecine Sciences: M/S 37(5): 541-543
Jariwala, M.P.; Laxer, R.M. 2021: NETosis in Rheumatic Diseases. Current Rheumatology Reports 23(2): 9
Kasperkiewicz, P.; Hempel, A.; Janiszewski, T.; Kołt, S.; Snipas, S.J.; Drag, M.; Salvesen, G.S. 2020: NETosis occurs independently of neutrophil serine proteases. Journal of Biological Chemistry 295(51): 17624-17631
Ciliberti, M.G.; Albenzio, M.; Claps, S.; Santillo, A.; Marino, R.; Caroprese, M. 2021: NETosis of Peripheral Neutrophils Isolated from Dairy Cows Fed Olive Pomace. Frontiers in Veterinary Science 8: 626314
Vorobjeva, N.V.; Chernyak, B.V. 2020: NETosis: Molecular Mechanisms, Role in Physiology and Pathology. BIOCHEMISTRY. Biokhimiia 85(10): 1178-1190
Zhu, K.; Zhu, Y.; Hou, X.; Chen, W.; Qu, X.; Zhang, Y.; Li, Z.; Wang, C.; Chen, J.; Lv, L.; Wang, J.; Zhang, D.; Hou, L. 2021: NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway. Frontiers in Neuroscience 15: 621477
Bordon, Y. 2018: NETs awaken sleeping cancer cells. Nature Reviews. Immunology 18(11): 665
Clarke, J. 2020: NETs directly injure cartilage in RA. Nature Reviews. Rheumatology 16(8): 410
Tambralli, A.; Gockman, K.; Knight, J.S. 2020: NETs in APS: Current Knowledge and Future Perspectives. Current Rheumatology Reports 22(10): 67
Dickson, I. 2020: NETs promote liver metastasis via CCDC25. Nature Reviews. Gastroenterology and Hepatology 17(8): 451
Wigerblad, G.; Kaplan, M.J. 2020: NETs spread ever wider in rheumatic diseases. Nature Reviews. Rheumatology 16(2): 73-74
Esmail, S.; Danter, W.R. 2021: NEUBOrg: Artificially Induced Pluripotent Stem Cell-Derived Brain Organoid to Model and Study Genetics of Alzheimer's Disease Progression. Frontiers in Aging Neuroscience 13: 643889
Packard, M.G.; Gadberry, T.; Goodman, J. 2021: Neural systems and the emotion-memory link. Neurobiology of Learning and Memory 185: 107503
Eiben, R.M.; Gartler, S.M. 1964: Neuraminic Acid Investigations of Human Cell Strains Derived from Explants of Skin in Cell Culture. Nature 201: 1050-1051
Nelson, B.; Amminger, G.P.; Yuen, H.P.; Markulev, C.; Lavoie, S.; Schäfer, M.R.; Hartmann, J.A.; Mossaheb, N.; Schlögelhofer, M.; Smesny, S.; Hickie, I.B.; Berger, G.; Chen, E.Y.H.; de Haan, L.; Nieman, D.H.; Nordentoft, M.; Riecher-Rössler, A.; Verma, S.; Thompson, A.; Yung, A.R.; McGorry, P.D. 2018: NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course. Npj Schizophrenia 4(1): 11
Liszka, W. 1963: Neurilemmoma. Polski Przeglad Chirurgiczny 35: 21-24
Kuts, A.P. 1965: Neurinoma of the Pharynx. Vestnik Otorinolaringologii 27: 102
Farkas, I.; Dubecz, S.; Kantor, E. 1964: Neurinoma of the Stomach. Zentralblatt für Chirurgie 89: 932-937
Ashirbekov, G. 2020: Neuro-Humoral Disorders of the Adaptation System under the Action of certain Classes of Pesticides. Georgian Medical News 308: 149-154
Leoz, G. 1963: Neuro-Ophthalmology. Revista Espanola de Oto-Neuro-Oftalmologia y Neurocirugia 22: 235-242
Crosby, E.; Lauer, E.W. 1963: Neuroanatomy. Progress in Neurology and Psychiatry 18: 1-19
Reiquam, C.W.; Bailey, W.C.; Allen, R.P. 1964: Neuroblastoma in Infancy and Childhood. Rocky Mountain Medical Journal 61: 30-38
Ikematsu, Y.; Tanaka, K.; Toyokawa, G.; Ijichi, K.; Ando, N.; Yoneshima, Y.; Iwama, E.; Inoue, H.; Tagawa, T.; Nakanishi, Y.; Okamoto, I. 2020: NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration. Lung Cancer 146: 97-104
Herron, J.T. 1965: Neurodermatitis. Medical Journal of Australia 1(12): 421-422
Ionescu, L.; Danila, R.; Vulpoi, C.; Ciobanu, D.; Lozneanu, L. 2016: Neuroendocrine Tumor of the Appendix and Tuberculosis of the Caecum in a Patient with Acute Appendicitis. Acta Endocrinologica 12(3): 368-369
Courvoisier, B. 1964: Neuroendocrinology. Revue Medicale de la Suisse Romande 84: 687-694
Siwá, A.; Autrata, R.; Vejmělková, K.; Pavelka, Z.; Zitterbart, K. 2019: Neurofibromatosis type 1 and Optic Pathway Glioma. Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 75(4): 200-208
Aita, J.A. 1965: Neurologic Manifestations of Hypoxia. Nebraska State Medical Journal 50: 131-135 Contd
Aita, J.A. 1965: Neurologic Manifestations of Hypoxia. Nebraska State Medical Journal 50: 278-283
Dreifuss, F.E. 1964: Neurological Complications of Diabetes. Virginia Medical Monthly 91: 112-113
Draeger, J. 1965: Neurological Complications of Hodgkin's Disease. British Medical Journal 1(5440): 943-944
Asatiani, N.; Todadze, K. 2020: Neurological Disorders among the Users of Homemade Artisanal Ephedrone Psychostimulants and Investigation of Thiogamma Efficacy in their Treatment. Georgian Medical News 306: 117-122
Chochia, A.; Geladze, N.; Gogberashvili, K.; Khachapuridze, N.; Bakhtadze, S.; Kapanadze, N. 2021: Neurological Disorders of Children Living in Ecologically affected Region of Georgia. Georgian Medical News 314: 91-95
Silva, F.S.C.A.d.; Bucur, A.; Rosado, S.N.; Balhana, S.íl.D.S.; Meneses-Oliveira, C.M. 2021: Neurological Dysfunction Associated with Covid-19. Revista Brasileira de Terapia Intensiva 33(2): 325
Markova, J.; Peleska, B.; Keszler, H. 1963: Neurological Picture of Central Nervous System Damage After Heart Arrest During Operative Surgery. Ceskoslovenska Neurologie 26: 252-258
Webb, H.E.; Smith, C.E. 1964: Neuroparalytic Accidents with Poliovaccines. British Medical Journal 2(5408): 569
Roizlin, L.; Gold, G.; Casselman, W.G. 1963: Neuropathology. Progress in Neurology and Psychiatry 18: 107-133
Loboantunes, J.A. 1963: Neuropathology. Revista Espanola de Oto-Neuro-Oftalmologia y Neurocirugia 22: 229-230
Oliverasdelariva, C. 1963: Neuropathology. Revista Espanola de Oto-Neuro-Oftalmologia y Neurocirugia 22: 231-234
Rabinowicz, T. 1964: Neuropathology. Revue Medicale de la Suisse Romande 84: 832-841
Hild, W.; Tasaki, I. 1964: Neurophysiology. Methods in Medical Research 10: 327-334
Yaremchuk, O.; Soroka, Y.; Kulitska, M.; Kuzmak, I.; Chernyashova, V.; Namoradze, M.; Delibashvili, D.; Posokhova, K. 2020: Neuroprotective effect of Aminoguanidine in Experimental Obstetric Antiphospholipid Syndrome. Georgian Medical News 301: 159-165
Xu, L.; Liang, J.; Jin, T.; Zhou, F. 2016: Neuroprotective Effects of Mangiferin on Acute Spinal Cord Injury in Rats and its Mechanism. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 30(8): 1019-1025
Spasov, A.A.; Murav'eva, V.U.; Gurova, N.A.; Cheplyaeva, N.I.; Reznikov, E.V.; Anisimova, V.A. 2016: Neuroprotective Properties of a new Inhibitor of Na+/H+ Exchanger (Compound Ru-1355) on the Model of Focal Ischemia in Rats. Eksperimental'naia i Klinicheskaia Farmakologiia 79(4): 3-7
Loganovsky, K.N.; Bomko, M.O.; Abramenko, I.V.; Kuts, K.V.; Belous, N.I.; Masiuk, S.V.; Gresko, M.V.; Loganovska, T.K.; Antypchuk, K.Yu.; Perchuk, I.V.; Kreinis, G.Yu.; Chumak, S.A. 2018: Neuropsychobiological Mechanisms of Affective and Cognitive Disorders in the Chornobyl Clean-Up Workers Taking into Account the Specific Gene Polymorphisms. Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 23: 373-409
Bull, J. 1963: Neuroradiology. Revista Espanola de Oto-Neuro-Oftalmologia y Neurocirugia 22: 182-187
Sutton, D. 1964: Neuroradiology. Practitioner 193: 89-95
Gundersen, B.B. 2015: NEUROSCIENCE: Targeting spines. Nature Methods 12(11): 1006-1007
Ktsulovic, J. 1963: Neurosecretion. Neurocirugia 21: 85-89
David, M. 1964: Neurosurgery. Techniques Hospitalieres Medico-Sociales et Sanitaires 19: 27-33
Lopes de Andrade, V.; Marreilha Dos Santos, A.P.; Aschner, M. 2021: Neurotoxicity of Metal Mixtures. Advances in Neurotoxicology 5: 329-364
Lešták, J. 2021: Neurotransmission in Visual Analyzer and Bionic Eye. a Review. Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 77(2): 55-59
Kerzner, M.S.; Redmon, W. 1964: Neurotrichinosis. Rhode Island Medical Journal 47: 388-391
Scholefield, B.R.; Martin, J.; Penny-Thomas, K.; Evans, S.; Kool, M.; Parslow, R.; Feltbower, R.; Draper, E.S.; Hiley, V.; Sitch, A.J.; Kanthimathinathan, H.K.; Morris, K.P.; Smith, F.; Thorburn, K.; Saxena, R.; Thiru, Y.; Levin, R.; Agbecko, R.; Thiruchelvam, T.; Skellett, S.; Inwald, D.; Weitz, J.; Deep, A.; Cooper, S.; Barry, P.; Davies, P.; Breatnach, C.; Gala-Peralta, S.; Lo, M.; Barber, R.; Reid, S.; Thomas, R.; Pappachan, J.; Dwarakanathan, B.; Oruganti, S.; Sadasivam, K.; Bebbington, M. 2020: NEUROlogical Prognosis After Cardiac Arrest in Kids (NEUROPACK) study: protocol for a prospective multicentre clinical prediction model derivation and validation study in children after cardiac arrest. Bmj Open 10(9): E037517
Chen, C.L.H.; Nguyen, Tọng.Hung.; Marasigan, S.; Lee, C.Fan.; Lu, Q.; Kandiah, N.; de Silva, D.; Chong, E.; Venketasubramanian, N. 2021: NEURoaid II (MLC901) in cognitively Impaired not demen TEd patientS (NEURITES): A pilot double blind, placebo-controlled randomized trial. Alzheimer's and Dementia 7(1): E12161
Frankel, J.W. 1964: Neutralizing Antibody Responses of Guinea-Pigs to Inactivated Rubella Virus Vaccine. Nature 204: 655-656
Dos Santos Ramos, A.; Viana, G.C.S.; de Macedo Brigido, M.; Almeida, J.F. 2021: Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets. Pharmacological Research 171: 105779
Naunova-Timovska, S.; Cekovska, S.; Sahpazova, E.; Tasić, V. 2020: Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Acute Kidney Injury in Newborns. Acta Clinica Croatica 59(1): 55-62
Szolc, P.; Niewiara, Łu.; Kawulak, M.; Szkodoń, K.; Ostrowska-Kaim, E.żb.; Nosal, M.; Krzanowski, M.; Żmudka, K.; Legutko, J.; Guzik, B.ło. 2020: Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as Predictors of Coronary Microcirculatory Disease Occurrence and Outcome in Patients with Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis. Wiadomosci Lekarskie 73(12 Cz 1: 2598-2606
Holliday, Z.M.; Alnijoumi, M.M.; Reed, M.A.; Earhart, A.P.; Schrum, A.G.; Allen, L.-A.H.; Krvavac, A. 2021: Neutrophils and secondary infections in COVID-19 induced acute respiratory distress syndrome. New Microbes and new Infections 44: 100944
A Leite, R.; Gschwandtner, T.; Miksch, S.; Gstrein, E.; Kuntner, J. 2020: NEVA: Visual Analytics to Identify Fraudulent Networks. Computer Graphics Forum: Journal of the European Association for Computer Graphics 39(6): 344-359
Juan, M. 2020: Never Alone: the Spirit of Sgna. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 43(3): 216-217
Rothschild, M. 1912: New and Non-Official Remedies. California State Journal of Medicine 10(4): 174-175
Puckner, W.A. 1916: New and Non-Official Remedies. California State Journal of Medicine 14(5): 170-171
Orjonikidze, A.; Mgebrishvili, S.; Orjonikidze, M.; Barbakadze, I.; Kipiani, N.V.; Sanikidze, T. 2020: New Approaches to the Treatment of Periimplantitis (Review). Georgian Medical News 302: 28-33
Dolidze, T.; Makharadze, M.; Uchaneishvili, S.; Nioradze, N.; Laliashvili, L. 2021: New Aspects of the Interaction of Copper (Ii) with Serum Albumin: Voltammetric and Microcalorimetric Studies. Georgian Medical News 318: 139-142
Dally, A. 1964: New Drug for Smallpox Tried out in Madras. Indian Journal of Public Health 8: 80-81
Leston, J.M. 1964: New Drugs in the Treatment of Pulmonary Tuberculosis. La Semana Medica 124: 855-860
Song, Q.; Liang, Z. 2019: New Emigration from China: Patterns, Causes and Impacts. Dang Dai Zhongguo Yan Jiu 26(1): 5-31
Ozturan, B.; Erinc, S.; Oz, T.T.; Ozkan, K. 2020: New Generation Nail Vs. Plate in the Treatment of Unstable Intertrochanteric Femoral Fracture. Acta Ortopedica Brasileira 28(6): 311-315
Nahum, L.H. 1963: New Hearts for Old. Connecticut Medicine 27: 523-527
Kotzen, S. 1963: New Menus Save time and Cut Costs. Hospital Management 96: 62-68
Ostrander, W.E.; Griffith, L.J. 1963: New Menus Save time and Cut Costs. Hospital Management 96: 75-80
Seay, G.L. 1963: New Menus Save time and Cut Costs. Hospital Management 96: 78-84
Gwyn, D.G.; Aitken, J.T. 1964: New Motor End-Plates and their Relationship to Muscle Fibre Injury. Nature 203: 651-652
Herman, Y.; Harel, L.; Nachum, E.; Kaplan, E.; Frenkel, G.; Tobar, A.; Lowental, A.; Amarilyo, G. 2021: New Onset of Valvular Heart Disease along with Ancient Pathologic Finding. Harefuah 160(2): 94-97
Pavlov, P.V.; Pirogov, S.S.; Karpov, E.S.; Sokolov, V.V.; Stepanov, S.O. 2016: New Opportunities of the Qualifying Endoscopic Diagnostics of Pancreas Neoplasms. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2016(10): 80-85
Rahemi Karizaki, S.; Alamdaran, S.A.; Bonakdaran, S.; Morovatdar, N.; Jafarain, A.H.; Sharifi Hadad, A.; Hadadzade, A. 2020: New Proposed Formula of Ti-Rads Classification Based on Ultrasound Findings. Acta Endocrinologica 16(2): 199-207
Collins, D.C. 1964: Newer Developments in Proctology: Viii. American Journal of Proctology 15: 207-229
Oakley, K.P.; Campbell, B.G. 1964: Newly Described Olduvai Hominid. Nature 202: 732
Baio, J.E.; Jaye, C.; Sullivan, E.; Rasmussen, M.H.; Fischer, D.A.; Gorb, S.; Weidner, T. 2019: NEXAFS imaging to characterize the physio-chemical composition of cuticle from African Flower Scarab Eudicella gralli. Nature Communications 10(1): 4758
Malone, W.; Nebgen, B.; White, A.; Zhang, Y.; Song, H.; Bjorgaard, J.A.; Sifain, A.E.; Rodriguez-Hernandez, B.; Freixas, V.M.; Fernandez-Alberti, S.; Roitberg, A.E.; Nelson, T.R.; Tretiak, S. 2020: NEXMD Software Package for Nonadiabatic Excited State Molecular Dynamics Simulations. Journal of Chemical Theory and Computation 16(9): 5771-5783
Stamberger, H.; Hammer, T.B.; Gardella, E.; Vlaskamp, D.R.M.; Bertelsen, B.; Mandelstam, S.; de Lange, I.; Zhang, J.; Myers, C.T.; Fenger, C.; Afawi, Z.; Almanza Fuerte, E.P.; Andrade, D.M.; Balcik, Y.; Ben Zeev, B.; Bennett, M.F.; Berkovic, S.F.; Isidor, B.; Bouman, A.; Brilstra, E.; Busk, Øyvind.L.; Cairns, A.; Caumes, R.; Chatron, N.; Dale, R.C.; de Geus, C.; Edery, P.; Gill, D.; Granild-Jensen, J.Bie.; Gunderson, L.; Gunning, B.; Heimer, G.; Helle, J.R.; Hildebrand, M.S.; Hollingsworth, G.; Kharytonov, V.; Klee, E.W.; Koeleman, B.P.C.; Koolen, D.A.; 2020: NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns. Genetics in Medicine: Official Journal of the American College of Medical Genetics 2020
Okamoto, Y.; Ohta, K.; Suzukawa, M.; Ohta, S.; Okano, M.; Sakurai, D.; Tashimo, H. 2020: Next-Generation Aria Care Pathways in Allergic Rhinitis. Arerugi 69(8): 689-700
Zhang, Y.; Zhang, Q.; Weng, X.; Du, Y.; Zhou, X. 2021: NEase-based amplification for detection of miRNA, multiple mi RNAs and circRNA. Analytica Chimica Acta 1145: 52-58
Viatour, P.; Bentires-Alj, M.; Chariot, A.; Deregowski, V.; de Leval, L.; Merville, M-P.; Bours, V. 2003: NF- kappa B2/p100 induces Bcl-2 expression. Leukemia 17(7): 1349-1356
Zhu, X.; Huang, L.; Gong, J.; Shi, C.; Wang, Z.; Ye, B.; Xuan, A.; He, X.; Long, D.; Zhu, X.; Ma, N.; Leng, S. 2017: NF- κ B pathway link with ER stress-induced autophagy and apoptosis in cervical tumor cells. Cell Death Discovery 3: 17059
Guo, Y.; Zhang, X.; Zhao, Z.; Lu, H.; Ke, B.; Ye, X.; Wu, B.; Ye, J. 2020: NF- κ B/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis. Acta Pharmaceutica Sinica. B 10(5): 825-836
Sbidian, E.; Wolkenstein, P.; Valeyrie-Allanore, L.; Rodriguez, D.; Hadj-Rabia, S.; Ferkal, S.; Lacour, J-Philippe.; Leonard, J-Claude.; Taillandier, L.; Sportich, Séphanie.; Berbis, P.; Bastuji-Garin, S. 2010: NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1. Journal of Investigative Dermatology 130(9): 2173-2178
Zhu, J.; McKeon, F. 1999: NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature 398(6724): 256-260
Northrop, J.P.; Ho, S.N.; Chen, L.; Thomas, D.J.; Timmerman, L.A.; Nolan, G.P.; Admon, A.; Crabtree, G.R. 1994: NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369(6480): 497-502
Zang, C.; Luyten, A.; Chen, J.; Liu, X.Shirley.; Shivdasani, R.A. 2016: NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes. Scientific Reports 6: 30255
Xue, J.; Yu, C.; Tang, Y.; Mo, W.; Tang, Z.; Sheng, W.; Jiao, Y.; Zhu, W.; Cao, J. 2021: NF-E2-Related Factor 2 (Nrf2) Ameliorates Radiation-Induced Skin Injury. Frontiers in Oncology 11: 680058
Han, S.; Zhuang, H.; Lee, P.Y.; Li, M.; Yang, L.; Nigrovic, P.A.; Reeves, W.H. 2020: NF-E2-Related Factor 2 Regulates Interferon Receptor Expression and Alters Macrophage Polarization in Lupus. Arthritis and Rheumatology 72(10): 1707-1720
Francastel, C.; Poindessous-Jazat, V.; Augery-Bourget, Y.; Robert-Lézénès, J. 1997: NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity. Leukemia 11(2): 273-280
Hussen, B.M.; Azimi, T.; Hidayat, H.J.; Taheri, M.; Ghafouri-Fard, S. 2021: NF-KappaB interacting LncRNA: Review of its roles in neoplastic and non-neoplastic conditions. Biomedicine and PharmacoTherapy 139: 111604
Oldfield, A.J.; Henriques, T.; Kumar, D.; Burkholder, A.B.; Cinghu, S.; Paulet, D.; Bennett, B.D.; Yang, P.; Scruggs, B.S.; Lavender, C.A.; Rivals, E.; Adelman, K.; Jothi, R. 2019: NF-Y controls fidelity of transcription initiation at gene promoters through maintenance of the nucleosome-depleted region. Nature Communications 10(1): 3072
Yamanaka, T.; Tosaki, A.; Kurosawa, M.; Matsumoto, G.; Koike, M.; Uchiyama, Y.; Maity, S.N.; Shimogori, T.; Hattori, N.; Nukina, N. 2014: NF-Y inactivation causes atypical neurodegeneration characterized by ubiquitin and p62 accumulation and endoplasmic reticulum disorganization. Nature Communications 5: 3354
Chen, J. 2021: NF-Y is critical for the proper growth of zebrafish embryonic heart and its cardiomyocyte proliferation. Rererences 2021: E23408
Hughes, R.; Kristiansen, M.; Lassot, I.; Desagher, S.; Mantovani, R.; Ham, J. 2011: NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons. Cell Death and Differentiation 18(6): 937-947
Gatta, R.; Dolfini, D.; Mantovani, R. 2011: NF-Y joins E2Fs, p53 and other stress transcription factors at the apoptosis table. Cell Death and Disease 2: E162
Curtis, D.J.; Dougherty, L.; Bodine, D.M. 2001: NF-Y regulates LIF-induced transcription of the signaling adaptor SKAP55R in myeloid cells. Leukemia 15(12): 1932-1940
Yang, W.-T.; Feng, Q.; Ma, H.-M.; Lei, D.; Zheng, P.-S. 2020: NF-YA promotes the cell proliferation and tumorigenic properties by transcriptional activation of SOX2 in cervical cancer. Journal of Cellular and Molecular Medicine 24(21): 12464-12475
Bai, A-Ning.; Lu, X-Duo.; Li, D-Qi.; Liu, J-Xin.; Liu, C-Ming. 2016: NF-YB1-regulated expression of sucrose transporters in aleurone facilitates sugar loading to rice endosperm. Cell Research 26(3): 384-388
Sato, H.; Suzuki, T.; Takahashi, F.; Shinozaki, K.; Yamaguchi-Shinozaki, K. 2019: NF-YB2 and NF-YB3 Have Functionally Diverged and Differentially Induce Drought and Heat Stress-Specific Genes. Plant Physiology 180(3): 1677-1690
Hennighausen, L.; Furth, P.A. 1990: NF-kB and HIV. Nature 343(6255): 218-219
Gaptulbarova, K.A.; Tsyganov, M.M.; Pevzner, A.M.; Ibragimova, M.K.; Litviakov, N.V. 2020: NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer. Experimental Oncology 42(4): 263-269
Kato, K.; Akeda, K.; Miyazaki, S.; Yamada, J.; Muehleman, C.; Miyamoto, K.; Asanuma, Y.A.; Asanuma, K.; Fujiwara, T.; Lenz, M.E.; Nakazawa, T.; An, H.; Masuda, K. 2021: NF-kB decoy oligodeoxynucleotide preserves disc height in a rabbit anular-puncture model and reduces pain induction in a rat xenograft-radiculopathy model. European Cells and Materials 42: 90-109
Dimitrakopoulos, F-Ioannis.D.; Antonacopoulou, A.G.; Kottorou, A.E.; Maroussi, S.; Panagopoulos, N.; Koukourikou, I.; Scopa, C.; Kalofonou, M.; Koutras, A.; Makatsoris, T.; Papadaki, H.; Dougenis, D.; Brock, M.; Kalofonos, H.P. 2018: NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival. Scientific Reports 8(1): 5259
De Donatis, G.M.; Le Pape, E.; Pierron, A.; Cheli, Y.; Hofman, V.; Hofman, P.; Allegra, M.; Zahaf, K.; Bahadoran, P.; Rocchi, S.; Bertolotto, C.; Ballotti, R.; Passeron, T. 2016: NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2. Oncogene 35(21): 2735-2745
De Donatis, G.M.; Le Pape, E.; Pierron, A.; Cheli, Y.; Hofman, V.; Hofman, P.; Allegra, M.; Zahaf, K.; Bahadoran, P.; Rocchi, S.; Bertolotto, C.; Ballotti, R.; Passeron, T. 2016: NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2. Oncogene 35(21): 2813
Javelaud, D.; Besançon, F. 2001: NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene 20(32): 4365-4372
Makarov, S.S.; Johnston, W.N.; Olsen, J.C.; Watson, J.M.; Mondal, K.; Rinehart, C.; Haskill, J.S. 1997: NF-kappa B as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA. Gene Therapy 4(8): 846-852
Meffert, M.K.; Chang, J.M.; Wiltgen, B.J.; Fanselow, M.S.; Baltimore, D. 2003: NF-kappa B functions in synaptic signaling and behavior. Nature Neuroscience 6(10): 1072-1078
Chen, Z.; Li, S.; Shen, L.; Wei, X.; Zhu, H.; Wang, X.; Yang, M.; Zheng, X. 2020: NF-kappa B interacting long noncoding RNA enhances the Warburg effect and angiogenesis and is associated with decreased survival of patients with gliomas. Cell Death and Disease 11(5): 323
Jo, H.; Zhang, R.; Zhang, H.; McKinsey, T.A.; Shao, J.; Beauchamp, R.D.; Ballard, D.W.; Liang, P. 2000: NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Oncogene 19(7): 841-849
Wang, Y.; Cui, H.; Schroering, A.; Ding, J.L.; Lane, W.S.; McGill, Gël.; Fisher, D.E.; Ding, H-Fei. 2002: NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function. Nature Cell Biology 4(11): 888-893
Nissim-Eliraz, E.; Nir, E.; Marsiano, N.; Yagel, S.; Shpigel, N.Y. 2021: NF-kappa-B activation unveils the presence of inflammatory hotspots in human gut xenografts. Plos one 16(5): E0243010
Heckman, C.A.; Mehew, J.W.; Boxer, L.M. 2002: NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 21(24): 3898-3908
Wuerzberger-Davis, S.M.; Nakamura, Y.; Seufzer, B.J.; Miyamoto, S. 2007: NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Oncogene 26(5): 641-651
Moscat, J.; Diaz-Meco, Mía.T.; Rennert, P. 2003: NF-kappaB activation by protein kinase C isoforms and B-cell function. Embo Reports 4(1): 31-36
Glanz, A.; Albrecht, J-Christian.; Heinemann, S.; Fleckenstein, B.; Isakov, N.; Biesinger, B. 2008: NF-kappaB activation by the viral oncoprotein StpC enhances IFN-gamma production in T cells. Immunology and Cell Biology 86(7): 622-630
Ozes, O.N.; Mayo, L.D.; Gustin, J.A.; Pfeffer, S.R.; Pfeffer, L.M.; Donner, D.B. 1999: NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401(6748): 82-85
Van Laere, S.J.; Van der Auwera, I.; Van den Eynden, G.G.; van Dam, P.; Van Marck, E.A.; Vermeulen, P.B.; Dirix, L.Y. 2007: NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British Journal of Cancer 97(5): 659-669
Tracey, L.; Streck, C.J.; Du, Z.; Williams, R.F.; Pfeffer, L.M.; Nathwani, A.C.; Davidoff, A.M. 2010: NF-kappaB activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia. Leukemia 24(4): 806-812
Kim, H.J.; Hawke, N.; Baldwin, A.S. 2006: NF-kappaB and IKK as therapeutic targets in cancer. Cell Death and Differentiation 13(5): 738-747
Bottero, V.; Withoff, S.; Verma, I.M. 2006: NF-kappaB and the regulation of hematopoiesis. Cell Death and Differentiation 13(5): 785-797
Karin, M.; Lin, A. 2002: NF-kappaB at the crossroads of life and death. Nature Immunology 3(3): 221-227
Dajee, M.; Lazarov, M.; Zhang, J.Y.; Cai, T.; Green, C.L.; Russell, A.J.; Marinkovich, M.Peter.; Tao, S.; Lin, Q.; Kubo, Y.; Khavari, P.A. 2003: NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421(6923): 639-643
Zhang, S-Ying.; Park, K-Woo.; Oh, S.; Cho, H-Ju.; Cho, H-Jai.; Park, J-Shik.; Cho, Y-Seok.; Koo, B-Kwon.; Chae, I-Ho.; Choi, D-Joo.; Kim, H-Soo.; Lee, M-Mook. 2005: NF-kappaB decoy potentiates the effects of radiation on vascular smooth muscle cells by enhancing apoptosis. Experimental and Molecular Medicine 37(1): 18-26
Mathes, E.; O'Dea, E.L.; Hoffmann, A.; Ghosh, G. 2008: NF-kappaB dictates the degradation pathway of IkappaBalpha. EMBO Journal 27(9): 1357-1367
Pizzi, M.; Sarnico, I.; Boroni, F.; Benarese, M.; Steimberg, N.; Mazzoleni, G.; Dietz, G.P.H.; Bähr, M.; Liou, H-C.; Spano, P.F. 2005: NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death and Differentiation 12(7): 761-772
Pikarsky, E.; Porat, R.M.; Stein, I.; Abramovitch, R.; Amit, S.; Kasem, S.; Gutkovich-Pyest, E.; Urieli-Shoval, S.; Galun, E.; Ben-Neriah, Y. 2004: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431(7007): 461-466
Lin, B.; Williams-Skipp, C.; Tao, Y.; Schleicher, M.S.; Cano, L.L.; Duke, R.C.; Scheinman, R.I. 1999: NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death and Differentiation 6(6): 570-582
Claudio, E.; Brown, K.; Siebenlist, U. 2006: NF-kappaB guides the survival and differentiation of developing lymphocytes. Cell Death and Differentiation 13(5): 697-701
Park, B.Keun.; Zhang, H.; Zeng, Q.; Dai, J.; Keller, E.T.; Giordano, T.; Gu, K.; Shah, V.; Pei, L.; Zarbo, R.J.; McCauley, L.; Shi, S.; Chen, S.; Wang, C-Yu. 2007: NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nature Medicine 13(1): 62-69
Karin, M.; Cao, Y.; Greten, F.R.; Li, Z-Wei. 2002: NF-kappaB in cancer: from innocent bystander to major culprit. Nature Reviews. Cancer 2(4): 301-310
De Ridder, M.; Van den Berge, D.L.; Verovski, V.N.; Monsaert, C.; Wauters, N.; Storme, G.A. 2003: NF-kappaB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase. British Journal of Cancer 88(1): 120-124
Diessenbacher, P.; Hupe, M.; Sprick, M.R.; Kerstan, A.; Geserick, P.; Haas, T.L.; Wachter, T.; Neumann, M.; Walczak, H.; Silke, J.; Leverkus, M. 2008: NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2. Journal of Investigative Dermatology 128(5): 1134-1147
Fabre, C.; Carvalho, G.; Tasdemir, E.; Braun, T.; Adès, L.; Grosjean, J.; Boehrer, S.; Métivier, D.; Souquère, S.; Pierron, G.; Fenaux, P.; Kroemer, G. 2007: NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 26(28): 4071-4083
Amschler, K.; Schön, M.P.; Pletz, N.; Wallbrecht, K.; Erpenbeck, L.; Schön, M. 2010: NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways. Journal of Investigative Dermatology 130(4): 1073-1086
Romashkova, J.A.; Makarov, S.S. 1999: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401(6748): 86-90
Schneider, A.; Martin-Villalba, A.; Weih, F.; Vogel, J.; Wirth, T.; Schwaninger, M. 1999: NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nature Medicine 5(5): 554-559
Nair, A.; Venkatraman, M.; Maliekal, T.T.; Nair, B.; Karunagaran, D. 2003: NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22(1): 50-58
Chae, G-Nam.; Kwak, S-June. 2003: NF-kappaB is involved in the TNF-alpha induced inhibition of the differentiation of 3T3-L1 cells by reducing PPARgamma expression. Experimental and Molecular Medicine 35(5): 431-437
Rius, J.; Guma, M.; Schachtrup, C.; Akassoglou, K.; Zinkernagel, A.S.; Nizet, V.; Johnson, R.S.; Haddad, G.G.; Karin, M. 2008: NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453(7196): 807-811
Radisky, D.C.; Bissell, M.J. 2007: NF-kappaB links oestrogen receptor signalling and EMT. Nature Cell Biology 9(4): 361-363
Uffort, D.G.; Grimm, E.A.; Ellerhorst, J.A. 2009: NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma. Journal of Investigative Dermatology 129(1): 148-154
Wyke, S.M.; Tisdale, M.J. 2005: NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. British Journal of Cancer 92(4): 711-721
Papa, S.; Bubici, C.; Pham, C.G.; Zazzeroni, F.; Franzoso, G. 2005: NF-kappaB meets ROS: an 'iron-ic' encounter. Cell Death and Differentiation 12(10): 1259-1262
Williams, S.A.; Chen, L-Feng.; Kwon, H.; Ruiz-Jarabo, C.M.; Verdin, E.; Greene, W.C. 2006: NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO Journal 25(1): 139-149
Fusco, A.J.; Huang, D-Bin.; Miller, D.; Wang, V.Ya-Fan.; Vu, D.; Ghosh, G. 2009: NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes. Embo Reports 10(2): 152-159
Souza, D.G.; Vieira, Aélica.T.; Pinho, V.; Sousa, Lândia.P.; Andrade, A.A.; Bonjardim, Cáudio.A.; McMillan, M.; Kahn, M.; Teixeira, M.M. 2005: NF-kappaB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury. British Journal of Pharmacology 145(2): 246-254
Kikuchi, H.; Ozaki, T.; Furuya, K.; Hanamoto, T.; Nakanishi, M.; Yamamoto, H.; Yoshida, K.; Todo, S.; Nakagawara, A. 2006: NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway. Oncogene 25(58): 7608-7617
Li, Q.; Verma, I.M. 2002: NF-kappaB regulation in the immune system. Nature Reviews. Immunology 2(10): 725-734
Chua, H.L.; Bhat-Nakshatri, P.; Clare, S.E.; Morimiya, A.; Badve, S.; Nakshatri, H. 2007: NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26(5): 711-724
Bui-Nguyen, T.M.; Pakala, S.B.; Sirigiri, R.D.; Xia, W.; Hung, M-C.; Sarin, S.K.; Kumar, V.; Slagle, B.L.; Kumar, R. 2010: NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene 29(8): 1179-1189
Wang, S.; Liu, Z.; Wang, L.; Zhang, X. 2009: NF-kappaB signaling pathway, inflammation and colorectal cancer. Cellular and Molecular Immunology 6(5): 327-334
Sun, B.; Karin, M. 2008: NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene 27(48): 6228-6244
Yang, J.P.; Hori, M.; Takahashi, N.; Kawabe, T.; Kato, H.; Okamoto, T. 1999: NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene 18(37): 5177-5186
Bentires-Alj, M.; Barbu, V.; Fillet, M.; Chariot, A.; Relic, B.; Jacobs, N.; Gielen, J.; Merville, M-Paule.; Bours, V. 2003: NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22(1): 90-97
Hardwick, J.C.; van den Brink, G.R.; Offerhaus, G.J.; van Deventer, S.J.; Peppelenbosch, M.P. 2001: NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene 20(7): 819-827
Delhalle, S.; Deregowski, Vérie.; Benoit, Vérie.; Merville, M-Paule.; Bours, V. 2002: NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene 21(24): 3917-3924
Hermisson, M.; Weller, M. 2003: NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells. Cell Death and Differentiation 10(9): 1078-1089
La Ferla-Brühl, K.; Westhoff, M.A.; Karl, S.; Kasperczyk, H.; Zwacka, R.M.; Debatin, K.M.; Fulda, S. 2007: NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. Oncogene 26(4): 571-582
Wang, J.; Ford, H.R.; Grishin, A.V. 2010: NF-kappaB-mediated expression of MAPK phosphatase-1 is an early step in desensitization to TLR ligands in enterocytes. Mucosal Immunology 3(5): 523-534
Courtois, G.; Smahi, A. 2006: NF-kappaB-related genetic diseases. Cell Death and Differentiation 13(5): 843-851
Thyss, Rël.; Virolle, V.; Imbert, Véronique.; Peyron, J-François.; Aberdam, D.; Virolle, T. 2005: NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death. EMBO Journal 24(1): 128-137
Turco, M.C.; Romano, M.F.; Petrella, A.; Bisogni, R.; Tassone, P.; Venuta, S. 2004: NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors. Leukemia 18(1): 11-17
Lu, Y.; Jamieson, L.; Brasier, A.R.; Fields, A.P. 2001: NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival. Oncogene 20(35): 4777-4792
Karin, M.; Greten, F.R. 2005: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nature Reviews. Immunology 5(10): 749-759
Natoli, G. 2010: NF-kappaB: no longer an island, but a piece of a continent. Embo Reports 11(4): 246-248
Vazquez-Santillan, K.; Melendez-Zajgla, J.; Jimenez-Hernandez, L.Enrique.; Gaytan-Cervantes, J.; Muñoz-Galindo, L.; Piña-Sanchez, P.; Martinez-Ruiz, G.; Torres, J.; Garcia-Lopez, P.; Gonzalez-Torres, C.; Ruiz, V.; Avila-Moreno, F.; Velasco-Velazquez, M.; Perez-Tapia, M.; Maldonado, V. 2016: NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer. Scientific Reports 6: 37340
Gun Bilgic, D.; Hatipoglu, O.F.; Cigdem, S.ık.; Bilgic, A.; Cora, T. 2020: NF-ĸβ upregulates ADAMTS5 expression by direct binding after TNF-α treatment in OUMS-27 chondrosarcoma cell line. Molecular Biology Reports 47(6): 4215-4223
Deng, Q.; Ma, L.; Chen, T.; Yang, Y.; Ma, Y.; Ma, L. 2021: NF-κB 1-induced LINC00665 regulates inflammation and apoptosis of neurons caused by spinal cord injury by targeting miR-34a-5p. Neurological Research 2021: 1-10
Lei, Z.; Yue, Y.; Stone, S.; Wu, S.; Lin, W. 2020: NF-κB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 40(33): 6444-6456
Stansel, T.; Wickline, S.A.; Pan, H. 2020: NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis. Journal of Cancer Science and Clinical Therapeutics 4(3): 256-265
Kircheis, R.; Haasbach, E.; Lueftenegger, D.; Heyken, W.T.; Ocker, M.; Planz, O. 2020: NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Frontiers in Immunology 11: 598444
Kumar, A.; Gordy, L.E.; Bezbradica, J.S.; Stanic, A.K.; Hill, T.M.; Boothby, M.R.; Van Kaer, L.; Joyce, S. 2017: NF-κB Protects NKT Cells from Tumor Necrosis Factor Receptor 1-induced Death. Scientific Reports 7(1): 15594
Shao, Y.; Le, K.; Cheng, H.; Aplin, A.E. 2015: NF-κB Regulation of c-FLIP Promotes TNFα-Mediated RAF Inhibitor Resistance in Melanoma. Journal of Investigative Dermatology 135(7): 1839-1848
Biancalana, M.; Natan, E.; Lenardo, M.J.; Fersht, A.R. 2021: NF-κB Rel subunit exchange on a physiological timescale. Protein Science: a Publication of the Protein Society 30(9): 1818-1832
Hammond, S.L.; Bantle, C.M.; Popichak, K.A.; Wright, K.A.; Thompson, D.; Forero, C.; Kirkley, K.S.; Damale, P.U.; Chong, E.K.P.; Tjalkens, R.B. 2020: NF-κB Signaling in Astrocytes Modulates Brain Inflammation and Neuronal Injury Following Sequential Exposure to Manganese and MPTP During Development and Aging. Toxicological Sciences: An Official Journal of the Society of Toxicology 177(2): 506-520
Shostak, K.; Wathieu, C.; Tielens, S.; Chariot, A. 2021: NF-κB Signaling in Ex-Vivo Mouse Intestinal Organoids. Methods in Molecular Biology 2366: 283-292
Bigot, N.; Beauchef, G.; Hervieu, M.; Oddos, T.; Demoor, M.; Boumediene, K.; Galéra, P. 2012: NF-κB accumulation associated with COL1A1 transactivators defects during chronological aging represses type I collagen expression through a -112/-61-bp region of the COL1A1 promoter in human skin fibroblasts. Journal of Investigative Dermatology 132(10): 2360-2367
Hikage, F.; Lennikov, A.; Mukwaya, A.; Lachota, M.; Ida, Y.; Utheim, T.P.; Chen, D.F.; Huang, H.; Ohguro, H. 2021: NF-κB activation in retinal microglia is involved in the inflammatory and neovascularization signaling in laser-induced choroidal neovascularization in mice. Experimental Cell Research 403(1): 112581
Liu, J.; Xiang, J.; Li, X.; Blankson, S.; Zhao, S.; Cai, J.; Jiang, Y.; Redmond, H.Paul.; Wang, J.Huai. 2017: NF-κB activation is critical for bacterial lipoprotein tolerance-enhanced bactericidal activity in macrophages during microbial infection. Scientific Reports 7: 40418
Sever, D.; Hershko-Moshe, A.; Srivastava, R.; Eldor, R.; Hibsher, D.; Keren-Shaul, H.; Amit, I.; Bertuzzi, F.; Krogvold, L.; Dahl-Jørgensen, K.; Ben-Dov, I.Z.; Landsman, L.; Melloul, D. 2021: NF-κB activity during pancreas development regulates adult β-cell mass by modulating neonatal β-cell proliferation and apoptosis. Cell Death Discovery 7(1): 2
Kloepper, J.E.; Ernst, N.; Krieger, K.; Bodó, Eő.; Bíró, Tás.; Haslam, I.S.; Schmidt-Ullrich, R.; Paus, R. 2014: NF-κB activity is required for anagen maintenance in human hair follicles in vitro. Journal of Investigative Dermatology 134(7): 2036-2038
Chaturvedi, M.M.; Sung, B.; Yadav, V.R.; Kannappan, R.; Aggarwal, B.B. 2011: NF-κB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30(14): 1615-1630
Vabeiryureilai, M.; Lalrinzuali, K.; Jagetia, G.C. 2022: NF-κB and COX-2 repression with topical application of hesperidin and naringin hydrogels augments repair and regeneration of deep dermal wounds. Burns: Journal of the International Society for Burn Injuries 48(1): 132-145
Wang, H.; Zhang, W.; Liu, J.; Gao, J.; Fang, L.E.; Liu, Z.; Xia, B.; Fan, X.; Li, C.; Lu, Q.; Qian, A. 2021: NF-κB and FosB mediate inflammation and oxidative stress in the blast lung injury of rats exposed to shock waves. Acta Biochimica et Biophysica Sinica 53(3): 283-293
Gómez-Chávez, F.; Correa, D.; Navarrete-Meneses, P.; Cancino-Diaz, J.C.; Cancino-Diaz, M.E.; Rodríguez-Martínez, S. 2021: NF-κB and its Regulators During Pregnancy. Frontiers in Immunology 12: 679106
Zarpou, S.; Mosavi, H.; Bagheri, A.; Malekzadeh Shafaroudi, M.; Khonakdar-Tarsi, A. 2021: NF-κB and NLRP3 gene expression changes during warm hepatic ischemia-reperfusion in rats with and without silibinin. Gastroenterology and Hepatology from Bed to Bench 14(3): 267-275
He, G.; Karin, M. 2011: NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Research 21(1): 159-168
Saengboonmee, C.; Phoomak, C.; Supabphol, S.; Covington, K.R.; Hampton, O.; Wongkham, C.; Gibbs, R.A.; Umezawa, K.; Seubwai, W.; Gingras, M.-C.; Wongkham, S. 2020: NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells. Life Sciences 262: 118548
Yoon, S.; Woo, S.U.; Kang, J.H.; Kim, K.; Shin, H-J.; Gwak, H-S.; Park, S.; Chwae, Y-J. 2012: NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells. Oncogene 31(29): 3467-3481
Andrés, R.M.; Montesinos, M.Carmen.; Navalón, P.; Payá, M.; Terencio, M.Carmen. 2013: NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH. Journal of Investigative Dermatology 133(10): 2362-2371
Zhu, B.; Zhang, X.; Sun, S.; Fu, Y.; Xie, L.; Ai, P. 2021: NF-κB and neutrophil extracellular traps cooperate to promote breast cancer progression and metastasis. Experimental Cell Research 405(2): 112707
Zhang, Q.; Yang, Z.; Ni, Y.; Bai, H.; Han, Q.; Yi, Z.; Yi, X.; Agbana, Y.L.; Kuang, Y.; Zhu, Y. 2020: NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC. Cancer Cell International 20: 483
Oliveira, K.C.; Zambom, F.F.F.; Albino, A.H.; Alarcon Arias, S.C.; Ávila, V.F.; Faustino, V.D.; Malheiros, D.M.A.C.; Camara, N.O.S.; Fujihara, C.K.; Zatz, R. 2020: NF-κB blockade during short-term l-NAME and salt overload strongly attenuates the late development of chronic kidney disease. American Journal of Physiology. Renal Physiology 319(2): F215-F228
Morel, K.L.; Hamid, A.A.; Clohessy, J.G.; Pandell, N.; Ellis, L.; Sweeney, C.J. 2021: NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants. Molecular Cancer Research: Mcr 19(7): 1137-1145
Vicioso, Y.; Wong, D.P.; Roy, N.K.; Das, N.; Zhang, K.; Ramakrishnan, P.; Parameswaran, R. 2021: NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells. Frontiers in Immunology 12: 652786
Dempsey, L.A. 2017: NF-κB citrullination. Nature Immunology 18(8): 876
Gerondakis, S.; Fulford, T.S.; Messina, N.L.; Grumont, R.J. 2014: NF-κB control of T cell development. Nature Immunology 15(1): 15-25
Mauro, C.; Leow, S.Chi.; Anso, E.; Rocha, S.; Thotakura, A.K.; Tornatore, L.; Moretti, M.; De Smaele, E.; Beg, A.A.; Tergaonkar, V.; Chandel, N.S.; Franzoso, G. 2011: NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nature Cell Biology 13(10): 1272-1279
Abd Ellah, N.H.; Taylor, L.; Ayres, N.; Elmahdy, M.M.; Fetih, G.N.; Jones, H.N.; Ibrahim, E.A.; Pauletti, G.M. 2016: NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells. Cancer Gene Therapy 23(5): 149-155
Creusot, Rémi.J. 2011: NF-κB in DCs: it takes effort to be immature. Nature Medicine 17(12): 1554-1556
Hayden, M.S.; Ghosh, S. 2011: NF-κB in immunobiology. Cell Research 21(2): 223-244
Eluard, B.; Thieblemont, C.; Baud, V.ér. 2020: NF-κB in the new Era of Cancer Therapy. Trends in Cancer 6(8): 677-687
Luedde, T.; Schwabe, R.F. 2011: NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nature Reviews. Gastroenterology and Hepatology 8(2): 108-118
Wullaert, A.; Bonnet, M.C.; Pasparakis, M. 2011: NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Research 21(1): 146-158
Thu, Y.M.; Su, Y.; Yang, J.; Splittgerber, R.; Na, S.; Boyd, A.; Mosse, C.; Simons, C.; Richmond, A. 2012: NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway. Oncogene 31(20): 2580-2592
Brightbill, H.D.; Suto, E.; Blaquiere, N.; Ramamoorthi, N.; Sujatha-Bhaskar, S.; Gogol, E.B.; Castanedo, G.M.; Jackson, B.T.; Kwon, Y.C.; Haller, S.; Lesch, J.; Bents, K.; Everett, C.; Kohli, P.Bir.; Linge, S.; Christian, L.; Barrett, K.; Jaochico, A.; Berezhkovskiy, L.M.; Fan, P.W.; Modrusan, Z.; Veliz, K.; Townsend, M.J.; DeVoss, J.; Johnson, A.R.; Godemann, R.; Lee, W.P.; Austin, C.D.; McKenzie, B.S.; Hackney, J.A.; Crawford, J.J.; Staben, S.T.; Alaoui Ismaili, M.H.; Wu, L.C.; Ghilardi, N. 2018: NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus. Nature Communications 9(1): 179
Deraska, P.V.; O'Leary, C.; Reavis, H.D.; Labe, S.; Dinh, T-Khang.; Lazaro, J-Bernard.; Sweeney, C.; D'Andrea, A.D.; Kozono, D. 2018: NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair. Cell Death Discovery 4: 10
Peterson, J.M.; Wang, D.J.; Shettigar, V.; Roof, S.R.; Canan, B.D.; Bakkar, N.; Shintaku, J.; Gu, J-Mo.; Little, S.C.; Ratnam, N.M.; Londhe, P.; Lu, L.; Gaw, C.E.; Petrosino, J.M.; Liyanarachchi, S.; Wang, H.; Janssen, P.M.L.; Davis, J.P.; Ziolo, M.T.; Sharma, S.M.; Guttridge, D.C. 2018: NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model. Nature Communications 9(1): 3431
Proto, J.D.; Tang, Y.; Lu, A.; Chen, W.C.W.; Stahl, E.; Poddar, M.; Beckman, S.A.; Robbins, P.D.; Nidernhofer, L.J.; Imbrogno, K.; Hannigan, T.; Mars, W.M.; Wang, B.; Huard, J. 2015: NF-κB inhibition reveals a novel role for HGF during skeletal muscle repair. Cell Death and Disease 6: E1730
Zhu, S.-B.; Xu, Y.-Q.; Gao, H.; Deng, Y. 2020: NF-κB inhibitor QNZ protects human chondrocyte degeneration by promoting glucose uptake through Glut4 activation. European Review for Medical and Pharmacological Sciences 24(9): 4642-4651
Zhou, M.-J.; Xing, Y.-J.; Yang, J. 2020: NF-κB inhibitor improves pulmonary vascular remodeling by reversing LPS-induced down-regulation of BMPRIi. Sheng Li Xue Bao: 72(5): 541-550
Avci, N.G.; Ebrahimzadeh-Pustchi, S.; Akay, Y.M.; Esquenazi, Y.; Tandon, N.; Zhu, J-Jiguang.; Akay, M. 2020: NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways. Scientific Reports 10(1): 13352
Glaeser, J.D.; Salehi, K.; Kanim, L.E.A.; NaPier, Z.; Kropf, M.A.; Cuéllar, J.M.; Perry, T.G.; Bae, H.W.; Sheyn, D. 2020: NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration. Spine Journal: Official Journal of the North American Spine Society 20(9): 1480-1491
Li, C-Shun.; Sarotti, A.M.; Huang, P.; Dang, U.T.; Hurdle, J.G.; Kondratyuk, T.P.; Pezzuto, J.M.; Turkson, J.; Cao, S. 2017: NF-κB inhibitors, unique γ-pyranol-γ-lactams with sulfide and sulfoxide moieties from Hawaiian plant Lycopodiella cernua derived fungus Paraphaeosphaeria neglecta FT462. Scientific Reports 7(1): 10424
Wang, C.; Zaman, K.H.A.U.; Sarotti, A.M.; Wu, X.; Zheng, S.-L.; Cao, S. 2021: NF-κB inhibitory, antimicrobial and antiproliferative potentials of compounds from Hawaiian fungus Aspergillus polyporicola FS910. 3 Biotech 11(8): 391
Wang, F.; Jiang, X.; Wang, P. 2020: NF-κB interaction long non-coding RNA inhibits migration, invasion and epithelial-mesenchymal transition of cervical cancer cells through inhibiting NF-κB signaling pathways. Experimental and Therapeutic Medicine 20(2): 1039-1047
Baltimore, D. 2011: NF-κB is 25. Nature Immunology 12(8): 683-685
Harte, M.T.; Gorski, J.J.; Savage, K.I.; Purcell, J.W.; Barros, E.M.; Burn, P.M.; McFarlane, C.; Mullan, P.B.; Kennedy, R.D.; Perkins, N.D.; Harkin, D.Paul. 2014: NF-κB is a critical mediator of BRCA1-induced chemoresistance. Oncogene 33(6): 713-723
Zhu, Y.; Zuo, W.; Shen, X.; Liu, Y.; Zhao, Y.; Xiong, Y.; Cao, H.; Wang, Y.; Liang, Z. 2021: NF-κB is involved in the regulation of autophagy in mutant p53 cells in response to ionizing radiation. Cell Death Discovery 7(1): 159
Irvin, A.E.; Jhala, G.; Zhao, Y.; Blackwell, T.S.; Krishnamurthy, B.; Thomas, H.E.; Kay, T.W.H. 2018: NF-κB is weakly activated in the NOD mouse model of type 1 diabetes. Scientific Reports 8(1): 4217
Wang, L.; Guo, J.; Zhou, J.; Wang, D.; Kang, X.; Zhou, L. 2020: NF-κB maintains the stemness of colon cancer cells by downregulating miR-195-5p/497-5p and upregulating MCM2. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 225
Hunter, J.E.; Willmore, E.; Irving, J.A.E.; Hostomsky, Z.; Veuger, S.J.; Durkacz, B.W. 2012: NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene 31(2): 251-264
Vonach, C.; Viola, K.; Giessrigl, B.; Huttary, N.; Raab, I.; Kalt, R.; Krieger, S.; Vo, T.P.N.; Madlener, S.; Bauer, S.; Marian, B.; Hämmerle, M.; Kretschy, N.; Teichmann, M.; Hantusch, B.; Stary, S.; Unger, C.; Seelinger, M.; Eger, A.; Mader, R.; Jäger, W.; Schmidt, W.; Grusch, M.; Dolznig, H.; Mikulits, W.; Krupitza, G. 2011: NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. British Journal of Cancer 105(2): 263-271
Lu, A.; Proto, J.D.; Guo, L.; Tang, Y.; Lavasani, M.; Tilstra, J.S.; Niedernhofer, L.J.; Wang, B.; Guttridge, D.C.; Robbins, P.D.; Huard, J. 2012: NF-κB negatively impacts the myogenic potential of muscle-derived stem cells. Molecular Therapy: the Journal of the American Society of Gene Therapy 20(3): 661-668
Yamamoto, M.; Taguchi, Y.; Ito-Kureha, T.; Semba, K.; Yamaguchi, N.; Inoue, J-ichiro. 2013: NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nature Communications 4: 2299
Cai, Q.; Tu, M.; Xu-Monette, Z.Y.; Sun, R.; Manyam, G.C.; Xu, X.; Tzankov, A.; Hsi, E.D.; Møller, M.B.; Medeiros, L.Jeffrey.; Ok, C.Young.; Young, K.H. 2017: NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 30(6): 854-876
Ruiz-Perera, L.M.; Schneider, L.; Windmöller, B.A.; Müller, J.; Greiner, J.F.W.; Kaltschmidt, C.; Kaltschmidt, B. 2018: NF-κB p65 directs sex-specific neuroprotection in human neurons. Scientific Reports 8(1): 16012
Daniel, P.V.; Dogra, S.; Rawat, P.; Choubey, A.; Khan, A.S.; Rajak, S.; Kamthan, M.; Mondal, P. 2021: NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet. Journal of Biological Chemistry 296: 100714
Xu, A.; Deng, F.; Chen, Y.; Kong, Y.; Pan, L.; Liao, Q.; Rao, Z.; Xie, L.; Yao, C.; Li, S.; Zeng, X.; Zhu, X.; Liu, H.; Gao, N.; Xue, L.; Chen, F.; Xu, G.; Wei, D.; Zhou, X.; Li, Z.; Sheng, X. 2020: NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity. Biomedicine and PharmacoTherapy 130: 110525
Laforge, M.; Rodrigues, V.; Silvestre, R.; Gautier, C.; Weil, R.; Corti, O.; Estaquier, J. 2016: NF-κB pathway controls mitochondrial dynamics. Cell Death and Differentiation 23(1): 89-98
Zheng, R-He.; Zhang, Y-Bo.; Qiu, F-Nan.; Liu, Z-Hui.; Han, Y.; Huang, R.; Zhao, Y.; Yao, P.; Qiu, Y.; Ren, J. 2021: NF-κB pathway play a role in SCD1 deficiency-induced ceramide de novo synthesis. Cancer Biology and Therapy 2021: 1-11
Machitani, M.; Sakurai, F.; Wakabayashi, K.; Nakatani, K.; Shimizu, K.; Tachibana, M.; Mizuguchi, H. 2016: NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector. Scientific Reports 6: 19922
Zhang, Y.; Ma, C.; Liu, C.; Wu, W. 2020: NF-κB promotes osteoclast differentiation by overexpressing MITF via down regulating microRNA-1276 expression. Life Sciences 258: 118093
Ariyakumar, G.; Morris, J.M.; McKelvey, K.J.; Ashton, A.W.; McCracken, S.A. 2021: NF-κB regulation in maternal immunity during normal and IUGR pregnancies. Scientific Reports 11(1): 20971
Böttcher, M.; Müller-Fielitz, H.; Sundaram, S.M.; Gallet, S.; Neve, V.; Shionoya, K.; Zager, A.; Quan, N.; Liu, X.; Schmidt-Ullrich, R.; Haenold, R.; Wenzel, J.; Blomqvist, A.; Engblom, D.; Prevot, V.; Schwaninger, M. 2020: NF-κB signaling in tanycytes mediates inflammation-induced anorexia. Molecular Metabolism 39: 101022
Banerjee, R.; Samanta, M.; Das, S. 2020: NF-κB signaling induces inductive expression of the downstream molecules and IgD gene in the freshwater carp, Catla catla. 3 Biotech 10(10): 445
Liu, Y.; Zhou, G.; Wang, Z.; Guo, X.; Xu, Q.; Huang, Q.; Su, L. 2015: NF-κB signaling is essential for resistance to heat stress-induced early stage apoptosis in human umbilical vein endothelial cells. Scientific Reports 5: 13547
Blonska, M.; Lin, X. 2011: NF-κB signaling pathways regulated by CARMA family of scaffold proteins. Cell Research 21(1): 55-70
Jin, W.Jong.; Kim, B.; Kim, D.; Park Choo, H-Young.; Kim, H-Hee.; Ha, H.; Lee, Z.Hee. 2017: NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells. Experimental and Molecular Medicine 49(2): E295
Lee, R.E.C.; Qasaimeh, M.A.; Xia, X.; Juncker, D.; Gaudet, S. 2016: NF-κB signalling and cell fate decisions in response to a short pulse of tumour necrosis factor. Scientific Reports 6: 39519
Zhang, G.-Z.; Liu, M.-Q.; Chen, H.-W.; Wu, Z.-L.; Gao, Y.-C.; Ma, Z.-J.; He, X.-G.; Kang, X.-W. 2021: NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. Cell Proliferation 54(7): E13057
Philippe, O.; Rio, Mène.; Malan, Vérie.; Van Esch, H.; Baujat, Gève.; Bahi-Buisson, N.; Valayannopoulos, V.; Gesny, R.; Bonnefont, J-Paul.; Munnich, A.; Froyen, G.; Amiel, J.; Boddaert, N.; Colleaux, L. 2013: NF-κB signalling requirement for brain myelin formation is shown by genotype/MRI phenotype correlations in patients with Xq28 duplications. European Journal of Human Genetics: Ejhg 21(2): 195-199
Wong, L.M.; Jiang, G. 2021: NF-κB sub-pathways and HIV cure: a revisit. Ebiomedicine 63: 103159
Nozawa, T.; Mihara-Tomiyama, N.; Chiba, T.; Imai, K. 2021: NF-κB subunit RELA suppression of mucosa-associated lymphoid tissue lymphoma translocation protein 1 expression in oral carcinoma cells. Biochemical and Biophysical Research Communications 542: 24-28
Cui, X.; Shen, D.; Kong, C.; Zhang, Z.; Zeng, Y.; Lin, X.; Liu, X. 2017: NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo. Scientific Reports 7: 40723
Taniguchi, K.; Karin, M. 2018: NF-κB, inflammation, immunity and cancer: coming of age. Nature Reviews. Immunology 18(5): 309-324
Özeş, A.R.; Miller, D.F.; Özeş, O.N.; Fang, F.; Liu, Y.; Matei, D.; Huang, T.; Nephew, K.P. 2016: NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene 35(41): 5350-5361
Lei, B.; Liu, J.; Yao, Z.; Xiao, Y.; Zhang, X.; Zhang, Y.; Xu, J. 2021: NF-κB-Induced Upregulation of miR-146a-5p Promoted Hippocampal Neuronal Oxidative Stress and Pyroptosis via TIGAR in a Model of Alzheimer's Disease. Frontiers in Cellular Neuroscience 15: 653881
Kraft, D.; Rall, M.; Volcic, M.; Metzler, E.; Groo, A.; Stahl, A.; Bauer, L.; Nasonova, E.; Salles, D.; Taucher-Scholz, G.; Bönig, H.; Fournier, C.; Wiesmüller, L. 2015: NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells. Leukemia 29(7): 1543-1554
Nakshatri, H.; Appaiah, H.N.; Anjanappa, M.; Gilley, D.; Tanaka, H.; Badve, S.; Crooks, P.A.; Mathews, W.; Sweeney, C.; Bhat-Nakshatri, P. 2015: NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT. Cell Death and Disease 6: E1608
Crescenzi, E.; Pacifico, F.; Lavorgna, A.; De Palma, R.; D'Aiuto, E.; Palumbo, G.; Formisano, S.; Leonardi, A. 2011: NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells. Oncogene 30(24): 2707-2717
Kim, J-Hee.; Kim, J-Yoon.; Park, M.; Kim, S.; Kim, T.; Kim, J.; Choi, S.; Park, W.; Hwang, J.Yun.; Choe, J.; Ha, K-Soo.; Won, M-Ho.; Ryoo, S.; Kwon, Y-Guen.; Kim, Y-Myeong. 2020: NF-κB-dependent miR-31/155 biogenesis is essential for TNF-α-induced impairment of endothelial progenitor cell function. Experimental and Molecular Medicine 52(8): 1298-1309
Shostak, K.; Zhang, X.; Hubert, P.; Göktuna, S.Ismail.; Jiang, Z.; Klevernic, I.; Hildebrand, J.; Roncarati, P.; Hennuy, B.; Ladang, Aélie.; Somja, J.; Gothot, Aé.; Close, P.; Delvenne, P.; Chariot, A. 2014: NF-κB-induced KIAA1199 promotes survival through EGFR signalling. Nature Communications 5: 5232
Echizen, K.; Horiuchi, K.; Aoki, Y.; Yamada, Y.; Minamoto, T.; Oshima, H.; Oshima, M. 2019: NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells. Oncogene 38(22): 4250-4263
Yan, S.; Xu, Z.; Lou, F.; Zhang, L.; Ke, F.; Bai, J.; Liu, Z.; Liu, J.; Wang, H.; Zhu, H.; Sun, Y.; Cai, W.; Gao, Y.; Su, B.; Li, Q.; Yang, X.; Yu, J.; Lai, Y.; Yu, X-Zhong.; Zheng, Y.; Shen, N.; Chin, Y.Eugene.; Wang, H. 2015: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nature Communications 6: 7652
Zhu, C.; Cai, Y.; Mo, S.; Zhu, J.; Wang, W.; Peng, B.; Guo, J.; Zhang, Z.; Chen, X. 2021: NF-κB-mediated TET2-dependent TNF promoter demethylation drives Mtb-upregulation TNF expression in macrophages. Tuberculosis 129: 102108
Zheng, Z-Nan.; Huang, G-Zhao.; Wu, Q-Qing.; Ye, H-Yu.; Zeng, W-Sen.; Lv, X-Zhi. 2020: NF-κB-mediated lncRNA AC007271.3 promotes carcinogenesis of oral squamous cell carcinoma by regulating miR-125b-2-3p/Slug. Cell Death and Disease 11(12): 1055
Jin, S.; Li, X.; Dai, Y.; Li, C.; Wang, D. 2020: NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells. Cellular Oncology 43(6): 1035-1048
Chen, C-C.; Liu, H-P.; Chao, M.; Liang, Y.; Tsang, N-M.; Huang, H-Y.; Wu, C-C.; Chang, Y-S. 2014: NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma. Oncogene 33(28): 3648-3659
Sanchez-Lopez, E.; Ghia, E.M.; Antonucci, L.; Sharma, N.; Rassenti, L.Z.; Xu, J.; Sun, B.; Kipps, T.J.; Karin, M. 2020: NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia. Cell Death and Differentiation 27(7): 2206-2216
Park, M.; Choi, S.; Kim, S.; Kim, J.; Lee, D-Keon.; Park, W.; Kim, T.; Jung, J.; Hwang, J.Yun.; Won, M-Ho.; Ryoo, S.; Kang, S.Goo.; Ha, K-Soo.; Kwon, Y-Guen.; Kim, Y-Myeong. 2019: NF-κB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase. Experimental and Molecular Medicine 51(2): 1-12
Liu, G.; Ye, X.; Miller, E.J.; Liu, S.Fang. 2014: NF-κB-to-AP-1 switch: a mechanism regulating transition from endothelial barrier injury to repair in endotoxemic mice. Scientific Reports 4: 5543
Fafián-Labora, J.A.; O'Loghlen, A. 2021: NF-κB/IKK activation by small extracellular vesicles within the SASP. Aging Cell 20(7): E13426
Gerloff, D.; Grundler, R.; Wurm, A.A.; Bräuer-Hartmann, D.; Katzerke, C.; Hartmann, J-U.; Madan, V.; Müller-Tidow, C.; Duyster, J.; Tenen, D.G.; Niederwieser, D.; Behre, G. 2015: NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia. Leukemia 29(3): 535-547
Wang, Y.; Lin, Y.; Cheng, C.; Chen, P.; Zhang, P.; Wu, H.; Li, K.; Deng, Y.; Qian, J.; Zhang, X.; Yu, B. 2020: NF-κB/TWIST1 Mediates Migration and Phagocytosis of Macrophages in the Mice Model of Implant-Associated Staphylococcus aureus Osteomyelitis. Frontiers in Microbiology 11: 1301
Yang, F.; Xu, Y.; Liu, C.; Ma, C.; Zou, S.; Xu, X.; Jia, J.; Liu, Z. 2018: NF-κB/miR-223-3p/ARID1A axis is involved in Helicobacter pylori CagA-induced gastric carcinogenesis and progression. Cell Death and Disease 9(1): 12
Urbanowicz, I.; Wołowiec, D.; Wysoczańska, B.; Łacina, P.; Jonkisz, A.; Nahaczewska, W.ła.; Tukiendorf, A.; Bil-Lula, I.; Bogunia-Kubik, K.; Pawlak, E. 2021: NF-κB1 -94del/del ATTG polymorphic variant maintains CLL at an early, mildest stage. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 30(5): 499-506
Sun, F.; Qu, Z.; Xiao, Y.; Zhou, J.; Burns, T.F.; Stabile, L.P.; Siegfried, J.M.; Xiao, G. 2016: NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function. Oncogene 35(18): 2299-2310
Antonacopoulou, A.; Kottorou, A.E.; Dimitrakopoulos, F.-I.; Marousi, S.; Kalofonou, F.; Koutras, A.; Makatsoris, T.; Tzelepi, V.; Kalofonos, H.P. 2021: NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease development. Translational Oncology 14(1): 100912
Jones, L.G.; Vaida, A.; Thompson, L.M.; Ikuomola, F.I.; Caamaño, J.H.; Burkitt, M.D.; Miyajima, F.; Williams, J.M.; Campbell, B.J.; Pritchard, D.Mark.; Duckworth, C.A. 2019: NF-κB2 signalling in enteroids modulates enterocyte responses to secreted factors from bone marrow-derived dendritic cells. Cell Death and Disease 10(12): 896
Barnabei, L.; Laplantine, E.; Mbongo, W.; Rieux-Laucat, F.éd.ér.; Weil, R. 2021: NF-κB: at the Borders of Autoimmunity and Inflammation. Frontiers in Immunology 12: 716469
Sheng, L.; Zhou, Y.; Chen, Z.; Ren, D.; Cho, K.Won.; Jiang, L.; Shen, H.; Sasaki, Y.; Rui, L. 2012: NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nature Medicine 18(6): 943-949
Bai, Y.; Lu, J.; Cheng, Y.; Zhang, F.; Fan, X.; Weng, Y.; Zhu, J. 2018: NF-кB increases LPS-mediated procalcitonin production in human hepatocytes. Scientific Reports 8(1): 8913
Zhang, P.; Liu, J.; Li, X.; Gao, M.; Feng, F.; Wang, W.; Zhang, Q.; Yao, W. 2021: NF1 and PTEN gene polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population: a case-control study. Experimental and Molecular Pathology 118: 104603
Dischinger, P.S.; Tovar, E.A.; Essenburg, C.J.; Madaj, Z.B.; Gardner, E.E.; Callaghan, M.E.; Turner, A.N.; Challa, A.K.; Kempston, T.; Eagleson, B.; Kesterson, R.A.; Bronson, R.T.; Bowman, M.J.; Graveel, C.R.; Steensma, M.R. 2018: NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer. Npj Breast Cancer 4: 29
Lou, H.; Zhai, C.; Gong, L.; Pan, H.; Pan, H.; Zhang, Y.; Yang, M.; Hu, Z. 2020: NF1 germline mutation in a Chinese family with colon cancer. Journal of International Medical Research 48(8): 300060519896435
Brosseau, J-Philippe.; Liao, C-Ping.; Wang, Y.; Ramani, V.; Vandergriff, T.; Lee, M.; Patel, A.; Ariizumi, K.; Le, L.Q. 2018: NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. Nature Communications 9(1): 5014
Mangues, R.; Corral, T.; Lu, S.; Symmans, W.F.; Liu, L.; Pellicer, A. 1998: NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity. Oncogene 17(13): 1705-1716
Lopes, J.; Teixeira, D.; Sousa, C.; Baptista, A.; Osório Ferreira, E. 2020: NF1 microdeletion syndrome: a phenotypical characterization of a rare case of neurofibromatosis type 1. Acta Dermatovenerologica Alpina Pannonica et Adriatica 29(2): 85-87
Moles, K.J.; Gowans, G.C.; Gedela, S.; Beversdorf, D.; Yu, A.; Seaver, L.H.; Schultz, R.A.; Rosenfeld, J.A.; Torchia, B.S.; Shaffer, L.G. 2012: NF1 microduplications: identification of seven nonrelated individuals provides further characterization of the phenotype. Genetics in Medicine: Official Journal of the American College of Medical Genetics 14(5): 508-514
Eisfeld, A-Kathrin.; Kohlschmidt, J.; Mrózek, K.; Mims, A.; Walker, C.J.; Blachly, J.S.; Nicolet, D.; Orwick, S.; Maharry, S.E.; Carroll, A.J.; Powell, B.L.; Kolitz, J.E.; Wang, E.S.; Stone, R.M.; de la Chapelle, A.; Byrd, J.C.; Bloomfield, C.D. 2018: NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome. Leukemia 32(12): 2536-2545
Scholz, S.L.; Cosgarea, I.; Süßkind, D.; Murali, R.; Möller, I.; Reis, H.; Leonardelli, S.; Schilling, B.; Schimming, T.; Hadaschik, E.; Franklin, C.; Paschen, A.; Sucker, A.; Steuhl, K.P.; Schadendorf, D.; Westekemper, H.; Griewank, K.G. 2018: NF1 mutations in conjunctival melanoma. British Journal of Cancer 118(9): 1243-1247
Imbard, A.; Pasmant, E.; Sabbagh, A.; Luscan, A.; Soares, M.; Goussard, P.; Blanché, Hélène.; Laurendeau, I.; Ferkal, S.; Vidaud, M.; Pinson, Séphane.; Bellanne-Chantelot, C.; Vidaud, D.; Wolkenstein, P.; Parfait, Béatrice. 2015: NF1 single and multi-exons copy number variations in neurofibromatosis type 1. Journal of Human Genetics 60(4): 221-224
Li, X.; Yu, J.; Wang, L. 2021: NF1-Mutant Cancer and Immune Checkpoint Inhibitors: A Large Database Analysis. International Journal of Radiation Oncology Biology Physics 111(3s): E421
Larribère, L.; Cakrapradipta Wibowo, Y.; Patil, N.; Abba, M.; Tundidor, I.; Aguiñón Olivares, R.én.G.; Allgayer, H.; Utikal, J. 2020: NF1-RAC1 axis regulates migration of the melanocytic lineage. Translational Oncology 13(12): 100858
Weiss, B.D.; Wolters, P.L.; Plotkin, S.R.; Widemann, B.C.; Tonsgard, J.H.; Blakeley, J.; Allen, J.C.; Schorry, E.; Korf, B.; Robison, N.J.; Goldman, S.; Vinks, A.A.; Emoto, C.; Fukuda, T.; Robinson, C.T.; Cutter, G.; Edwards, L.; Dombi, E.; Ratner, N.; Packer, R.; Fisher, M.J. 2021: NF106: a Neurofibromatosis Clinical Trials Consortium Phase Ii Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults with NF1-Related Plexiform Neurofibromas. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 39(7): 797-806
Seizinger, B.R. 1993: NF1: a prevalent cause of tumorigenesis in human cancers?. Nature Genetics 3(2): 97-99
Sun, X.; Li, S.; Gan, X.; Chen, K.; Yang, D.; Yang, Y. 2020: NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells. Aging 12(10): 9726-9744
Leone, P.E.; Bello, M.J.; de Campos, J.M.; Vaquero, J.; Sarasa, J.L.; Pestaña, A.; Rey, J.A. 1999: NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 18(13): 2231-2239
Rutland, J.W.; Gill, C.M.; Loewenstern, J.; Arib, H.; Pain, M.; Umphlett, M.; Kinoshita, Y.; McBride, R.B.; Bederson, J.; Donovan, M.; Sebra, R.; Shrivastava, R.K.; Fowkes, M. 2021: NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas. Cancer Immunology Immunotherapy: Cii 70(1): 169-176
Bosco, E.E.; Nakai, Y.; Hennigan, R.F.; Ratner, N.; Zheng, Y. 2010: NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation. Oncogene 29(17): 2540-2549
Tsai, H.-I.; Zeng, X.; Liu, L.; Xin, S.; Wu, Y.; Xu, Z.; Zhang, H.; Liu, G.; Bi, Z.; Su, D.; Yang, M.; Tao, Y.; Wang, C.; Zhao, J.; Eriksson, J.E.; Deng, W.; Cheng, F.; Chen, H. 2021: NF45/NF90-mediated rDNA transcription provides a novel target for immunosuppressant development. Embo Molecular Medicine 13(3): E12834
Grasso, G.; Higuchi, T.; Mac, V.; Barbier, J.ér.ôm.; Helsmoortel, M.; Lorenzi, C.; Sanchez, G.; Bello, M.; Ritchie, W.; Sakamoto, S.; Kiernan, R. 2020: NF90 modulates processing of a subset of human pri-miRNAs. Nucleic Acids Research 48(12): 6874-6888
Ding, D.; Huang, H.; Li, Q.; Yu, W.; Wang, C.; Ma, H.; Wu, J.; Dang, Y.; Yu, L.; Jiang, W. 2020: NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2. Cell Death Discovery 6: 3
Ding, D.; Huang, H.; Li, Q.; Yu, W.; Wang, C.; Ma, H.; Wu, J.; Dang, Y.; Yu, L.; Jiang, W. 2020: NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2. Cell Death Discovery 6(1): 3
Long, J.; Chen, J.; Wang, Q.; Gao, F.; Lian, M.; Zhang, P.; Yang, Y.; Zhu, H. 2020: NFAT activating protein with ITAM motif 1 (NFAM1) is upregulated on circulating monocytes in coronary artery disease and potentially correlated with monocyte chemotaxis. Atherosclerosis 307: 39-51
Koga, T.; Matsui, Y.; Asagiri, M.; Kodama, T.; de Crombrugghe, B.; Nakashima, K.; Takayanagi, H. 2005: NFAT and Osterix cooperatively regulate bone formation. Nature Medicine 11(8): 880-885
Arron, J.R.; Winslow, M.M.; Polleri, A.; Chang, C-Pin.; Wu, H.; Gao, X.; Neilson, J.R.; Chen, L.; Heit, J.J.; Kim, S.K.; Yamasaki, N.; Miyakawa, T.; Francke, U.; Graef, I.A.; Crabtree, G.R. 2006: NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441(7093): 595-600
Bretz, C.A.; Savage, S.R.; Capozzi, M.E.; Suarez, S.; Penn, J.S. 2015: NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis. Scientific Reports 5: 14963
Yahia-Cherbal, H.; Rybczynska, M.; Lovecchio, D.; Stephen, T.; Lescale, Cé.; Placek, K.; Larghero, Jérome.; Rogge, L.; Bianchi, E. 2019: NFAT primes the human RORC locus for RORγt expression in CD4 + T cells. Nature Communications 10(1): 4698
Mancini, M.; Toker, A. 2009: NFAT proteins: emerging roles in cancer progression. Nature Reviews. Cancer 9(11): 810-820
Macian, F. 2005: NFAT proteins: key regulators of T-cell development and function. Nature Reviews. Immunology 5(6): 472-484
Tidu, F.; De Zuani, M.; Jose, S.S.; Bendíčková, K.; Kubala, L.áš; Caruso, F.; Cavalieri, F.; Forte, G.; Frič, J. 2021: NFAT signaling in human mesenchymal stromal cells affects extracellular matrix remodeling and antifungal immune responses. Iscience 24(6): 102683
Flockhart, R.J.; Armstrong, J.L.; Reynolds, N.J.; Lovat, P.E. 2009: NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma. British Journal of Cancer 101(8): 1448-1455
Catherinet, C.; Passaro, D.; Gachet, S.ép.; Medyouf, H.; Reynaud, A.; Lasgi, C.èn.; Ghysdael, J.; Tran Quang, C. 2021: NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia. Plos one 16(7): E0254184
Müller, M.R.; Rao, A. 2010: NFAT, immunity and cancer: a transcription factor comes of age. Nature Reviews. Immunology 10(9): 645-656
Märklin, M.; Heitmann, J.S.; Fuchs, A.R.; Truckenmüller, F.M.; Gutknecht, M.; Bugl, S.; Saur, S.J.; Lazarus, J.; Kohlhofer, U.; Quintanilla-Martinez, L.; Rammensee, H-Georg.; Salih, H.R.; Kopp, H-Georg.; Haap, M.; Kirschniak, A.; Kanz, L.; Rao, A.; Wirths, S.; Müller, M.R. 2017: NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia. Nature Communications 8(1): 755
Wang, J.; Zhang, Y.; Liu, L.; Cui, Z.; Shi, R.; Hou, J.; Liu, Z.; Yang, L.; Wang, L.; Li, Y. 2020: NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression. Bmc Cancer 20(1): 966
Fougère, M.; Gaudineau, B.; Barbier, J.; Guaddachi, F.; Feugeas, J-P.; Auboeuf, D.; Jauliac, S. 2010: NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene. Oncogene 29(15): 2292-2301
Wang, K.; Zhang, D-L.; Long, B.; An, T.; Zhang, J.; Zhou, L-Y.; Liu, C-Y.; Li, P-F. 2015: NFAT4-dependent miR-324-5p regulates mitochondrial morphology and cardiomyocyte cell death by targeting Mtfr1. Cell Death and Disease 6: E2007
Wang, Q.; Zhou, Y.; Rychahou, P.; Liu, C.; Weiss, H.L.; Evers, B.M. 2013: NFAT5 represses canonical Wnt signaling via inhibition of β-catenin acetylation and participates in regulating intestinal cell differentiation. Cell Death and Disease 4: E671
Kumar, R.; DuMond, J.F.; Khan, S.H.; Thompson, E.Brad.; He, Y.; Burg, M.B.; Ferraris, J.D. 2020: NFAT5, which protects against hypertonicity, is activated by that stress via structuring of its intrinsically disordered domain. Proceedings of the National Academy of Sciences of the United States of America 117(33): 20292-20297
Dulong, J.; Kouakou, C.; Mesloub, Y.; Rorteau, J.; Moratille, S.; Chevalier, F.P.; Vinasco-Sandoval, T.; Martin, M.èl.T.; Lamartine, J.ér.ôm. 2020: NFATC2 Modulates Radiation Sensitivity in Dermal Fibroblasts from Patients with Severe Side Effects of Radiotherapy. Frontiers in Oncology 10: 589168
Subbalakshmi, A.R.; Kundnani, D.; Biswas, K.; Ghosh, A.; Hanash, S.M.; Tripathi, S.C.; Jolly, M.K. 2020: NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype. Frontiers in Oncology 10: 553342
Metzelder, S.K.; Michel, C.; von Bonin, M.; Rehberger, M.; Hessmann, E.; Inselmann, S.; Solovey, M.; Wang, Y.; Sohlbach, K.; Brendel, C.; Stiewe, T.; Charles, J.; Ten Haaf, A.; Ellenrieder, V.; Neubauer, A.; Gattenlöhner, S.; Bornhäuser, M.; Burchert, A. 2015: NFATc1 as a therapeutic target in FLT3-ITD-positive AML. Leukemia 29(7): 1470-1477
Klein-Hessling, S.; Muhammad, K.; Klein, M.; Pusch, T.; Rudolf, R.; Flöter, J.; Qureischi, M.; Beilhack, A.; Vaeth, M.; Kummerow, C.; Backes, C.; Schoppmeyer, R.; Hahn, U.; Hoth, M.; Bopp, T.; Berberich-Siebelt, F.; Patra, A.; Avots, A.; Müller, N.; Schulze, A.; Serfling, E. 2017: NFATc1 controls the cytotoxicity of CD8 + T cells. Nature Communications 8(1): 511
Murti, K.; Neti, N.; Kurniawati, N.F.; Kartika, I.; Rasyid, R.S.P.; Hafy, Z. 2021: NFATc1 is Suppressed in Tumor Microenvironment of Hodgkin Lymphoma. Asian Pacific Journal of Cancer Prevention: Apjcp 22(6): 1943-1948
Shen, T.; Yue, C.; Wang, X.; Wang, Z.; Wu, Y.; Zhao, C.; Chang, P.; Sun, X.; Wang, W. 2021: NFATc1 promotes epithelial-mesenchymal transition and facilitates colorectal cancer metastasis by targeting SNAI1. Experimental Cell Research 408(1): 112854
Manda, K.R.; Tripathi, P.; Hsi, A.C.; Ning, J.; Ruzinova, M.B.; Liapis, H.; Bailey, M.; Zhang, H.; Maher, C.A.; Humphrey, P.A.; Andriole, G.L.; Ding, L.; You, Z.; Chen, F. 2016: NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence. Oncogene 35(25): 3282-3292
Alrefai, H.; Muhammad, K.; Rudolf, R.; Pham, D.Anh.Thuy.; Klein-Hessling, S.; Patra, A.K.; Avots, A.; Bukur, V.; Sahin, U.; Tenzer, S.; Goebeler, M.; Kerstan, A.; Serfling, E. 2016: NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells. Nature Communications 7: 11724
Rengarajan, J.; Tang, B.; Glimcher, L.H. 2002: NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naïve T(H)cells. Nature Immunology 3(1): 48-54
Perotti, V.; Baldassari, P.; Bersani, I.; Molla, A.; Vegetti, C.; Tassi, E.; Dal Col, J.; Dolcetti, R.; Anichini, A.; Mortarini, R. 2012: NFATc2 is a potential therapeutic target in human melanoma. Journal of Investigative Dermatology 132(11): 2652-2660
Perotti, V.; Baldassari, P.; Molla, A.; Vegetti, C.; Bersani, I.; Maurichi, A.; Santinami, M.; Anichini, A.; Mortarini, R. 2016: NFATc2 is an intrinsic regulator of melanoma dedifferentiation. Oncogene 35(22): 2862-2872
Liu, M.; Zhang, S.-B.; Luo, Y.-X.; Yang, Y.-L.; Zhang, X.-Z.; Li, B.; Meng, Y.; Chen, Y.-J.; Guo, R.-X.; Xiong, Y.-C.; Xin, W.-J.; Li, D. 2020: NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel. Journal of Neuroinflammation 17(1): 310
Perret, R.; Escuriol, J.; Velasco, Vérie.; Mayeur, L.; Soubeyran, I.; Delfour, C.; Aubert, Sébastien.; Polivka, M.; Karanian, M.; Meurgey, A.; Le Guellec, S.; Weingertner, N.; Hoeller, S.; Coindre, J-Michel.; Larousserie, Fédérique.; Pierron, Gëlle.; Tirode, F.; Le Loarer, Fçois. 2020: NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 33(10): 1930-1944
Urso, K.; Fernández, Aés.; Velasco, P.; Cotrina, J.; de Andrés, Bén.; Sánchez-Gómez, P.; Hernández-Laín, A.; Hortelano, S.; Redondo, J.Miguel.; Cano, E. 2019: NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells. Scientific Reports 9(1): 9361
Zao, X.; Cheng, J.; Shen, C.; Guan, G.; Feng, X.; Zou, J.; Zhang, J.; Liu, T.; Zheng, H.; Zhang, T.; Wang, J.; Liu, J.; Li, D.; Lu, F.; You, F.; Chen, X. 2021: NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcription. Oncoimmunology 10(1): 1869388
Martinez-Chantar, M.L.; Foti, M. 2020: NFATc4: new hub in NASH development. Journal of Hepatology 73(6): 1313-1315
Ju, Q.; Li, X.; Zhang, H.; Yan, S.; Li, Y.; Zhao, Y. 2020: NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: a Pan-Cancer Analysis. Oxidative Medicine and Cellular Longevity 2020: 3580719
Paul, K.C.; Sinsheimer, J.S.; Cockburn, M.; Bronstein, J.M.; Bordelon, Y.; Ritz, B. 2018: NFE2L2, PPARGC1α, and pesticides and Parkinson's disease risk and progression. Mechanisms of Ageing and Development 173: 1-8
Ren, Y.; Wang, Y.; Hao, S.; Yang, Y.; Xiong, W.; Qiu, L.; Tao, J.; Tang, A. 2020: NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt/β‑catenin pathway. Journal of Cancer 11(23): 6939-6949
Lee, D.-S.; Roh, S.Y.; Choi, H.; Park, J.-C. 2020: NFI-C Is Required for Epiphyseal Chondrocyte Proliferation during Postnatal Cartilage Development. Molecules and Cells 43(8): 739-748
Tchieu, J.; Calder, E.L.; Guttikonda, S.R.; Gutzwiller, E.M.; Aromolaran, K.A.; Steinbeck, J.A.; Goldstein, P.A.; Studer, L. 2019: NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells. Nature Biotechnology 37(3): 267-275
Chen, H.; Yu, C.; Shen, L.; Wu, Y.; Wu, D.; Wang, Z.; Song, G.; Chen, L.; Hong, Y. 2020: NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p. Pathology Research and Practice 216(12): 153236
Chang, C-Ying.; Pasolli, H.Amalia.; Giannopoulou, E.G.; Guasch, Géraldine.; Gronostajski, R.M.; Elemento, O.; Fuchs, E. 2013: NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche. Nature 495(7439): 98-102
Wang, N.; Yuan, J.; Liu, F.; Wei, J.; Liu, Y.; Xue, M.; Dong, R. 2021: NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription. Peerj 9: E10848
Tang, H.; Tan, C.; Cao, X.; Liu, Y.; Zhao, H.; Liu, Y.; Zhao, Y. 2021: NFIL3 Facilitates Neutrophil Autophagy, Neutrophil Extracellular Trap Formation and Inflammation During Gout via REDD1-Dependent mTOR Inactivation. Frontiers in Medicine 8: 692781
Kashiwada, M.; Cassel, S.L.; Colgan, J.D.; Rothman, P.B. 2011: NFIL3/E4BP4 controls type 2 T helper cell cytokine expression. EMBO Journal 30(10): 2071-2082
Luo, J-Yi.; Li, Y-Hong.; Fang, B-Bin.; Tian, T.; Liu, F.; Li, X-Mei.; Gao, X-Ming.; Yang, Y-Ning. 2020: NFKB1 gene rs28362491 ins/del variation is associated with higher susceptibility to myocardial infarction in a Chinese Han population. Scientific Reports 10(1): 19518
Guo, Y.; Liu, Z.; Wang, M. 2021: NFKB1-mediated downregulation of microRNA-106a promotes oxidative stress injury and insulin resistance in mice with gestational hypertension. Cytotechnology 73(1): 115-126
Wang, X.; Wu, H.; Zhang, Q.; Liu, F.; Wang, J.; Wei, C.; Liu, F.; Li, J. 2021: NFKB2 inhibits NRG1 transcription to affect nucleus pulposus cell degeneration and inflammation in intervertebral disc degeneration. Mechanisms of Ageing and Development 197: 111511
Manuel Sánchez-Maldonado, J.; Martínez-Bueno, M.; Canhão, H.; Ter Horst, R.; Muñoz-Peña, S.; Moñiz-Díez, A.; Rodríguez-Ramos, A.; Escudero, A.; Sorensen, S.B.; Hetland, M.L.; Ferrer, M.A.; Glintborg, B.; Filipescu, I.; Pérez-Pampin, E.; Conesa-Zamora, P.; García, A.; den Broeder, A.; De Vita, S.; Hove Jacobsen, S.Erik.; Collantes, E.; Quartuccio, L.; Netea, M.G.; Li, Y.; Fonseca, Jão.E.; Jurado, M.; López-Nevot, M.Ángel.; Coenen, M.J.H.; Andersen, V.; Cáliz, R.; Sainz, J. 2020: NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium. Scientific Reports 10(1): 4316
Chapman, S.J.; Khor, C.C.; Vannberg, F.O.; Rautanen, A.; Segal, S.; Moore, C.E.; Davies, R.J.O.; Day, N.P.; Peshu, N.; Crook, D.W.; Berkley, J.A.; Williams, T.N.; Scott, J.A.; Hill, A.V.S. 2010: NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes and Immunity 11(4): 319-325
Delaby, C.; Julian, A.; Page, G.; Ragot, S.; Lehmann, S.; Paccalin, M. 2021: NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline. Scientific Reports 11(1): 10283
Yang, Y.; Ikezoe, T.; Nishioka, C.; Bandobashi, K.; Takeuchi, T.; Adachi, Y.; Kobayashi, M.; Takeuchi, S.; Koeffler, H.P.; Taguchi, H. 2006: NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines. British Journal of Cancer 95(12): 1653-1662
Feng, L.; Xu, X.; Zhao, K. 2021: NFYB potentiates STK33 activation to promote cisplatin resistance in diffuse large B-cell lymphoma. Leukemia Research 111: 106708
Tharyan, R.George.; Annibal, A.; Schiffer, I.; Laboy, R.; Atanassov, I.; Weber, A.Luise.; Gerisch, B.; Antebi, A. 2020: NFYB-1 regulates mitochondrial function and longevity via lysosomal prosaposin. Nature Metabolism 2(5): 387-396
Nadjar, Aès.; Tridon, V.; May, M.J.; Ghosh, S.; Dantzer, R.; Amédée, T.; Parnet, P. 2005: NFkappaB activates in vivo the synthesis of inducible Cox-2 in the brain. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 25(8): 1047-1059
Shimizu, H.; Nakagami, H.; Tsukamoto, I.; Morita, S.; Kunugiza, Y.; Tomita, T.; Yoshikawa, H.; Kaneda, Y.; Ogihara, T.; Morishita, R. 2006: NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts. Gene Therapy 13(12): 933-941
Hegazy, D.M.; O'Reilly, D.A.; Yang, B.M.; Hodgkinson, A.D.; Millward, B.A.; Demaine, A.G. 2001: NFkappaB polymorphisms and susceptibility to type 1 diabetes. Genes and Immunity 2(6): 304-308
Nettles, K.W.; Bruning, J.B.; Gil, G.; Nowak, J.; Sharma, S.K.; Hahm, J.B.; Kulp, K.; Hochberg, R.B.; Zhou, H.; Katzenellenbogen, J.A.; Katzenellenbogen, B.S.; Kim, Y.; Joachmiak, A.; Greene, G.L. 2008: NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nature Chemical Biology 4(4): 241-247
Bisht, V.; Acharjee, A.; Gkoutos, G.V. 2021: NFnetFu: a novel workflow for microbiome data fusion. Computers in Biology and Medicine 135: 104556
Ferrandez, E.; Gutierrez, O.; Segundo, D.San.; Fernandez-Luna, J.L. 2018: NFκB activation in differentiating glioblastoma stem-like cells is promoted by hyaluronic acid signaling through TLR4. Scientific Reports 8(1): 6341
Odqvist, L.; Montes-Moreno, S.; Sánchez-Pacheco, R.E.; Young, K.H.; Martín-Sánchez, E.; Cereceda, L.; Sánchez-Verde, L.; Pajares, R.; Mollejo, M.; Fresno, M.F.; Mazorra, F.; Ruíz-Marcellán, C.; Sánchez-Beato, M.; Piris, M.A. 2014: NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 27(10): 1331-1337
Guo, X.; Hong, S.; He, H.; Zeng, Y.; Chen, Y.; Mo, X.; Li, J.; Li, L.; Steinmetz, R.; Liu, Q. 2020: NFκB promotes oxidative stress-induced necrosis and ischemia/reperfusion injury by inhibiting Nrf2-ARE pathway. Free Radical Biology and Medicine 159: 125-135
Nicolae, C.M.; O'Connor, M.J.; Constantin, D.; Moldovan, G-Lucian. 2018: NFκB regulates p21 expression and controls DNA damage-induced leukemic differentiation. Oncogene 37(27): 3647-3656
McCall, P.; Bennett, L.; Ahmad, I.; Mackenzie, L.M.; Forbes, I.W.G.; Leung, H.Y.; Sansom, O.J.; Orange, C.; Seywright, M.; Underwood, M.A.; Edwards, J. 2012: NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression. British Journal of Cancer 107(9): 1554-1563
Menzel, M.; Akbarshahi, H.; Mahmutovic Persson, I.; Andersson, C.; Puthia, M.; Uller, L. 2022: NFκB1 Dichotomously Regulates Pro-Inflammatory and Antiviral Responses in Asthma. Journal of Innate Immunity 14(3): 182-191
Wilson, C.L.; Jurk, D.; Fullard, N.; Banks, P.; Page, A.; Luli, S.; Elsharkawy, A.M.; Gieling, R.G.; Chakraborty, J.Bagchi.; Fox, C.; Richardson, C.; Callaghan, K.; Blair, G.E.; Fox, N.; Lagnado, A.; Passos, J.F.; Moore, A.J.; Smith, G.R.; Tiniakos, D.G.; Mann, J.; Oakley, F.; Mann, D.A. 2015: NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nature Communications 6: 6818
Cui, Y.; Cui, Z.; Xu, J.; Hao, D.; Shi, J.; Wang, D.; Xiao, H.; Duan, X.; Chen, R.; Li, W. 2020: NG-Circos: next-generation Circos for data visualization and interpretation. Nar Genomics and Bioinformatics 2(3): Lqaa 069
Orucevic, A.; Lala, P.K. 1996: NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. British Journal of Cancer 73(2): 189-196
Lopez-Millan, B.; Sanchéz-Martínez, D.; Roca-Ho, H.; Gutiérrez-Agüera, F.; Molina, O.; Diaz de la Guardia, R.; Torres-Ruiz, Rúl.; Fuster, J.Luís.; Ballerini, P.; Suessbier, U.; Nombela-Arrieta, C.; Bueno, C.; Menéndez, P. 2019: NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia. Leukemia 33(7): 1557-1569
Bueno, C.; Montes, R.; Martín, L.; Prat, I.; Hernandez, M.C.; Orfao, A.; Menendez, P. 2008: NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?. Leukemia 22(8): 1475-1478
Prieto, C.; López-Millán, B.; Roca-Ho, H.; Stam, R.W.; Romero-Moya, D.; Rodríguez-Baena, F.J.; Sanjuan-Pla, A.; Ayllón, V.; Ramírez, M.; Bardini, M.; De Lorenzo, P.; Valsecchi, M.G.; Stanulla, M.; Iglesias, M.; Ballerini, P.; Carcaboso, Á.M.; Mora, J.; Locatelli, F.; Bertaina, A.; Padilla, L.; Rodríguez-Manzaneque, J.Carlos.; Bueno, C.; Menéndez, P. 2018: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. Leukemia 32(3): 633-644
Zhu, L.; Su, Q.; Jie, X.; Liu, A.; Wang, H.; He, B.; Jiang, H. 2016: NG2 expression in microglial cells affects the expression of neurotrophic and proinflammatory factors by regulating FAK phosphorylation. Scientific Reports 6: 27983
Nakano, M.; Tamura, Y.; Yamato, M.; Kume, S.; Eguchi, A.; Takata, K.; Watanabe, Y.; Kataoka, Y. 2017: NG2 glial cells regulate neuroimmunological responses to maintain neuronal function and survival. Scientific Reports 7: 42041
Joo, N.E.; Watanabe, T.; Chen, C.; Chekenya, M.; Stallcup, W.B.; Kapila, Y.L. 2008: NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation. Cell Death and Differentiation 15(5): 899-907
Solga, A.C.; Gianino, S.M.; Gutmann, D.H. 2014: NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma. Oncogene 33(3): 289-299
Rippe, C.; Morén, Börn.; Liu, L.; Stenkula, K.G.; Mustaniemi, J.; Wennström, M.; Swärd, K. 2021: NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells. Scientific Reports 11(1): 5955
Nickolas, T.L.; Forster, C.S.; Sise, M.E.; Barasch, N.; Solá-Del Valle, D.; Viltard, M.; Buchen, C.; Kupferman, S.; Carnevali, M.Luisa.; Bennett, M.; Mattei, S.; Bovino, A.; Argentiero, L.; Magnano, A.; Devarajan, P.; Mori, K.; Erdjument-Bromage, H.; Tempst, P.; Allegri, L.; Barasch, J. 2012: NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney International 82(6): 718-722
Hu, L.; Hittelman, W.; Lu, T.; Ji, P.; Arlinghaus, R.; Shmulevich, I.; Hamilton, S.R.; Zhang, W. 2009: NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Laboratory Investigation; a Journal of Technical Methods and Pathology 89(5): 531-548
Chen, Y.; Hu, W.; Li, Q.; Zhao, S.; Zhao, D.; Zhang, S.; Wei, Z.; Yang, X.; Chen, Y.; Li, X.; Liao, C.; Han, J.; Miao, Q.R.; Duan, Y. 2021: NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity. Journal of Biological Chemistry 296: 100624
Ohashi, Y.; Uchida, K.; Fukushima, K.; Satoh, M.; Koyama, T.; Tsuchiya, M.; Saito, H.; Takahira, N.; Inoue, G.; Takaso, M. 2021: NGF Expression and Elevation in Hip Osteoarthritis Patients with Pain and Central Sensitization. Biomed Research International 2021: 9212585
Ruggeri, P.; Cappabianca, L.; Farina, A.R.; Gneo, L.; Mackay, A.R. 2016: NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells. Cell Death and Disease 7: E2139
Humpel, C. 2021: NGF Released from Blood Cells or Collagen Hydrogels as a Therapeutic Target in Alzheimer's Disease?. Advances in Experimental Medicine and Biology 1331: 193-202
Yamashita, N. 2021: NGF Signaling in Endosomes. Advances in Experimental Medicine and Biology 1331: 19-29
Woo, C-Wook.; Lucarelli, E.; Thiele, C.J. 2004: NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number. Oncogene 23(8): 1522-1530
Baldassarro, V.A.; Lorenzini, L.; Bighinati, A.; Giuliani, A.; Alastra, G.; Pannella, M.; Fernandez, M.; Giardino, L.; Calzà, L. 2021: NGF and Endogenous Regeneration: from Embryology Toward Therapies. Advances in Experimental Medicine and Biology 1331: 51-63
Rocco, M.L.; Calzà, L.; Aloe, L. 2021: NGF and Retinitis Pigmentosa: Structural and Molecular Studies. Advances in Experimental Medicine and Biology 1331: 255-263
Triaca, V.; Ruberti, F.; Canu, N. 2021: NGF and the Amyloid Precursor Protein in Alzheimer's Disease: from Molecular Players to Neuronal Circuits. Advances in Experimental Medicine and Biology 1331: 145-165
Esposito, G.; Balzamino, B.O.; Bruno, L.; Cacciamani, A.; Micera, A. 2021: NGF in Inflammatory and Neurodegenerative Diseases of the Eye: new Findings Supporting Neuroprotection and Proper Tissue Remodeling in Vitreoretinal Disorders. Advances in Experimental Medicine and Biology 1331: 265-273
Zhang, X.; Huang, J.; McNaughton, P.A. 2005: NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO Journal 24(24): 4211-4223
Yan, T.; Zhang, Z.; Li, D. 2020: NGF receptors and PI3K/AKT pathway involved in glucose fluctuation-induced damage to neurons and α-lipoic acid treatment. Bmc Neuroscience 21(1): 38
Ruggeri, P.; Cappabianca, L.; Farina, A.R.; Gneo, L.; Mackay, A.R. 2016: NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis. Cell Death Discovery 2: 16004
Rukwied, R.R.; Main, M.; Weinkauf, B.; Schmelz, M. 2013: NGF sensitizes nociceptors for cowhage- but not histamine-induced itch in human skin. Journal of Investigative Dermatology 133(1): 268-270
Bernard, N.J. 2019: NGF vaccine reduces pain. Nature Reviews. Rheumatology 15(5): 251
Ye, J.; Gong, P. 2020: NGF-CS/HA-coating composite titanium facilitates the differentiation of bone marrow mesenchymal stem cells into osteoblast and neural cells. Biochemical and Biophysical Research Communications 531(3): 290-296
Lee, S.; Hwang, C.; Marini, S.; Tower, R.J.; Qin, Q.; Negri, S.; Pagani, C.A.; Sun, Y.; Stepien, D.M.; Sorkin, M.; Kubiak, C.A.; Visser, N.D.; Meyers, C.A.; Wang, Y.; Rasheed, H.A.; Xu, J.; Miller, S.; Huber, A.K.; Minichiello, L.; Cederna, P.S.; Kemp, S.W.P.; Clemens, T.L.; James, A.W.; Levi, B. 2021: NGF-TrkA signaling dictates neural ingrowth and aberrant osteochondral differentiation after soft tissue trauma. Nature Communications 12(1): 4939
Zhou, Y.; Lu, T-Jia.; Xiong, Z-Qi. 2009: NGF-dependent retrograde signaling: survival versus death. Cell Research 19(5): 525-526
O'Keeffe, G.W.; Gutierrez, H.; Pandolfi, P.Paolo.; Riccardi, C.; Davies, A.M. 2008: NGF-promoted axon growth and target innervation requires GITRL-GITR signaling. Nature Neuroscience 11(2): 135-142
Ammannaya, G.Kumar.K. 2020: NGF/TrKA Signaling Pathway and Atrial Fibrillation: Is There a Link?. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 2020: 1-2
Kim, S.; Burette, A.; Chung, H.Sun.; Kwon, S-Kyu.; Woo, J.; Lee, H.Woo.; Kim, K.; Kim, H.; Weinberg, R.J.; Kim, E. 2006: NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. Nature Neuroscience 9(10): 1294-1301
Nazuk, A.; Nadir, S.; Ansari, A.R.; Nawaz, R. 2020: NGO online disclosures index in the presence of auxiliary information. Plos one 15(9): E0238297
Zhou, Z.; He, G.; Zhang, X.; Lv, X.; Zhang, X.; Liu, A.; Xia, S.; Xie, H.; Dang, R.; Han, L.; Qi, J.; Meng, Y.; Yu, S.; Xie, W.; Jia, Z. 2021: NGPF2 triggers synaptic scaling up through ALK-LIMK-cofilin-mediated mechanisms. Cell Reports 36(7): 109515
Seidi, K.; Jahanban-Esfahlan, R.; Monhemi, H.; Zare, P.; Minofar, B.; Daei Farshchi Adli, A.; Farajzadeh, D.; Behzadi, R.; Mesgari Abbasi, M.; Neubauer, H.A.; Moriggl, R.; Zarghami, N.; Javaheri, T. 2018: NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth. Oncogene 37(29): 3967-3980
Di Matteo, P.; Hackl, C.; Jedeszko, C.; Valentinis, B.; Bordignon, C.; Traversari, C.; Kerbel, R.S.; Rizzardi, G-P. 2013: NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells. British Journal of Cancer 109(2): 360-369
Terrón-Camero, L.C.; Andrés-León, E. 2021: NGS Methodologies and Computational Algorithms for the Prediction and Analysis of Plant Circular RNAs. Methods in Molecular Biology 2362: 119-145
Goecks, J.; Coraor, N.; Nekrutenko, A.; Taylor, J. 2012: NGS analyses by visualization with Trackster. Nature Biotechnology 30(11): 1036-1039
Yu, Z.; Xie, Q.; Zhao, Y.; Duan, L.; Qiu, P.; Fan, H. 2021: NGS plus bacterial culture: a more accurate method for diagnosing forensic-related nosocomial infections. Legal Medicine 52: 101910
Romero, D. 2020: NGS reveals relevant resistance mutations. Nature Reviews. Clinical Oncology 17(4): 197
Skrzypczak-Zielinska, M.; Gabryel, M.; Marszalek, D.; Dobrowolska, A.; Slomski, R. 2021: NGS study of glucocorticoid response genes in inflammatory bowel disease patients. Archives of Medical Science: Ams 17(2): 417-433
Dylus, D.; Pillonel, T.; Opota, O.; Wüthrich, D.; Seth-Smith, H.M.B.; Egli, A.; Leo, S.; Lazarevic, V.; Schrenzel, J.; Laurent, S.; Bertelli, C.; Blanc, D.S.; Neuenschwander, S.; Ramette, A.; Falquet, L.; Imkamp, F.; Keller, P.M.; Kahles, A.; Oberhaensli, S.; Barbié, V.ér.; Dessimoz, C.; Greub, G.; Lebrand, A. 2020: NGS-Based S. aureus Typing and Outbreak Analysis in Clinical Microbiology Laboratories: Lessons Learned from a Swiss-Wide Proficiency Test. Frontiers in Microbiology 11: 591093
Li, D.; Yang, D.; Cui, S.; Pan, E.; Yang, P.; Dai, Z. 2021: NGS-Based ctDNA Profiling After the Resistance of Second-Line Osimertinib for Patient with EGFR-Mutated Pulmonary Adenocarcinoma. Oncotargets and Therapy 14: 4261-4265
Wen, B.; Jung, H.J.; Chen, L.; Saeed, F.; Knepper, M.A. 2020: NGS-Integrator: An efficient tool for combining multiple NGS data tracks using minimum Bayes' factors. Bmc Genomics 21(1): 806
Kechin, A.; Borobova, V.; Boyarskikh, U.; Khrapov, E.; Subbotin, S.; Filipenko, M. 2020: NGS-PrimerPlex: High-throughput primer design for multiplex polymerase chain reactions. Plos Computational Biology 16(12): E1008468
Ge, Z.; Bowles, K.; Goetz, K.; Scholl, H.P.N.; Wang, F.; Wang, X.; Xu, S.; Wang, K.; Wang, H.; Chen, R. 2015: NGS-based Molecular diagnosis of 105 eyeGENE(®) probands with Retinitis Pigmentosa. Scientific Reports 5: 18287
Liu, Y.; Zhou, K.; Guo, S.; Wang, Y.; Ji, X.; Yuan, Q.; Su, L.; Guo, X.; Gu, X.; Xing, J. 2021: NGS-based accurate and efficient detection of circulating cell-free mitochondrial DNA in cancer patients. Molecular Therapy. Nucleic Acids 23: 657-666
Chandrani, P.; Kulkarni, V.; Iyer, P.; Upadhyay, P.; Chaubal, R.; Das, P.; Mulherkar, R.; Singh, R.; Dutt, A. 2015: NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome. British Journal of Cancer 112(12): 1958-1965
Palumbo, F.; Scariolo, F.; Vannozzi, A.; Barcaccia, G. 2020: NGS-based barcoding with mini-COI gene target is useful for pet food market surveys aimed at mislabelling detection. Scientific Reports 10(1): 17767
Singh, K.; Bijarnia-Mahay, S.; Ramprasad, V.L.; Puri, R.D.; Nair, S.; Sharda, S.; Saxena, R.; Kohli, S.; Kulshreshtha, S.; Ganguli, I.; Gujral, K.; Verma, I.C. 2020: NGS-based expanded carrier screening for genetic disorders in North Indian population reveals unexpected results - a pilot study. Bmc Medical Genetics 21(1): 216
Re, M.; Tomasetti, M.; Monaco, F.; Amati, M.; Rubini, C.; Foschini, M.P.; Sollini, G.; Gioacchini, F.M.; Pasquini, E.; Santarelli, L. 2021: NGS-based mi RNome identifies miR-449 cluster as marker of malignant transformation of sinonasal inverted papilloma. Oral Oncology 122: 105554
Zhao, S.; Wang, W.; Wang, Y.; Han, R.; Fan, C.; Ni, P.; Guo, F.; Zeng, F.; Yang, Q.; Yang, Y.; Sun, Y.; Zhang, X.; Chen, Y.; Zhu, B.; Cai, W.; Chen, S.; Cai, R.; Guo, X.; Zhang, C.; Zhou, Y.; Huang, S.; Liu, Y.; Chen, B.; Yan, S.; Chen, Y.; Ding, H.; Shang, X.; Xu, X.; Sun, J.; Peng, Z. 2020: NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study. European Journal of Human Genetics: Ejhg 2020
Cao, Y.; Agarwal, R.; Dituri, F.; Lupo, L.; Trerotoli, P.; Mancarella, S.; Winter, P.; Giannelli, G. 2017: NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC. Cell Death and Disease 8(2): E2634
Gaia, A.Sérgio.Cruz.; de Sá, P.Henrique.Caracciolo.Gomes.; de Oliveira, Mônica.Silva.; Veras, A.Allan.de.Oliveira. 2019: NGSReadsTreatment - A Cuckoo Filter-based Tool for Removing Duplicate Reads in NGS Data. Scientific Reports 9(1): 11681
Lee, D.-J.; Kwon, T.; Kim, C.-K.; Seol, Y.-J.; Park, D.-S.; Lee, T.-H.; Ahn, B.-O. 2020: NGS_SNPAnalyzer: a desktop software supporting genome projects by identifying and visualizing sequence variations from next-generation sequencing data. Genes and Genomics 42(11): 1311-1317
Mora-Márquez, F.; Vázquez-Poletti, J.é L.; López de Heredia, U. 2021: NGScloud2: optimized bioinformatic analysis using Amazon Web Services. Peerj 9: E11237
Srivastava, K.; Doescher, A.; Wagner, F.F.; Flegel, W.A. 2020: NG_007494.1(RHD):c.[4A>T;5G>C;6_7insG] with an RhD-negative phenotype. Transfusion 60(11): E45-E47
Hutton, B. 1995: NH and MRC support for physics projects. Australasian Physical and Engineering Sciences in Medicine 18(1): 58-59
Nivetha, R.; Gothandapani, K.; Raghavan, V.; Jacob, G.; Sellapan, R.; Kannan, A.M.; Pitchaimuthu, S.; Pandiaraj, S.; Almuqrin, A.H.; Alodhayb, A.; Muthuramamoorthy, M.; Van Le, Q.; Jeong, S.K.; Grace, A.N. 2021: NH2-MIL-125(Ti) doped CdS/Graphene composite as electro and photo catalyst in basic medium under light irradiation. Environmental Research 200: 111719
Warren, C.M.; Halas, M.; Feng, H.-Z.; Wolska, B.M.; Jin, J.-P.; Solaro, R.J. 2021: NH2-Terminal Cleavage of Cardiac Troponin i Signals Adaptive Response to Cardiac Stressors. Journal of Cellular Signaling 2(3): 162-171
Gao, J.; Qin, J.; Chang, J.; Liu, H.; Wu, Z.-S.; Feng, L. 2020: NH3 Sensor Based on 2D Wormlike Polypyrrole/Graphene Heterostructures for a Self-Powered Integrated System. Acs Applied Materials and Interfaces 12(34): 38674-38681
Gessler, A.; Rienks, M.; Rennenberg, H. 2000: NH3 and NO2 fluxes between beech trees and the atmosphere - correlation with climatic and physiological parameters. New Phytologist 147(3): 539-560
Reiners, M.; Baabe, D.; Münster, K.; Zaretzke, M-Kevin.; Freytag, M.; Jones, P.G.; Coppel, Y.; Bontemps, Sébastien.; Rosal, I.Del.; Maron, L.; Walter, M.D. 2020: NH 3 formation from N 2 and H 2 mediated by molecular tri-iron complexes. Nature Chemistry 12(8): 740-746
Liu, X.; Wu, Y.; Sun, R.; Hu, S.; Qiao, Z.; Wang, S.; Mi, X. 2020: NH4+-N/NO3--N ratio controlling nitrogen transformation accompanied with NO2--N accumulation in the oxic-anoxic transition zone. Environmental Research 189: 109962
Martin, F.; Cõté, R.; Canet, D. 1994: NH4 + assimilation in the ectomycorrhizal basidiomycete Laccaria bicolor (Maire) Orton, a 15 N-NMR study. New Phytologist 128(3): 479-485
Duan, J.; Zhang, L.; Xu, G.; Chen, H.; Ding, X.; Mao, Y.; Rong, B.; Zhu, N.; Guo, K. 2020: NH4I-Triggered [4 + 2] Annulation of α,β-Unsaturated Ketoxime Acetates with N-Acetyl Enamides for the Synthesis of Pyridines. Journal of Organic Chemistry 85(12): 8157-8165
Ishizuka, T.; Sakashita, R.; Iwanaga, O.; Morimoto, T.; Mori, S.; Ishida, M.; Toganoh, M.; Takegoshi, K.; Osuka, A.; Furuta, H. 2020: NH Tautomerism of N-Confused Porphyrin: Solvent/Substituent Effects and Isomerization Mechanism. Journal of Physical Chemistry. a 124(28): 5756-5769
Spiegelberg, H.L. 1975: NH2-terminal amino acid sequence of the Fc fragment of IgD resembles IgE and IgG sequences. Nature 254(5502): 723-725
Poli, Y.; Nallamothu, V.; Hao, A.; Goud, M.Deeksha.; Wang, X.; Desiraju, S.; Mangrauthia, S.K.; Jain, A. 2021: NH787 EMS mutant of rice variety Nagina22 exhibits higher phosphate use efficiency. Scientific Reports 11(1): 9156
Williams, K.M.; Hnatiuk, O.; Mitchell, S.A.; Baird, K.; Gadalla, S.M.; Steinberg, S.M.; Shelhamer, J.; Carpenter, A.; Avila, D.; Taylor, T.; Grkovic, L.; Pulanic, D.; Comis, L.E.; Blacklock-Schuver, B.; Gress, R.E.; Pavletic, S.Z. 2014: NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT. Bone Marrow Transplantation 49(4): 561-566
Liu, L.; Guo, D.; Wang, J. 2020: NHC-Catalyzed Asymmetric α-Regioselective [4 + 2] Annulation to Construct α-Alkylidene-δ-lactones. Organic Letters 22(17): 7025-7029
Meng, D.; Xie, Y.; Peng, Q.; Wang, J. 2020: NHC-Catalyzed Enantioselective [3 + 3] Annulation to Construct 5,6-Dihydropyrimidin-4-ones. Organic Letters 22(19): 7635-7639
Chen, Y.; Dang, L.; Ho, C-Yu. 2020: NHC-Ni catalyzed enantioselective synthesis of 1,4-dienes by cross-hydroalkenylation of cyclic 1,3-dienes and heterosubstituted terminal olefins. Nature Communications 11(1): 2269
Hu, Y.; Wang, Z.; Luo, H.; Jin, H.; Liu, Y.; Zhou, B. 2021: NHC-catalyzed Truce-Smiles rearrangement of N-aryl methacrylamides for the synthesis of trans-cinnamides. Organic and Biomolecular Chemistry 19(17): 3834-3837
Yang, G.; Guo, D.; Meng, D.; Wang, J. 2019: NHC-catalyzed atropoenantioselective synthesis of axially chiral biaryl amino alcohols via a cooperative strategy. Nature Communications 10(1): 3062
Song, R.; Jin, Z.; Chi, Y.R. 2021: NHC-catalyzed covalent activation of heteroatoms for enantioselective reactions. Chemical Science 12(14): 5037-5043
Davies, A.T.; Greenhalgh, M.D.; Slawin, A.M.Z.; Smith, A.D. 2020: NHC-catalyzed enantioselective synthesis of β-trifluoromethyl-β-hydroxyamides. Beilstein Journal of Organic Chemistry 16: 1572-1578
Cheng, X.; Haeberle, S.; Shytaj, I.Luca.; Gama-Brambila, R.A.; Theobald, J.; Ghafoory, S.; Wölker, J.; Basu, U.; Schmidt, C.; Timm, A.; Taškova, K.; Bauer, A.S.; Hoheisel, Jörg.; Tsopoulidis, N.; Fackler, O.T.; Savarino, A.; Andrade-Navarro, M.A.; Ott, I.; Lusic, M.; Hadaschik, E.N.; Wölfl, S. 2020: NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice. Communications Biology 3: 10
Cheng, X.; Haeberle, S.; Luca Shytaj, I.; Gama-Brambila, R.A.; Theobald, J.; Ghafoory, S.; Wölker, J.; Basu, U.; Schmidt, C.; Timm, A.; Taškova, K.; Bauer, A.S.; Hoheisel, Jörg.; Tsopoulidis, N.; Fackler, O.T.; Savarino, A.; Andrade-Navarro, M.A.; Ott, I.; Lusic, M.; Hadaschik, E.N.; Wölfl, S. 2020: NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice. Communications Biology 3(1): 10
Han, Y.-F.; Gao, Z.-H.; Zhang, C.-L.; Ye, S. 2020: NHC/Copper-Cocatalyzed [4 + 3] Annulations of Salicylaldehydes with Aziridines for the Synthesis of 1,4-Benzoxazepinones. Organic Letters 22(21): 8396-8400
Riedlberger, F.; Todisco, S.; Mastrorilli, P.; Timoshkin, A.Y.; Seidl, M.; Scheer, M. 2020: NHCs as Neutral Donors towards Polyphosphorus Complexes. Chemistry 26(69): 16251-16255
Lewis, T.R.; Smith, J.; Griffin, K.; Aguiar, S.; Rueb, K.F.; Holmberg-Douglas, N.; Sampson, E.M.; Tomasetti, S.; Rodriguez, S.; Stachura, D.L.; Arpin, C.C. 2020: NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation. Plos one 15(8): E0236839
Sun, Z.; Luan, S.; Yao, Y.; Qin, T.; Xu, X.; Shen, Z.; Yao, R.; Yue, L. 2020: NHE1 Mediates 5-Fu Resistance in Gastric Cancer via STAT3 Signaling Pathway. Oncotargets and Therapy 13: 8521-8532
Xia, C-hong.; Liu, H.; Cheung, D.; Tang, F.; Chang, B.; Li, M.; Gong, X. 2015: NHE8 is essential for RPE cell polarity and photoreceptor survival. Scientific Reports 5: 9358
Lieber, M.R. 2010: NHEJ and its backup pathways in chromosomal translocations. Nature Structural and Molecular Biology 17(4): 393-395
Ray, U.; Vartak, S.V.; Raghavan, S.C. 2020: NHEJ inhibitor SCR7 and its different forms: Promising CRISPR tools for genome engineering. Gene 763: 144997
Dai, J.Le.; Wang, L.; Sahin, A.A.; Broemeling, L.D.; Schutte, M.; Pan, Y. 2004: NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 23(53): 8681-8687
Castellani, S.; Guerra, L.; Favia, M.; Di Gioia, S.; Casavola, V.; Conese, M. 2012: NHERF1 and CFTR restore tight junction organisation and function in cystic fibrosis airway epithelial cells: role of ezrin and the RhoA/ROCK pathway. Laboratory Investigation; a Journal of Technical Methods and Pathology 92(11): 1527-1540
Wang, Q.; Qin, Q.; Song, R.; Zhao, C.; Liu, H.; Yang, Y.; Gu, S.; Zhou, D.; He, J. 2018: NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression. Cell Death and Disease 9(6): 668
Morales, F.C.; Hayashi, Y.; van Pelt, C.S.; Georgescu, M-M. 2012: NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor. Cell Death and Disease 3: E391
Tiron, C.Elena.; Luta, G.; Butura, M.; Zugun-Eloae, F.; Stan, C.S.; Coroaba, A.; Ursu, E-Laura.; Stanciu, G.Dumitrita.; Tiron, A. 2020: NHF-derived carbon dots: prevalidation approach in breast cancer treatment. Scientific Reports 10(1): 12662
Vujin, A.; Jones, S.J.; Zetka, M. 2020: NHJ-1 Is Required for Canonical Nonhomologous End Joining in Caenorhabditis elegans. Genetics 215(3): 635-651
Raghunandan, M.; Geelen, D.; Majerova, E.; Decottignies, A. 2021: NHP2 downregulation counteracts hTR-mediated activation of the DNA damage response at ALT telomeres. EMBO Journal 40(6): E106336
Hackanson, B.; Abdelkarim, M.; Jansen, J.H.; Lübbert, M. 2010: NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells. Leukemia 24(4): 860-861
Lamb, D.; Greenberg, N.; Hotopf, M.; Raine, R.; Razavi, R.; Bhundia, R.; Scott, H.; Carr, E.; Gafoor, R.; Bakolis, I.; Hegarty, S.; Souliou, E.; Rafferty, A.M.; Rhead, R.; Weston, D.; Gnangapragasam, S.; Marlow, S.; Wessely, S.; Stevelink, S. 2021: NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers. Bmj Open 11(6): E051687
Pitts, N.B. 2003: NHS Dentistry: Options for Change in context--a personal overview of a landmark document and what it could mean for the future of dental services. British Dental Journal 195(11): 631-635
Murray, J.J. 2003: NHS Dentistry: Options for Change. Impressions one year on. British Dental Journal 195(11): 627-629
Mahase, E. 2021: NHS England agrees deal for gene therapy for spinal muscular atrophy. Bmj 372: N653
Agarwal, R. 2021: NHS England should release trust level data from the Medical Workforce Race Equality Standard. Bmj 374: N2181
Rimmer, A. 2020: NHS England workforce plan fails to tackle staff shortages, say health leaders. Bmj 370: M3057
Mahase, E. 2020: NHS England's media briefings caused rise in complaints against GPs, say doctors. Bmj 371: M4684
Rasoul, H.; Fyyaz, S.; Noakes, D.; Shakespeare, C.; David, S.; Khawaja, Z.M.; Papamichail, N.; Alfakih, K. 2021: NHS England-funded CT fractional flow reserve in the era of the ISCHEMIA trial. Clinical Medicine 21(2): 90-95
Morgan, F. 2010: NHS Evidence - oral health. Evidence-BasedDentistry 11(2): 59
McGrady, M.G.; Pickford, J.; Hawthorn, E.; Waterall, J.; Bridgman, C. 2015: NHS Health Checks in a primary care dental setting - an opportunity for the profession to maximise uptake for public health partners?. British Dental Journal 219(3): 107-109
Robson, J.; Garriga, C.; Coupland, C.; Hippisley-Cox, J. 2021: NHS Health Checks: Equity and outcomes 2009-17: An observational study. British Journal of General Practice: the Journal of the Royal College of General Practitioners 2021
Torjesen, I. 2021: NHS Test and Trace: lack of progress is "deeply disappointing". Bmj 373: N1636
Patel, S. 2021: NHS Volunteer Responders Scheme. British Dental Journal 230(5): 271
Dyer, C. 2021: NHS agrees to pay £13m for boy who was left brain damaged from lack of nutrition after birth. Bmj 372: N371
Torjesen, I. 2020: NHS aims to become world's first "net zero" health service by 2040. Bmj 371: M3856
Mahase, E. 2021: NHS and social care need an extra £12bn to get back on track after pandemic, says think tank. Bmj 372: N721
Christie, B. 2020: NHS and social care staff in Scotland get bonus for work during pandemic. Bmj 371: M4700
Old, R.; Pharoah, P.; Wald, N. 2021: NHS announces a pilot of a blood test for early detection of many cancers. Journal of Medical Screening 28(1): 1-2
Wise, J. 2021: NHS backlog: Realism is needed about how far £8.1bn will stretch, say health leaders. Bmj 372: N836
Dyer, C. 2000: NHS bill for negligence set to soar again. Bmj 320(7239): 891
Martin, P.M. 2021: NHS blood tube shortage reminds us of our waste. Bmj 375: N2401
Iacobucci, G. 2020: NHS blood unit is "systemically racist" and "psychologically unsafe," investigation finds. Bmj 369: M2308
Richards, D. 2009: NHS clinical knowledge summaries. Evidence-Based Dentistry 10(4): 118-119
Harris, J.C.; Bradbury, J.; Porritt, J.; Nilchian, F.; Franklin, C.D. 2011: NHS dental professionals' evaluation of a child protection learning resource. British Dental Journal 210(2): 75-79
McKenzie, K.W.; Goodwin, M.; Pretty, I. 2017: NHS dental service utilisation and social deprivation in older adults in North West England. British Dental Journal 223(2): 102-107
Sanderson, S. 2010: NHS dentistry and our new government. British Dental Journal 208(9): 377
Lynn, A. 1995: NHS dentistry--the road to a better future. British Dental Journal 179(5): 183-187
Gibson, A. 1995: NHS dentistry--the road to a better future. British Dental Journal 179(10): 370; Author Reply 371
Glickman, M. 2017: NHS dentistry: A lack of help. British Dental Journal 222(7): 496
Cabral, M. 2018: NHS dentistry: Culture of fear. British Dental Journal 224(6): 392-393
Gill, A. 2018: NHS dentistry: Historically weak. British Dental Journal 224(3): 122
MacKessack-Leitch, E.C. 2017: NHS dentistry: Improving our public standing. British Dental Journal 223(6): 389-390
Power, A.; Bowden, E.; Adams, A.; Carter, L. 2017: NHS dentistry: Slow the troubling trend. British Dental Journal 223(5): 308
Shuttleworth, J.; Smith, W. 2016: NHS dentistry: The social media challenge. British Dental Journal 220(4): 153
Rossi, M. 2016: NHS dentistry: UDA disaster. British Dental Journal 221(6): 279
Elworthy née Wilks, S. 2014: NHS dentistry: a serious shift. British Dental Journal 216(2): 48-49
Olabi, Y.; Campbell, S.; Greenhill, B.; Morgan, A. 2021: NHS frontline staff experiences of an in-house psychological support service during the COVID-19 pandemic. Psychology Health and Medicine 2021: 1-8
Mahase, E. 2021: NHS funding: £5.4bn boost must be first of many, say health leaders. Bmj 374: N2204
Owen, C.; Seddon, C.; Clarke, K.; Bysouth, T. 2019: NHS general dentistry in Wales: evaluation of patient access and budget expenditure. British Dental Journal 226(12): 967-978
O'Dowd, A. 2020: NHS health checks should start at age 25 for BAME patients, MPs hear. Bmj 369: M2462
Dyer, C. 2021: NHS ignored women's safety concerns for too long, says former prime minister. Bmj 374: N1759
Wilkinson, E. 2021: NHS in England on track to hit first year carbon reduction target. Bmj 375: N2466
Kmietowicz, Z. 2020: NHS launches Race and Health Observatory after BMJ's call to end inequalities. Bmj 369: M2191
Aldhous, P. 1991: NHS launches first strategy. Nature 351(6321): 7
Burns, R.W. 2020: NHS limits: we're heading for a two tier system. Bmj 371: M4315
Diaper, C. 2021: NHS needs more capacity to tackle surgery backlog. Bmj 372: N696
Mahase, E. 2020: NHS offers lung volume reduction procedures for severe emphysema. Bmj 371: M4308
Mundell, I. 1992: NHS opens meta-analysis centre. Nature 359(6397): 660
Edlin, P.A. 1996: NHS or private--a balanced choice. BritishDentalJournal 181(11-12): 398
Birch, S. 1985: NHS patient charges and the privatisation of dental care. British Dental Journal 159(11): 377-378
Rimmer, A. 2021: NHS pensions: what do changes to the lifetime allowance mean?. Bmj 372: N660
Dixon, M.; Derwent, S.K. 2001: NHS plan--proposal for new approach. British Dental Journal 191(1): 2
Murray, R. 2021: NHS reforms: politicians will be back in the driving seat. Bmj 372: N481
Alderwick, H. 2020: NHS reorganisation after the pandemic. Bmj 371: M4468
Mahase, E. 2021: NHS reorganisation must not be rushed through during pandemic, leaders warn. Bmj 372: N431
Iacobucci, G. 2020: NHS should vary price it pays for cancer drugs to improve access, say experts. Bmj 371: M4322
Appleby, J. 2021: NHS sickness absence during the covid-19 pandemic. Bmj 372: N471
Mahase, E. 2021: NHS staff face growing tide of abuse from patients frustrated by long waits for care. Bmj 375: N2495
Ike, I.D.; Durand-Hill, M.; Elmusharaf, E.; Asemota, N.; Silva, E.; White, E.; Awad, W.I. 2021: NHS staff mental health status in the active phase of the COVID-19 era: a staff survey in a large London hospital. General Psychiatry 34(2): E100368
O'Dowd, A. 2021: NHS staff's stress levels rose last year as covid pandemic took its toll. Bmj 372: N703
Iacobucci, G. 2021: NHS to trial "artificial pancreas" for patients with type 1 diabetes. Bmj 373: N1538
Dyer, C. 2020: NHS trust was negligent in failing to recognise child's serious bacterial infection, says High Court. Bmj 369: M2527
Foster, S. 2021: NHS trusts must continue to tackle racism. British Journal of Nursing 30(15): 941
Manning, V.; Pattani, S. 2021: NHS workplace health and wellbeing during COVID-19. Perspectives in Public Health 141(1): 9-10
Iacobucci, G. 2020: NHS's plan to abolish CCGs must not dilute primary care's influence, say leaders. Bmj 371: M4730
Greiner, J.W.; Morillon, Y.M.; Schlom, J. 2021: NHS-IL12, a Tumor-Targeting Immunocytokine. Immunotargets and Therapy 10: 155-169
Anwar, A. 2020: NHS-funded implants: are they as common as they seem?. British Dental Journal 228(3): 160
Richards, W. 2005: NHS:private ratio. British Dental Journal 199(11): 694
Li, W.; Chen, J.; Chen, P.; Yu, L.; Cui, X.; Li, Y.; Cheng, F.; Ouyang, W. 2021: NIA-Network: Towards improving lung CT infection detection for COVID-19 diagnosis. Artificial Intelligence in Medicine 117: 102082
Kagan, J.; Goodman, G.N.; Oh, R.; Whitworth, D.; Gladden, D.; Graves, G.; Nguyen, A.; Shrestha, O.; Burge, G.; Smolskis, M.; Andrews, J.; Cramer, B.; Lane, H.C. 2021: NIAID ClinRegs-a Public Database of Country Clinical Research Regulatory and Ethics Requirements: Design and Utilization Analysis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 73(7): 1296-1301
Watanabe, M.E. 2000: NIAID funds new groups to develop HIV vaccines. Nature Medicine 6(8): 844
Novak, K. 1999: NIAID to begin clinical transplant tolerance trials. Nature Medicine 5(5): 470-471
Zeituni, E.M.; Raterman, E.L. 2020: NIAID's Comprehensive Support Mechanisms for Antibiotic Development. Acs Infectious Diseases 6(6): 1299-1301
White, V.M.; Molfenter, T.; Gustafson, D.H.; Horst, J.; Greller, R.; Gustafson, D.H.; Kim, J.-S.; Preuss, E.; Cody, O.; Pisitthakarm, P.; Toy, A. 2020: NIATx-Ti versus typical product training on e-health technology implementation: a clustered randomized controlled trial study protocol. Implementation Science: Is 15(1): 94
Raggam, P.; Bauernfeind, G.ün.; Wriessnegger, S.C. 2020: NICA: a Novel Toolbox for Near-Infrared Spectroscopy Calculations and Analyses. Frontiers in Neuroinformatics 14: 26
Wise, J. 2021: NICE approves monoclonal antibody dupilumab for severe asthma. Bmj 375: N2546
Wise, J. 2021: NICE approves new cholesterol lowering drug after NHS strikes deal with manufacturer. Bmj 374: N2143
Hughes, M.; Prescott, C.; Elliott, N.; Adler, A.I. 2021: NICE guidance on caplacizumab for treating acute acquired thrombotic thrombocytopenia purpura. LANCET. Haematology 8(1): E14-E15
Adler, A.I. 2017: NICE guidance on eluxadoline for treating irritable bowel syndrome with diarrhoea. LANCET. Gastroenterology and Hepatology 2(11): 779-780
Byrne, P.; Demasi, M.; Smith, S.M. 2021: NICE guidance on inclisiran should be reconsidered. Bmj 375: N2462
Adler, A.I.; Sutcliffe, F. 2017: NICE guidance on sorafenib for treating advanced hepatocellular carcinoma. LANCET. Gastroenterology and Hepatology 2(11): 781-782
Farook, S.A.; Davis, A.K.J.; Khawaja, N.; Sheikh, A.M. 2012: NICE guideline and current practice of antibiotic prophylaxis for high risk cardiac patients (HRCP) among dental trainers and trainees in the United Kingdom (UK). British Dental Journal 213(4): E6
Ní Ríordáin, R.; McCreary, C. 2009: NICE guideline on antibiotic prophylaxis against infective endocarditis: attitudes to the guideline and implications for dental practice in Ireland. British Dental Journal 206(6): E11; Discussion 320-1
Sivan, M.; Taylor, S. 2020: NICE guideline on long covid. Bmj 371: M4938
Mansoor, J.; Jowett, A.; Coulthard, P. 2013: NICE or not so NICE?. British Dental Journal 215(5): 209-212
Mayor, S. 2016: NICE proposes faster process to appraise cheaper drugs. Bmj 355(7): I5592
Wise, J. 2021: NICE recommends inducing pregnant women one week earlier. Bmj 373: N1358
Mahase, E. 2021: NICE recommends new CAR-T treatment for lymphoma for some patients on NHS. Bmj 372: N184
Mahase, E. 2020: NICE reconsiders esketamine for depression. Bmj 370: M3479
Dolan, P. 2009: NICE should value real experiences over hypothetical opinions. Nature 462(7269): 35
Brada, M. 2002: NICE verdict on Temozolomide: where next?. British Journal of Cancer 86(4): 499-500
Greaves, F.; Boysen, M. 2021: NICE's approach to measuring value. Bmj 372: N7
Gupta, S.; Kamat, A.M. 2020: NICE's rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?. Nature Reviews. Urology 17(9): 491-492
Du, L.; Wu, Y.; Han, X.; Wang, C.; Li, A.; Huang, G. 2021: NICE-3-knockdown induces cell cycle arrest and autophagy in lung adenocarcinoma cells via the AKT/mTORC1 signaling pathway. Experimental and Therapeutic Medicine 21(6): 625
Low, E. 2007: NICE: friend and foe. Nature Clinical Practice. Oncology 4(3): 135
Rai, L.C.; Raizada, M. 1986: Nickel induced Stimulation of Growth, Heterocyst Differentiation, 14 Co2 Uptake and Nitrogenase Activity in Nostoc Muscorum. New Phytologist 104(1): 111-114
O'Dell, L.E. 2011: NICO-TEEN: neural substrates that mediate adolescent tobacco abuse. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 36(1): 356-357
Sunderland, D.W.; Merrett, M.J. 1963: Nicotinamide Adenine Dinucleotide and Nicotinamide Adenine Dinucleotide Phosphate Concentrations in Leaves of Nicotiana Glutinosa Infected by Tobacco Mosaic Virus. Nature 200: 921
Sunderland, D.W.; Merrett, M.J. 1963: Nicotinamide-Adenine Dinucleotides, Adenosine Diphosphate and Adenosine Triphosphate Content of Tissues Infected by Tobacco Mosaic Virus. Nature 199: 1116-1117
Marana, J. 2020: NICU Collaboration During the COVID-19 Worldwide Pandemic: a Memory of Gratitude. Advances in Neonatal Care: Official Journal of the National Association of Neonatal Nurses 20(6): 424-425
Winans, M. 2020: NICU Disaster Preparedness:: Were we Ready for COVID-19?. Nurse Leader 18(6): 561-564
LeDuff, L.D.; Carter, B.M.; Cunningham, C.A.; Braun, L.A.; Gallaher, K.J. 2021: NICU Fathers: Improving the Quality of Paternal Support in the NICU. Advances in Neonatal Care: Official Journal of the National Association of Neonatal Nurses 21(5): 387-398
Provenzi, L.; Olson, K.; Giusti, L.; Montirosso, R.; DeSantis, A.; Tronick, E. 2018: NICU Network Neurobehavioral Scale: 1-month normative data and variation from birth to 1 month. Pediatric Research 83(6): 1104-1109
Buek, K.W.; Cortez, D.; Mandell, D.J. 2021: NICU and postpartum nurse perspectives on involving fathers in newborn care: a qualitative study. Bmc Nursing 20(1): 35
Purdy, I.B.; Craig, J.W.; Zeanah, P. 2015: NICU discharge planning and beyond: recommendations for parent psychosocial support. Journal of Perinatology: Official Journal of the California Perinatal Association 35 Suppl. 1: S24-S28
Catlin, A. 2014: NICU handoff lacks completion. Journal of Perinatology: Official Journal of the California Perinatal Association 34(8): 650
Catlin, A. 2014: NICU handoff lacks completion. Journal of Perinatology 34(8): 650
Johnson, T.J.; Patra, K.; Greene, M.M.; Hamilton, M.; Dabrowski, E.; Meier, P.P.; Patel, A.L. 2019: NICU human milk dose and health care use after NICU discharge in very low birth weight infants. Journal of Perinatology: Official Journal of the California Perinatal Association 39(1): 120-128
Grunberg, V.A.; Geller, P.A.; Bonacquisti, A.; Patterson, C.A. 2019: NICU infant health severity and family outcomes: a systematic review of assessments and findings in psychosocial research. Journal of Perinatology: Official Journal of the California Perinatal Association 39(2): 156-172
Dweck, N.; Augustine, M.; Pandya, D.; Valdes-Greene, R.; Visintainer, P.; Brumberg, H.L. 2008: NICU lactation consultant increases percentage of outborn versus inborn babies receiving human milk. Journal of Perinatology: Official Journal of the California Perinatal Association 28(2): 136-140
McAndrew, S.; Acharya, K.; Nghiem-Rao, T.Hang.; Leuthner, S.; Clark, R.; Lagatta, J. 2018: NICU management and outcomes of infants with trisomy 21 without major anomalies. Journal of Perinatology: Official Journal of the California Perinatal Association 38(8): 1068-1073
Stavroudis, T.A.; Shore, A.D.; Morlock, L.; Hicks, R.W.; Bundy, D.; Miller, M.R. 2010: NICU medication errors: identifying a risk profile for medication errors in the neonatal intensive care unit. Journal of Perinatology: Official Journal of the California Perinatal Association 30(7): 459-468
Cheldelin, L.V.; Dunham, S.; Stewart, V. 2013: NICU patient satisfaction: how you measure counts. Journal of Perinatology: Official Journal of the California Perinatal Association 33(4): 324-326
Swanson, J.R.; Peters, C.; Lee, B.H. 2013: NICU redesign from open ward to private room: a longitudinal study of parent and staff perceptions. Journal of Perinatology: Official Journal of the California Perinatal Association 33(6): 466-469
Sharp, M.; Huber, N.; Ward, L.G.; Dolbier, C. 2021: NICU-Specific Stress Following Traumatic Childbirth and its Relationship with Posttraumatic Stress. Journal of Perinatal and Neonatal Nursing 35(1): 57-67
Kreek, M.Jeanne.; Jones, R.; Kleber, H.D.; Kosten, T.; O'Brien, C. 2004: NIDA's commitment to tackling drug abuse. Nature 430(7003): 965
Rasmussen, K.; White, D.A.; Acri, J.B. 2019: NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 44(4): 657-659
Als, H.; Duffy, F.H.; McAnulty, G.; Butler, S.C.; Lightbody, L.; Kosta, S.; Weisenfeld, N.I.; Robertson, R.; Parad, R.B.; Ringer, S.A.; Blickman, J.G.; Zurakowski, D.; Warfield, S.K. 2012: NIDCAP improves brain function and structure in preterm infants with severe intrauterine growth restriction. Journal of Perinatology: Official Journal of the California Perinatal Association 32(10): 797-803
Ueda, Y.; Nosaki, S.; Sakuraba, Y.; Miyakawa, T.; Kiba, T.; Tanokura, M.; Yanagisawa, S. 2020: NIGT1 family proteins exhibit dual mode DNA recognition to regulate nutrient response-associated genes in Arabidopsis. Plos Genetics 16(11): E1009197
Dove, A. 2000: NIH 'glues' cell biologists together. Nature Medicine 6(10): 1072
Check, E. 2003: NIH 'roadmap' charts course to tackle big research issues. Nature 425(6957): 438
Wadman, M. 1998: NIH 'should help sharing of research tools'. Nature 393(6685): 505
Gee, H. 1994: NIH 'should rethink pricing clause'. Nature 372(6506): 488
Wadhwa, R.; Takano, S.; Mitsui, Y.; Kaul, S.C. 1999: NIH 3T3 cells malignantly transformed by mot-2 show inactivation and cytoplasmic sequestration of the p53 protein. Cell Research 9(4): 261-269
Irving, B.A.; Weltman, J.Y.; Brock, D.W.; Davis, C.K.; Gaesser, G.A.; Weltman, A. 2007: NIH ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue. Obesity 15(2): 370-376
Rubin, R. 2020: NIH Launches Platform to Serve as Depository for COVID-19 Medical Data. JAMA 324(4): 326
Riley, W.T.; Riddle, M.; Lauer, M. 2018: NIH Policies on Experimental Studies with Humans. Nature Human Behaviour 2(2): 103-106
Rogers, M.; Lyster, P.; Okita, R. 2013: NIH Support for the Emergence of Quantitative and Systems Pharmacology. Cpt: Pharmacometrics and Systems Pharmacology 2: E37
Meissner, H.I.; Sharma, K.; Mandal, R.J.; Garcia-Cazarin, M.; Wanke, K.L.; Moyer, J.; Liggins, C. 2022: NIH Tobacco Research and the Emergence of Tobacco Regulatory Science. Nicotine and Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco 24(4): 463-468
Distefano, R.; Fiat, A.E.; Merrick, J.S.; Slotkin, J.; Zelazo, P.David.; Carlson, S.M.; Masten, A.S. 2021: NIH Toolbox executive function measures with developmental extensions: Reliability and validity with preschoolers in emergency housing. Child Neuropsychology: a Journal on Normal and Abnormal Development in Childhood and Adolescence 2021: 1-9
Dolgin, E. 2012: NIH accused of being overly literal on stem cell approvals. Nature Medicine 18(3): 325
Check, E. 2004: NIH acts to quench 'conflict of interest' allegations. Nature 427(6973): 385
Macilwain, C. 1993: NIH acts to reduce discrimination. Nature 366(6455): 495
Anderson, C. 1992: NIH aims at 'glass ceiling'. Nature 356(6364): 6
Raven, K. 2012: NIH aims to facilitate extramural research through new grants. Nature Medicine 18(9): 1309
Macilwain, C. 1997: NIH and genome project set for more funds. Nature 388(6640): 316
Shalev, M. 2005: NIH announces final rules on ethics. Lab Animal 34(9): 17
Birmingham, K. 2000: NIH announces plans for 2001 budget. Nature Medicine 6(3): 239
Kaiser, J. 2021: NIH apologizes for 'structural racism,' pledges change. Science 371(6533): 977
Macilwain, C. 1995: NIH backers pledge last-ditch stand. Nature 375(6529): 267
Wadman, M. 1997: NIH backers take Clinton to task over impact of budget pact. Nature 387(6635): 745
Norman, C.et. 1974: NIH backing for NAS ban. Nature 250(5464): 278-280
Novak 1999: NIH backs large transplant tolerance project. Nature Medicine 5(11): 1222
Culliton, B.J. 1994: NIH baffled by drop in applications. Nature 370(6485): 87
Wadman, M. 1998: NIH basks in broad support. Nature 391(6667): 522
Wadman, M. 1999: NIH budget prospect bright despite political stalemate. Nature 400(6743): 391
Anderson, C. 1992: NIH cDNA patent rejected; backers want to amend law. Nature 359(6393): 263
Mirin, A.A. 2020: NIH can no longer turn its back on Chronic Fatigue Syndrome. Work 66(2): 365-366
Smaglik, P. 2000: NIH cancer researchers to get free access to 'OncoMouse'. Nature 403(6768): 350
Dalton, R. 2000: NIH cash tied to compulsory training in good behaviour. Nature 408(6813): 629
Wadman, M. 2011: NIH centre faces spell in limbo. Nature 477(7363): 141-142
Shalev, M. 2002: NIH changes rules governing timing of protocol reviews; Funds chimpanzee sanctuary. Lab Animal 31(10): 17
Pippin, J. 2012: NIH chimps: Texas lab is not a sanctuary. Nature 491(7426): 672
Capaldo, T. 2012: NIH chimps: don't sell sanctuary short. Nature 491(7426): 672
VandeBerg, J.L. 2012: NIH chimps: use existing facilities. Nature 491(7426): 672
Wadman, M. 1996: NIH clinical research plans under fire from Republicans. Nature 380(6572): 277
Smith, C. 2002: NIH commercializes new imaging technique. Nature Medicine 8(9): 906
Korn, D.; Ehringhaus, S.H. 2005: NIH conflicts rules are not right for universities. Nature 434(7035): 821
Barinaga, M. 1988: NIH cuts bring in hard times for biomedical researchers. Nature 336(6198): 414
Williams, D.A. 2007: NIH decides against continuing NGVLs in their current form. Molecular Therapy: the Journal of the American Society of Gene Therapy 15(7): 1223